SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
x
6:45 AM - 6:50 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
CORONARY STENTS
6:50 AM - 6:55 AM What Is New In Coronary Artery Stenting: How Good Are New Drug Eluting Stents: Is There A Role For Bare Metal Stents
  Presenter(s):Martin B. Leon, MD  
6:56 AM - 7:01 AM The EXCEL Trial At 5 Years: Take Home Messages
  Presenter(s):Gregg W. Stone, MD  
TRANSCATHETER HEART VALVES
7:02 AM - 7:07 AM Update On Status Of Transcatheter Mitral Valve Repair (TMVR)
  Presenter(s):Juan F. Granada, MD  
7:08 AM - 7:13 AM DEBATE: Update On Transcatheter Aortic Valve Replacement (TAVR): A Cardiologist’s View
  Presenter(s):Martin B. Leon, MD  
7:14 AM - 7:19 AM DEBATE: Update On Current State Of TAVR: A Cardiac Surgeon’s View: What Is The Role Of Surgery In Aortic Valve Disease Treatment
  Presenter(s):Ali Khoynezhad, MD, PhD  
THE ASCENDING AORTA
7:20 AM - 7:25 AM Progress In Endovascular Graft Treatment Of Ascending Aortic Lesions
  Presenter(s):Rodney A. White, MD  
7:26 AM - 7:31 AM Progress In Endovascular Combined Devices For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept
  Presenter(s):Ali Khoynezhad, MD, PhD  
7:32 AM - 7:37 AM Update On Endovascular Treatment Of Ascending Aortic Lesions: What Is Here And What Is On The Horizon
  Presenter(s):Christoph A. Nienaber, MD, PhD  
7:38 AM - 7:43 AM Endovascular Treatment Of Type A Aortic Dissections (TAADs): What Is Here And What Is Coming
  Presenter(s):Ali Azizzadeh, MD  
7:44 AM - 7:50 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
x
7:50 AM - 7:55 AM Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results
  Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD  
7:56 AM - 8:01 AM Complete Aortic Arch Replacement With Elephant Trunk Or FET Is Rarely The End Of The Story With Aortic Dissections: What To Do About It
  Presenter(s):Götz M. Richter, MD, PhD  
8:02 AM - 8:07 AM Endovascular Arch Repair With Cook 2- Or 3-Branched Device For Lesions Involving The Entire Aortic Arch: Indications, Contraindications And Results
  Presenter(s):Stephan Haulon, MD  
8:08 AM - 8:13 AM Comparison Of Early And Midterm Results With 2-Branched Endograft (Relay – Terumo Aortic) And Single Branched Device (Nexus – Endospan) For Treatment Of Zone 0 Arch Lesions
  Presenter(s):Toru Kuratani, MD, PhD  
8:14 AM - 8:19 AM Update On RelayBranch Double Branched Device (Terumo Aortic) For Arch Lesion Endograft Repairs: Advantages, Limitations And Results
  Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD  
8:20 AM - 8:25 AM Direction-Turnover Technique For Endovascular Repair Of Aortic Arch Lesions With Branched Or In Vitro Fenestrated Endografts
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
8:26 AM - 8:31 AM Total And Partial Aortic Arch Lesion Repairs With the Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations
  Presenter(s):Michael D. Dake, MD  
8:32 AM - 8:37 AM How Best To Treat TBADs Extending Into The Arch Or Ascending Aorta; When Open, When Endo, When Hybrid
  Presenter(s):I-Hui Wu, MD, PhD  
8:38 AM - 8:43 AM How To Prevent Complications During Partial Or Total Endovascular Aortic Arch Repairs
  Presenter(s):Chang Shu, MD  
8:44 AM - 8:49 AM How Best To Treat Aortic Arch Lesions: Customized Versus Chimney Versus Physician Modified Endografts: When Open: Role Of Each
  Presenter(s):Nicola Mangialardi, MD  
8:50 AM - 8:55 AM Value Of Ascending Aortic Banding As Primary Or Adjunctive Treatment For Aortic Arch Lesions
  Presenter(s):Chun Che Shih, MD, PhD  
8:56 AM - 9:02 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILIZE, AND MORE
x
9:02 AM - 9:07 AM New SVS-STS Aortic Dissection Reporting Standards And Classification System: How Are They Different And Better
  Presenter(s):Joseph V. Lombardi, MD  
9:08 AM - 9:13 AM The TEM Aortic Dissection Classification System: What Is It And How Does It Improve Clinical Practice
  Presenter(s):Martin Czerny, MD  
9:14 AM - 9:19 AM Current Advances And Trends In TEVAR Treatment For Type B Aortic Dissection In China: More Or Less Liberal Use; More Or Less Aortic Coverage; What Adjunctive Procedures Are Used More
  Presenter(s):Weiguo Fu, MD  
9:20 AM - 9:25 AM Update On The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: How It Works, Precautions And Results
  Presenter(s):Jean-Marc Alsac, MD, PhD  
9:26 AM - 9:31 AM Experience With The STABILISE Technique For Acute And Subacute TBADs: Indications, Technical Tips, Precautions And Results
  Presenter(s):Andrea Kahlberg, MD / Germano Melissano, MD / Roberto Chiesa, MD  
9:32 AM - 9:37 AM Duel Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: Indications, Technique And Results
  Presenter(s):Christoph A. Nienaber, MD, PhD  
9:38 AM - 9:43 AM DEBATE: Fenestrated And Branched Endovascular Grafts (F/B/EVAR) Are Usually The Best Treatment For Post-Dissection Thoraco-Abdominal Aneurysms (TAAAs)
  Presenter(s):Gustavo S. Oderich, MD, FACS  
9:44 AM - 9:49 AM DEBATE: There Will Always Be A Need For Open Repair For Post-Dissection TAAAs: In What Circumstances
  Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD  
9:50 AM - 9:55 AM Distal Stent-Graft Induced New Re-Entry Tears (SINEs) With TEVAR Treatment Of TBADs: Prevention By Avoiding Oversizing And Ballooning And Using Tapered Endografts
  Presenter(s):Ludovic Canaud, MD, PhD  
9:56 AM - 10:01 AM The Impact Of Distal Stent-Graft Induced New Entry Tears On Aortic Remodeling Of Chronic TBADs: How To Prevent And Treat Them
  Presenter(s):Chun Che Shih, MD, PhD  
10:02 AM - 10:07 AM When Is TEVAR The Best Treatment For Marfan Syndrome And Its Complications
  Presenter(s):James H. Black, III, MD  
10:08 AM - 10:14 AM Panel Discussion
10:14 AM - 10:24 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
x
10:24 AM - 10:29 AM Long-Term Durability Of Open Repair Of Type I-IV TAAAs Remains Excellent: When Should It Be The First Line Treatment And When Should A Hybrid (Endo + Open) Down-Staging Approach Be Used To Improve Outcomes: How To Do The Latter
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
10:30 AM - 10:35 AM New Strategies And Indications For Open TAAA Repair Including Failed EVAR And F/B/EVAR: Technical Tips And Results
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD  
10:36 AM - 10:41 AM Aortic Arch Repairs With Frozen Elephant Trunk (FET) Followed By Open Or Endo Extensions For TAAA Repairs: Techniques And Outcomes; Importance Of Staging
  Presenter(s):Michael J. Jacobs, MD  
10:42 AM - 10:47 AM Lessons Learned From The STABLE I And II Trials: What Are The Advantages And Limitations Of A Distal Bare Stent Combined With A Proximal Covered Stent
  Presenter(s):Joseph V. Lombardi, MD  
10:48 AM - 10:53 AM Changing Current Trends In Management And Outcomes With Acute TBADs: Based On 3000 Patients In The IRAD Registry: What Is Helping And What Is Not
  Presenter(s):Santi Trimarchi, MD, PhD  
10:54 AM - 10:59 AM Why Is F/B/EVAR The Best Treatment For Post TBAD TAAAs: Challenges And Results
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
11:00 AM - 11:05 AM Roles Of Inner And Outer Branched Endografts And The t-Branched OTS Device (Cook) To Treat TAAAs After TBADs: Technical Tips And Results
  Presenter(s):Marcelo Ferreira, MD  
11:06 AM - 11:12 AM Panel Discussion
11:12 AM - 11:17 AM Gore TAMBE Endovascular Graft Device For TAAA Repair: How Does It Work: Results To Date, Advantages And Limitations
  Presenter(s):Mark A. Farber, MD  
11:18 AM - 11:23 AM How To Predict TAAA Patients Who Should Not Have An Endovascular Repair And How To Minimize Mortality: Age And Mural Thrombus Matter
  Presenter(s):Patrick W. Kelly, MD  
11:24 AM - 11:29 AM How To Treat Dynamic Branch Occlusion And Malperfusion With TBADs If Blood Pressure Control And TEVAR Coverage Of The Primary Tear Does Not Work: A Step Wise Plan
  Presenter(s):Firas F. Mussa, MD  
11:30 AM - 11:35 AM Improved Aortic Remodeling With TEVAR And A Distal Bare Metal Stent In Acute Complicated TBAD
  Presenter(s):Christoph A. Nienaber, MD, PhD  
11:36 AM - 11:41 AM Embolization Strategies To Achieve False Lumen Thrombosis With False Lumen TAAAs After TEVAR For TBADs
  Presenter(s):Carlos H. Timaran, MD  
11:41 AM - 11:47 AM Varying Solutions To Treat Type 1 Endoleaks After TEVAR And EVAR
  Presenter(s):Nicola Mangialardi, MD  
11:48 AM - 11:53 AM High Failure Rate Of Best Medical Treatment For Intramural Hematoma Mandates Increased Use Of TEVAR: Does This Help Outcomes
  Presenter(s):Jean M. Panneton, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING) (5 AND 4 3/4-MINUTE [SS] TALKS)
x
1:00 PM - 1:05 PM Current Pros And Cons Of The Nellix EVAS Endograft For AAA Repair: First Update Of The EVAS2 IDE Trial Of The Modified Improved Nellix Endograft
  Presenter(s):Jeffrey P. Carpenter, MD  
1:06 PM - 1:11 PM Update On The Nellix EVAS Endograft For AAA Repair: Indications, Advantages And Limitations
  Presenter(s):Matt M. Thompson, MD  
1:12 PM - 1:17 PM Failing EVARs Are An Emerging Epidemic: Etiology And How Best To Avoid And Treat The Problem
  Presenter(s):Murray L. Shames, MD  
1:18 PM - 1:23 PM Diabetes And AAAs: Facts, Clues And Potential Treatment Opportunities
  Presenter(s):Ronald L. Dalman, MD  
1:24 PM - 1:28 PM [SS] How Does Metformin Work To Slow AAA Growth At The Cellular Level: Could It Be Effective Treatment For Small AAAs: Is It The Reason For Decreased AAA Incidence In Diabetes
  Presenter(s):Kak Khee Yeung, MD, PhD  
1:28 PM - 1:33 PM Further Thoughts About The Odd Relationship Between Diabetes And AAA Disease: How Should It Influence Treatment
  Presenter(s):Christos D. Liapis, MD  
1:34 PM - 1:39 PM Should Saccular AAAs Be Fixed At A Smaller Diameter Than Fusiform AAAs: How Should Saccular AAA Diameter Be Measured: To Include The Normal Aorta Or Not
  Presenter(s):Frans L. Moll, MD, PhD  
1:40 PM - 1:46 PM Panel Discussion
Moderator(s): Mark A. Adelman, MD / Michel Makaroun, MD  
1:46 PM - 1:51 PM How Should AAA Sac Behavior After EVAR Be Used To Assess Treatment Success And Patient Prognosis
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
1:52 PM - 1:56 PM [SS] Impact Of AAA Sac Size On EVAR Outcomes Short And Long-Term: Large Size Is Associated With Failure: What To Do About It
  Presenter(s):Carlos H. Timaran, MD  
1:56 PM - 2:00 PM [SS] Decreased AAA Sac Diameter After EVAR Is Associated With Good Outcomes While Sac Stability Is Not
  Presenter(s):Andres Schanzer, MD  
2:00 PM - 2:05 PM In Patients Suitable for EVAR Or Open Repair, Adverse Neck Anatomy (Short, Wide, Angulated) Is Associated With Increased Reintervention And Mortality Rates Equally After Open and Endo Repairs: From The DREAM RCT: How Should This Influence Treatment
  Presenter(s):Jan D. Blankensteijn, MD  
2:06 PM - 2:10 PM [SS] Why AAA Diameter Is Often Not Enough To Make A Decision Regarding Threshold For Repair Or Re-Treatment After EVAR: What Other Parameters Should Enter Into The Decision
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
2:10 PM - 2:15 PM Improved AAA Sac Diameter Surveillance After EVAR Using A Home Smart Phone Ultrasound System: Device Description And Why It Will Improve Outcomes
  Presenter(s):Roger M. Greenhalgh, MD / Ian Loftus, MD  
2:16 PM - 2:21 PM Key New Developments In Long-Term Evaluation Of EVAR For AAA Treatment
  Presenter(s):Jason T. Lee, MD  
2:22 PM - 2:27 PM Long-Term EVAR Outcomes Have Improved Over Time Whereas Open Repair Outcomes Have Remained Stable: A VQI Propensity Study Explains Differing Results Of RCTs And Shows Late Survival Advantage Of EVAR
  Presenter(s):Marc L. Schermerhorn, MD  
2:28 PM - 2:40 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: MORE ABOUT AAAs, EVAR AND THE PUBLISHED UK NICE AAA GUIDELINES AND THEIR IMPACT ON AAA TREATMENT IN THE UK AND ELSEWHERE (5 AND 4-MINUTE TALKS)
x
2:40 PM - 2:45 PM Key Points In The Recently Published NICE Guidelines For Treatment Of AAAs And What Data Justifies Them: A View From The Writing Committee Chairman
  Presenter(s):Andrew W. Bradbury, MD, FRCSEd  
2:46 PM - 2:51 PM The Scientific Rationale Underlying The AAA NICE Guidelines: A View From A Writing Committee Member
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
2:52 PM - 2:57 PM Long-Term Results Of The OVER RCT: Pertinence To NICE AAA Guidelines: How Operator Training And Experience Influence EVAR Outcomes
  Presenter(s):Jon S. Matsumura, MD  
2:58 PM - 3:03 PM Why EVAR Is The Best Treatment For AAAs – Especially In Young Patients With A Long Life Expectancy
  Presenter(s):Fabio Verzini, MD, PhD  
3:04 PM - 3:09 PM Impact Of NICE Guidelines On AAA Practice In The UK: Decreased Use Of EVAR Is NOT Justified By Recent Data Showing That EVAR Has Better 10-Year Survival Than Open Repair
  Presenter(s):Ian Loftus, MD  
3:10 PM - 3:15 PM What Is Happening Due To The NICE AAA Guidelines In The UK And Why It Is Harmful
  Presenter(s):Nicholas J.W. Cheshire, MD  
3:16 PM - 3:20 PM [SS] Are The NICE AAA Guidelines The End Of EVAR In The UK: Why The Guidelines Are Wrong And Can They Be Fixed
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
3:20 PM - 3:24 PM What Is Wrong With The NICE AAA Guidelines: Do They Still Limit The Use Of EVAR As In The Draft Guidelines
  Presenter(s):Bijan Modarai, PhD, FRCS  
3:24 PM - 3:28 PM [SS] Impact Of NICE AAA Draft And Final Guidelines On Complex AAA Endovascular Repair: Will They Be Good For Patients
  Presenter(s):Tara M. Mastracci, MD  
3:28 PM - 3:32 PM [SS] What Are The Flaws In The Final Version Of The NICE AAA Guidelines
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
3:32 PM - 3:37 PM Impact Of UK NICE AAA Guidelines On Other Countries Served By The European ESVS Guidelines
  Presenter(s):Anders Wanhainen, MD, PhD  
3:38 PM - 3:42 PM [SS] Will The UK NICE AAA Guidelines Have An Impact Outside The UK And EU: What Will It Be
  Presenter(s):Andrew Holden, MBChB  
3:42 PM - 3:46 PM [SS] Why Are The NICE AAA Guidelines So Flawed: Has Bias Played A Role
  Presenter(s):Frans L. Moll, MD, PhD  
3:46 PM - 3:50 PM [SS] The UK NICE AAA Guidelines Are Based On Outdated Data And Are Therefore Misleading
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
3:50 PM - 3:56 PM Panel Discussion
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
x
3:56 PM - 4:01 PM Update On Stroke Reduction Strategies With TEVAR (Including For Arch Repairs): How To Decrease Particulate And Gas Emboli: What Is The STEP 2 Study Telling Us
  Presenter(s):Tilo Koelbel, MD, PhD / Stephan Haulon, MD  
4:02 PM - 4:07 PM Advances In Stroke Prevention From TEVAR: How To Decrease Gas And Particulate Emboli: When Should These Methods Be Used
  Presenter(s):Richard G.J. Gibbs, FRCS  
4:08 PM - 4:13 PM Update On Value Of Embolic Brain Protection Devices For Proximal TEVAR And TAVR Procedures: When Are They Mandatory
  Presenter(s):Jeffrey P. Carpenter, MD  
4:14 PM - 4:19 PM What Is Best Medical Treatment For TBAD Patients: How Best To Control Blood Pressure And To Get Patients To Comply: They Don’t
  Presenter(s):Colin D. Bicknell, MD, FRCS  
4:20 PM - 4:25 PM Material Properties Of The Aortic Arch Can Predict Bird Beaking And Type 1A Endoleaks With TEVAR: Will Conformable Endografts With Proximal Adjustable Angle Control Eliminate The Problem
  Presenter(s):Thomas L. Forbes, MD  
4:26 PM - 4:31 PM Natural History Of Aortic Intramural Hematomas (IMHs) And Predictors Of Need For TEVAR Treatment: Which IMH Patients Do Not Need TEVAR
  Presenter(s):I-Hui Wu, MD, PhD  
4:32 PM - 4:37 PM How To Deal With An Uncontrolled And Enlarging False Lumen After TEVAR For TBADs
  Presenter(s):Cherrie Z. Abraham, MD  
4:38 PM - 4:43 PM Long-Term (>5 Years) Good Results Of Valiant Captiva Endografts For TEVAR In TBAD Patients: What Are The Differences Between The Captiva And Navion Systems
  Presenter(s):Joseph E. Bavaria, MD  
4:44 PM - 4:49 PM How To Treat Aortic Dissections With An Entry Tear In The Aortic Arch
  Presenter(s):Santi Trimarchi, MD, PhD  
4:50 PM - 4:56 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
x
4:56 PM - 5:01 PM Long-Term Outcomes Of Medically Managed Acute TBADs: How Were Patients Selected For This Treatment
  Presenter(s):Thomas C. Bower, MD  
MEGA DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs
5:02 PM - 5:07 PM DEBATE: Many Uncomplicated Acute TBADs Never Need Invasive Interventions And Are Better Treated Medically; How To Select Such Patients
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
5:08 PM - 5:13 PM DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset And Then Limiting Aortic Coverage With TEVAR
  Presenter(s):Mark A. Farber, MD  
5:14 PM - 5:19 PM DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients
  Presenter(s):William D. Jordan Jr., MD  
5:20 PM - 5:25 PM DEBATE: Early Intervention For Acute TBADs (7-30 Days After Onset) With TEVAR For Acute TBADs Prevents Abdominal Extension Of False Lumen And TAAA Formation
  Presenter(s):Rodney A. White, MD  
5:26 PM - 5:31 PM Ideal Timing And Patient Selection Of TEVAR In Acute Uncomplicated TBAD Patients: When Is Medical Treatment Indicated
  Presenter(s):Ali Azizzadeh, MD  
5:32 PM - 5:36 PM [SS] Varying Solutions To Treat Type 1A Endoleaks After TEVAR And EVAR
  Presenter(s):Nicola Mangialardi, MD  
5:36 PM - 5:40 PM [SS] Impact Of Cocaine Abuse On The Course Of Acute TBADs And Their Treatment: What Is The Mechanism
  Presenter(s):Frank R. Arko, MD  
5:40 PM - 5:45 PM Techniques For And Advantages Of Rerouting A Misplaced TEVAR Which Is Leading To A Growing False Lumen And Malperfusion In Acute TBAD Patients
  Presenter(s):David M. Williams, MD  
5:46 PM - 5:51 PM Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears Improves Outcomes: How To Do It
  Presenter(s):Jean M. Panneton, MD  
5:52 PM - 5:58 PM Panel Discussion
End Of Program A

END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY AND SIMULATION
x
6:44 AM - 6:49 AM Opening Remarks
  Presenter(s):Enrico Ascher, MD  
6:50 AM - 6:55 AM Update On Endovascular Robotics: They Have A Promising Future
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS,FACS  
6:56 AM - 7:01 AM Robotic Decompression Of The Median Arcuate Ligament (Video Presentation)
  Presenter(s):Michael J. Singh, MD  
7:02 AM - 7:07 AM Laparoscopic Assisted Aortofemoral Bypasses For Juxtarenal Aortic Occlusions: Why It Is The Best Treatment Method
  Presenter(s):Joseph S. Giglia, MD  
7:08 AM - 7:13 AM Laparoscopic Robotic Assisted Aortic Surgery: Is It Worthwhile And Cost Effective In The Endovascular Era: Based On A 7-Year Experience In 87 Patients
  Presenter(s):Pierre-Olivier Thiney, MD  
7:14 AM - 7:19 AM Present Status And Future Potential Of Radiation Free Guidewire And Catheter Guidance: The Fiber Optic RealShape (FORS) From Philips: What Are Microbots And How Do They Work
  Presenter(s):Barry T. Katzen, MD  
7:20 AM - 7:25 AM Updated Experience With Radiation Free Fiberoptic 3D Endovascular Guidance With The FORS System (Philips): Advantages And Limitations
  Presenter(s):Joost A. van Herwaarden, MD, PhD  
7:26 AM - 7:31 AM Update On The 3D Radiation Free Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: How Does It Work, Advantages And Limitations
  Presenter(s):Matthew J. Eagleton, MD  
7:32 AM - 7:37 AM The MAZE BOX: A Simple Table Top Endovascular Simulator For Training In Endovascular Tasks And Procedures
  Presenter(s):Barend M.E. Mees, MD, PhD  
7:38 AM - 7:44 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
x
7:44 AM - 7:49 AM Variations In Carotid Treatment Within Countries And Between Countries In Europe, The US And Australia Is Great Despite All The RCTs: What Are The Implications
  Presenter(s):Maarit Venermo, MD, PhD  
7:50 AM - 7:55 AM Current Optimal Treatment For Carotid Artery Dissection: When Best Medical Therapy (BMT), When Open Surgery, When Carotid Stenting (CAS) With Proximal Embolic Protection
  Presenter(s):Felice Pecoraro, MD  
7:56 AM - 8:01 AM What Vascular Surgeons And Vascular Specialists Need To Know About What Can Be Learned From MRI And MRA Studies Of The Head And Neck
  Presenter(s):Emmanuel M. Houdart, MD  
8:02 AM - 8:07 AM Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA): How Are They Best Treated: Do We Have Updated Evidence
  Presenter(s):Christos D. Liapis, MD  
8:08 AM - 8:13 AM Radiation And Carotid Stenosis: What Is The Relationship And How Is Radiation Stenosis Best Treated When Asymptomatic And When Symptomatic
  Presenter(s):Cynthia K. Shortell, MD  
8:14 AM - 8:20 AM Panel Discussion
DIFFERING VIEWS ON TREATMENT OF ACS
8:20 AM - 8:25 AM DEBATE: Almost ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
8:26 AM - 8:31 AM DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated
  Presenter(s):Bruce A. Perler, MD, MBA  
8:32 AM - 8:37 AM DEBATE: Both Views Are Wrong: About 5-10% Of ACS Patients Should Be Treated Invasively And Benefit From Such Treatment: Why Are Too Many ACS Patients Getting CEA Or CAS
  Presenter(s):Kosmas I. Paraskevas, MD  
8:38 AM - 8:43 AM DEBATE: ACS: When Not To Treat Invasively And When To Treat Invasively: A Balanced Logical View – But No One Knows Which View Is Right Or Best
  Presenter(s):Martin Storck, MD, PhD  
DIFFERING VIEWS ON CAROTID SCREENING
8:44 AM - 8:49 AM DEBATE: The Case For Widespread Carotid Screening
  Presenter(s):George S. Lavenson, MD  
8:50 AM - 8:55 AM DEBATE: The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
8:56 AM - 9:01 AM DEBATE: Lifeline Proprietary Carotid Screening: Who Profits: Is It A Good Thing Or A Hoax And A Scam: What Can It Tell Us About The Prevalence Of ACS
  Presenter(s):Thomas G. Brott, MD  
9:02 AM - 9:07 AM Screening For ACS And Common Femoral Artery Disease: How Can It Guide Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
9:08 AM - 9:15 AM Panel Discussion
9:15 AM - 9:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
x
9:30 AM - 9:35 AM Carotid Webs Can Cause Strokes In Young Patients – How Are They Best Diagnosed And Treated: Should They Be Treated In Asymptomatic Patients
  Presenter(s):Emmanuel M. Houdart, MD  
9:36 AM - 9:41 AM When After Thrombolysis Treatment From A Stroke Should Carotid Endarterectomy (CEA) Be Performed And What Is The Best Timing For Those CEAs: Delay Has Consequences
  Presenter(s):Maarit Venermo, MD, PhD  
9:42 AM - 9:47 AM Why Vascular Surgeons Should Become Involved In Intracranial Endovascular Treatments For Acute Strokes: How To Learn These Procedures And Benefit Patients
  Presenter(s):Laura Capoccia, MD  
9:48 AM - 9:43 AM What Is New With Endovascular Intracranial Techniques For Arterial Clot Removal For Acute Strokes: New Methods; When And How Can The Time Window For Success Be Increased
  Presenter(s):Colin P. Derdeyn, MD  
9:54 AM - 9:59 AM Update And New Developments In Intracranial Endovascular Treatment For Acute Strokes: Should Other Specialists Learn How To Do It And the Ways To Learn
  Presenter(s):L. Nelson Hopkins, MD  
10:00 AM - 10:05 AM Acute Stroke Interventions: What Is New: Who Should Do Them And Lessons Learned
  Presenter(s):Horst Sievert, MD  
10:06 AM - 10:11 AM How Best To Treat An ICA Occlusion With Distal Embolization: Sequence Of Treatment: Team Composition: Technical Tips
  Presenter(s):Timothy M. Sullivan, MD  
10:12 AM - 10:17 AM Improvements In The Treatment Of Acute Strokes: Why A Dedicated Stroke Center Matters: What And Who Must Be Involved: Yes, It Does Matter In Better Patient Outcomes
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
10:18 AM - 10:23 AM Endovascular Interventions In The Vertebro-Basilar System For Acute Strokes: A New Horizon, What Is Involved And Results
  Presenter(s):Ivo Petrov, MD, PhD  
10:24 AM - 10:30 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
x
10:30 AM - 10:35 AM Current Concepts And Techniques For Treating External Iliac Artery Endofibrosis In Committed Athletes: What Works And Doesn’t Work: Is There A role For Endovascular Treatment
  Presenter(s):Kenneth J. Cherry, MD  
10:36 AM - 10:41 AM Iliac Stenosis In Professional Cyclists: How To Diagnose And Treat: ABIs Don’t Help
  Presenter(s):Gabriel Szendro, MD  
10:42 AM - 10:47 AM Value Of VBX Balloon Expandable Covered Stents In Treating Complex Aorto-Iliac Occlusive Disease: Advantages And Limitations
  Presenter(s):Ehrin Armstrong, MD  
COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE
10:48 AM - 10:53 AM Midterm Outcomes Of The CERAB And Chimney CERAB Procedure With Covered Stents For Complex Aorto-Iliac Occlusive Disease: Why It’s Better Than Kissing Stents And Which Covered Stent Works Best
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
10:54 AM - 10:59 AM CERAB Procedure Versus Kissing Stents For Complex Aorto-Iliac Occlusive Diseases: Advantages And Disadvantages Of Each: CERAB Requires More Time And Radiation
  Presenter(s):Maria A. Ruffino, MD, EBIR  
11:00 AM - 11:05 AM Covered Endovascular Reconstruction Of The Aortic Bifurcation (CERAB) Procedure: Indications, Challenges And Technical Tips
  Presenter(s):Hany Zayed, MD  
11:06 AM - 11:11 AM Value Of Shockwave Intravascular Lithotripsy For Calcified Aorto-Iliac Occlusive Disease Treatment
  Presenter(s):Andrew Holden, MBChB  
11:12 AM - 11:18 AM Panel Discussion
11:18 AM - 11:23 AM Treatment Of Isolated Aortic Stenosis Without Iliac Disease: When Stents; When Stent-Grafts; When Open Bypass
  Presenter(s):Sigrid Nikol, MD  
11:24 AM - 11:29 AM Endovascular Treatment Of Difficult Aorto-Iliac Occlusions: Technical Tips: Is Open Repair Ever Needed
  Presenter(s):Sonia Ronchey, MD,PhD  
11:30 AM - 11:35 AM DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go
  Presenter(s):David J. Minion, MD  
11:36 AM - 11:41 AM DEBATE: Not So: Open Surgery Is the Best Way To Treat Flush Juxtarenal Aortic Occlusions Safely: Technical Tips On How To Do It
  Presenter(s):Thomas C. Bower, MD  
11:42 AM - 11:47 AM DEBATE: Both Wrong: Hybrid Repairs Are Best For Complex Aorto-Iliac Occlusive Disease: Technical Tips On How To Do It
  Presenter(s):Yamume Tshomba, MD  
11:48 AM - 11:53 AM Impact Of Female Gender On Outcomes Of Endovascular Treatment Of Aorto-Iliac Occlusive Disease: When Is Open Repair Indicated
  Presenter(s):Franco Grego, Vascular Surgery  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break –2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI)
x
1:00 PM - 1:05 PM What Is Big Data In Vascular Surgery: How Can It Be Used With Artificial Intelligence (AI) In Evidence Based Medicine: Could It Replace Randomized Controlled Trials (RCTs)
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
1:06 PM - 1:11 PM What Is The Bright Future Of AI And Robotic Technology In Vascular Surgery
  Presenter(s):Willem Wisselink, MD  
1:12 PM - 1:17 PM How AI Will Change The Way We Practice Medicine
  Presenter(s):Lindsay Machan, MD  
1:18 PM - 1:23 PM How Vascular Treatment Will Intersect With Other New Technologies: Wearable Trackers, AI, And Tissue Engineering
  Presenter(s):David H. Deaton, MD, FACS  
1:24 PM - 1:29 PM How 3D And 4D Machine Learning Is Changing Vascular Surgery
  Presenter(s):Matthew T. Menard, MD  
1:30 PM - 1:35 PM How Can AI Be Used To Predict Endoleaks And AAA Growth: Will It Have Clinical Value
  Presenter(s):Kak Khee Yeung, MD, PhD  
1:36 PM - 1:41 PM How Can AI Facilitate AAA Monitoring Before And After EVAR
  Presenter(s):Stephan Haulon, MD  
1:42 PM - 1:47 PM Value Of Computational Fluid Dynamic Studies To Evaluate Closure Techniques With CEA, Predict Restenosis And Help In AAA Treatment
  Presenter(s):Santi Trimarchi, MD, PhD  
1:48 PM - 1:53 PM Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease
  Presenter(s):Ravi K. Veeraswamy, MD  
1:54 PM - 1:59 PM Totally Radiation Free Deployment Of A Complex AAA Endograft Using An Intraoperative Positioning System (IOPS From Centerline) And Positional Markers On Graft Components As Well As Catheters And Wires To Enable Accurate 3D Guidance: It Is Analogous To Precise GPS Targeting
  Presenter(s):Gustavo S. Oderich, MD, FACS  
2:00 PM - 2:05 PM Is Image Fusion Guidance For Complex And Simple Aortic Procedures Really Worthwhile And Cost Effective: Why Is It A Question
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
2:06 PM - 2:12 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: VASCULAR SURGERY’S NUMBERS, IDENTITY, RECOGNITION, INDEPENDENT SPECIALTY STATUS; HOW TO INCREASE OUR NUMBERS TO MEET FUTURE NEEDS FOR OUR SERVICES
x
2:12 PM - 2:17 PM Updated Workforce Model Predicts A Shortage Of Vascular Surgeons For The Next 20 Years: What Should Vascular Surgery And The American Board of Surgery (ABS) Do About It
  Presenter(s):K. Craig Kent, MD / Bhagwan Satiani, MD, MBA  
2:18 PM - 2:23 PM What Makes Vascular Surgery Different, Why Are There Insufficient Numbers Of Vascular Surgeons: How Can We Expand Our Numbers
  Presenter(s):Evan C. Lipsitz, MD, MBA  
2:24 PM - 2:29 PM The Clouded Identity Of Vascular Surgery Amongst Other Doctors And The Public: Why Is It So And What Can Be Done About It
  Presenter(s):James C. Stanley, MD / Frank J. Veith, MD  
2:30 PM - 2:35 PM Why US News & World Report Cannot And Does Not Rank Vascular Surgery Programs: Vascular Surgery Needs To Be An Independent ABMS Approved Specialty: Why Isn’t It
  Presenter(s):James H. Black, III, MD  
2:36 PM - 2:41 PM The American Board Of Vascular Surgery Or ABVS: Its Time Is Now
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
2:42 PM - 2:47 PM The SVS Executive Committee: What Is Its Function And How Has It Not Promoted Vascular Surgery And Thereby Failed To Serve Its Membership’s Interests
  Presenter(s):Benjamin W. Starnes, MD  
2:48 PM - 2:53 PM What Will Happen If Vascular Surgery Does Not Become A Separate Specialty: How Have Our Vascular Societies Failed Vascular Surgeons
  Presenter(s):David H. Deaton, MD, FACS  
2:54 PM - 2:59 PM Why Vascular Surgery Must Be An Independent Specialty: It Needs Independent Departments So As To Not Be Exploited By Other Department Chairs
  Presenter(s):Patrick J. Geraghty, MD  
3:00 PM - 3:05 PM The Key To More Vascular Surgeons Is Better Exposure To Medical Students: We Are A Hidden Specialty Because Of Our Subordinate Specialty Status Which Also Limits Our Training Programs
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
3:06 PM - 3:11 PM Vascular Surgery Training Program’s Update For 0+5 And 5+2 Programs: Do We Need More Applicants Or More Programs Or Both: How Can We Get There
  Presenter(s):Murray L. Shames, MD  
3:12 PM - 3:17 PM Is Getting A Vascular Surgery Training Position Becoming Less Competitive For 0+5 Residencies; For 5+2 Fellowships
  Presenter(s):Peter L. Faries, MD, FACS  
3:18 PM - 3:23 PM Leadership Roles Vascular Surgeons And Vascular Specialists Should Seek: Why They Are Important And How To Get There Without Abandoning Your Original Specialty
  Presenter(s):Christopher J. Kwolek, MD, MBA  
3:24 PM - 3:36 PM Panel Discussion And Break
Visit Pavilions And Exhibits (2nd and 3rd Floors)

END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
x
3:36 PM - 3:41 PM DEBATE: All Visceral And Renal Artery Aneurysms Can Be Treated Endovascularly
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
3:42 PM - 3:47 PM DEBATE: Open Treatment Of Visceral And Renal Artery Aneurysms Is Sometimes Best: When Is This
  Presenter(s):Timur P. Sarac, MD  
3:48 PM - 3:53 PM Technical Tips For Percutaneous Endovascular Treatment Of Visceral And Renal Artery Aneurysms
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
3:54 PM - 3:59 PM Update On New SVS Practice Guidelines For Treating Visceral Artery Aneurysms; When Endo; When Open
  Presenter(s):Rabih A. Chaer, MD  
4:00 PM - 4:05 PM Technical Tips For Recanalizing Long Complex Visceral Artery (SMA) Occlusions
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
4:06 PM - 4:11 PM Current Optimal Treatment Of Pancreatico-Duodenal Aneurysms With And Without Celiac Axis Occlusion: When Endo; When Open: Why They Are Both Challenging
  Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD  
4:12 PM - 4:17 PM With Acute Mesenteric Ischemia With Peritoneal Signs, Laparotomy And Retrograde SMA Stenting Is The Best Treatment: Technical Tips To Do it Safely And Quickly
  Presenter(s):Markus K. Furrer, MD  
4:18 PM - 4:23 PM At What Size Do Renal Artery Aneurysms Need to Be Treated Invasively: A New Vascular Consortium Study Shows They Are Only Dangerous When >3 cm In Diameter
  Presenter(s):Peter F. Lawrence, MD  
4:24 PM - 4:39 PM Optimal Current Treatment Of Renal Artery Aneurysms: When Endo; When Open; Technical Tips
  Presenter(s):Fred A. Weaver, MD, MMM  
4:30 PM - 4:36 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (5-MINUTE AND SOME 4 3/4-MINUTE SHORT SUMMARY [SS] TALKS)
x
OPEN AND HYBRID VASCULAR SURGERY
4:36 PM - 4:41 PM New Techniques To Improve The Open Repair Of TAAAs
  Presenter(s):Laurent Chiche, MD, FEBVS  
4:42 PM - 4:47 PM Technical Tips For Performing Retroperitoneal Aorto-Bifemoral Bypass (Video Presentation)
  Presenter(s):William J. Quinones-Baldrich, MD  
4:48 PM - 4:53 PM Tips And Tricks For Open Retroperitoneal Exposure Of The Aorta And All Its Abdominal Branches
  Presenter(s):Kamphol Laohapensang, MD  
4:54 PM - 4:59 PM Minimal Incision For Retroperitoneal Aorto-Bifemoral Bypass: Technical Tips And Limitations
  Presenter(s):Robert M. Proczka, MD, PhD  
5:00 PM - 5:05 PM [SS] Duplex Surveillance Should Be Used After All Aorto-Bifemoral Bypasses: It Improves Outcomes
  Presenter(s):Keith D. Calligaro, MD  
5:05 PM - 5:10 PM [SS] Thoraco-Bifemoral Bypass: A Good Option After All Endo And Open Standard Approaches Have Failed: Technical Tips
  Presenter(s):Manju Kalra, MBBS  
5:10 PM - 5:15 PM [SS] Axillo-Unifemoral And Axillo-Bifemoral Bypasses Have Equal Patency For More Than A Year: Why The Bilateral Procedure Should Only Be Used When Bilateral Ischemia Exists
  Presenter(s):Jeffrey J. Siracuse, MD  
5:15 PM - 5:20 PM Panel Discussion
5:20 PM - 5:25 PM Technical Tips For Aortic And Inferior Vena Cava Resections During Cancer Operations
  Presenter(s):Benjamin M. Jackson, MD  
5:26 PM - 5:31 PM Update On Renal Consequences Of Left Renal Vein Division During Open AAA Repair: It Is Not Always Benign
  Presenter(s):Kimihiro Komori, MD, PhD  
UPDATE ON COARCTATION TREATMENT
5:32 PM - 5:37 PM DEBATE: Endovascular Techniques Are The Best Treatment For Aortic Coarctations: When Bare Stents; When Covered Stents; Precautions
  Presenter(s):Zvonimir Krajcer, MD, FACC  
5:38 PM - 5:43 PM DEBATE: Not So: Open Surgery Is Sometimes Needed: What Are The Indications
  Presenter(s):Michael J. Jacobs, MD  
5:44 PM - 5:49 PM Value Of BeGraft (From Bentley), A Balloon Expandable Covered Stent In Treating Aortic Coarctations: Can It Treat All Cases
  Presenter(s):Elchanan Bruckheimer, MBBS  
5:50 PM - 5:55 PM Long-Term Outcomes Of Stent-Graft Treatment Of Aortic Coarctations
  Presenter(s):Frank R. Arko, MD  
5:56 PM - 6:02 PM Panel Discussion
End of Program B

END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH - PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Raghu Kolluri, MD  
7:25 AM - 7:35 AM Do We Need An Echo To Manage Acute Submassive PE
  Presenter(s):David M. Dudzinski, MD  
7:35 AM - 7:45 AM Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE
  Presenter(s):Brian B. Ghoshhajra, MD, MBA  
7:45 AM - 8:00 AM Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
8:00 AM - 8:10 AM Testing For Cancer And Other Hypercoagulable States In PE
  Presenter(s):Rachel Rosovsky, MD, MPH  
8:10 AM - 8:20 AM The First Opportunity – The Emergency Physician Algorithm For Acute PE Management
  Presenter(s):D. Mark Courtney, MD  
8:20 AM - 8:35 AM Intravenous Thrombolytic Therapy For PE: No Need For Catheter-Based Intervention
  Presenter(s):Jay Giri, MD, MPH  
8:35 AM - 8:45 AM Ultrasound-Assisted Pharmacomechanical Thrombectomy: Does This Really Work
  Presenter(s):Charles B. Ross, MD  
8:45 AM - 8:55 AM Ultrasound-Assisted Pharmacomechanical Thrombectomy: The Indigo System
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
8:55 AM - 9:05 AM What Strategy Is Best For Acute PE Intervention
  Presenter(s):Patrick Troy, MD  
9:05 AM - 9:15 AM Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE
  Presenter(s):Gary M. Ansel, MD  
9:15 AM - 9:25 AM Percutaneous Mechanical Thrombectomy Without Lytics: Where Does This Fit
  Presenter(s):Mitchell D. Weinberg, MD  
Moderator(s): Michael R. Jaff, DO  
9:25 AM - 9:40 AM Panel Discussion
  Panelist(s): Gary M. Ansel, MD / D. Mark Courtney, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / Charles B. Ross, MD / Patrick Troy, MD / Mitchell D. Weinberg, MD  
9:40 AM - 10:10 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 2
Moderators:Michael R. Jaff, DO  
x
10:10 AM - 10:20 AM Low-Does Systemic Lytics: Is This An Effective Strategy For Acute PE Treatment
  Presenter(s):Mohsen Sharifi, MD  
10:20 AM - 10:30 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD, MBA  
10:30 AM - 10:40 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why
  Presenter(s):Mark G. Davies, MD  
10:40 AM - 10:55 AM Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Ido Weinberg, MD, MSc  
10:55 AM - 11:10 AM Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When
  Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR  
11:10 AM - 11:25 AM Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream
  Presenter(s):Kenneth Rosenfield, MD  
11:25 AM - 11:35 AM The Team Approach To PE Management: The National PERT Consortium
  Presenter(s):Victor F. Tapson, MD  
Moderator(s): Michael R. Jaff, DO  
11:35 AM - 12:00 PM Challenging Cases And “PERT” Decisions
  Panelist(s): Mark G. Davies, MD / Ziv J. Haskal, MD, FACR, FAHA, FSIR / Christopher J. Kwolek, MD, MBA / Kenneth Rosenfield, MD / Mohsen Sharifi, MD / Victor F. Tapson, MD / Mitchell D. Weinberg, MD  
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
End of Program C-1

END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: INTRODUCTION TO VASCULAR MALFORMATIONS
x
1:00 PM - 1:02 PM Welcome And Introduction
  Presenter(s):Krassi Ivancev, MD, PhD  
1:02 PM - 1:10 PM International Society for the Study of Vascular Anomalies (ISSVA) Classification Of Vascular Malformations
  Presenter(s):Laurence M. Boon, MD, PhD  
1:11 PM - 1:19 PM Genetic Diagnosis And Molecular Therapies Of Vascular Anomalies
  Presenter(s):Miikka Vikkula, MD, PhD  
1:20 PM - 1:28 PM The Yakes AVM Classification System: A Guide To Curative AVM Treatment
  Presenter(s):Fiona Rohlffs, MD, PhD  
1:29 PM - 1:34 PM Case Examples Utilizing The Yakes AVM Classification System For Curative Treatment Of Complex AVMs
  Presenter(s):Robert L. Vogelzang, MD  
1:35 PM - 1:40 PM Case Examples Utilizing The Yakes AVM Classification System For Curative Treatment Of Complex AVMs
  Presenter(s):Fiona Rohlffs, MD, PhD  
1:41 PM - 1:46 PM Case Examples Utilizing The Yakes AVM Classification System For Curative Treatment Of Complex AVMs
  Presenter(s):Krassi Ivancev, MD, PhD  
1:47 PM - 2:04 PM The Yakes AVM Classification System: Treatment Outcomes In 100 Consecutive Patients
  Presenter(s):Krassi Ivancev, MD, PhD  
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: SURGICAL AND ENDOVASCULAR MANAGEMENT OF VASCULAR MALFORMATIONS
x
2:05 PM - 2:13 PM Combined Endovascular And Surgical Management Of Head & Neck Vascular Malformations
  Presenter(s):Laurence M. Boon, MD, PhD  
2:14 PM - 2:22 PM Curative Ethanol Endovascular Treatment Of Complex Head & Neck AVMs
  Presenter(s):Wayne F. Yakes, MD  
2:23 PM - 2:31 PM The Best Laid Plans: Complications And Difficult Outcomes In Challenging Vascular Malformations
  Presenter(s):Robert L. Vogelzang, MD  
2:32 PM - 2:40 PM Endovascular Ethanol Treatment Of Complex Venous Malformations
  Presenter(s):Wayne F. Yakes, MD  
2:41 PM - 2:49 PM The Kerber Potpourri: The World’s First Microcatheter System And Polymerizing Embolic Agents To First Enter Brain Arteries, The World’s First Carotid Angioplasty, Supradose Cisplatin Head & Neck Carcinoma Therapy, And Modern Uses Of Cyanoacrylates
  Presenter(s):Charles Kerber, MD  
2:50 PM - 3:00 PM Panel Discussion/Q&A (Combined Sessions 19 and 20)
End of Program C-2

END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE (ALL TALKS ARE 4 ¾ MINUTES)
x
3:00 PM - 3:05 PM Key Steps For Success With Radial Artery Access For Remote Visceral, Renal Or Lower Extremity Lesion Treatment
  Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR  
3:05 PM - 3:10 PM Mortality Rates After Paclitaxel Coated Device Use Only In Patients With Critical Limb Ischemia (CLI): A Systematic Review And Meta-Analysis Of Randomized Controlled Trials Shows No Increased Mortality With Paclitaxel Coated Devices
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
3:10 PM - 3:15 PM How To Use Microcatheters To Facilitate Complex Peripheral Interventions
  Presenter(s):Jos C. van den Berg, MD, PhD  
3:15 PM - 3:20 PM Why And When Angiographic Final Evaluation Of Interventional Treatment Is Inadequate: What Else Is Needed And When
  Presenter(s):Gary M. Ansel, MD  
3:20 PM - 3:25 PM DEBATE: CO2 As A Contrast Agent Is Valuable For Lower Extremity Angiography And Treatments If Used Appropriately
  Presenter(s):Palma M. Shaw, MD  
3:25 PM - 3:30 PM DEBATE: Not So: CO2 As A Lower Extremity Contrast Agent Is Unnecessary And Has Downsides
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
3:30 PM - 3:35 PM Importance Of Technical Factors In Use Of Drug Coated Balloons (DCBs): Value Of IVUS And DCB Undersizing
  Presenter(s):Jihad A. Mustapha, MD  
3:35 PM - 3:40 PM Local Anesthetic Injection Into Lesion Site Facilitates PTA And Stent Placement: How To Do It (Video Presentation)
  Presenter(s):Andrej Schmidt, MD  
3:40 PM - 3:45 PM Panel Discussion
3:45 PM - 3:50 PM Value Of Tack Optimized Balloon Angioplasty In Lower Extremity Interventions: When Should They Be Used And When Not (Tacks From Intact Vascular)
  Presenter(s):Lawrence A. Garcia, MD  
3:50 PM - 3:55 PM The .014 Lutonix Balloon (From Becton Dickinson) Is Safe And Effective For Below The Knee (BTK) Lesions Up To 24 Months
  Presenter(s):Dierk Scheinert, MD  
3:55 PM - 4:00 PM The Optimal Stent And Techniques For Treating Occlusive Lesions In Heavily Calcified Superficial Femoral Arteries
  Presenter(s):Hany Zayed, MD  
4:00 PM - 4:05 PM How Best To Use DCBs To Treat Femoro-Popliteal Lesions
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
4:05 PM - 4:10 PM What Is Small Artery Disease (SAD) And What Are Good Therapeutic Options For Treating SAD Occurring In Patients With Chronic Limb Threatening Ischemic (CLTI)
  Presenter(s):Marianne Brodmann, MD  
4:10 PM - 4:15 PM Heel Ulceration And Ischemic Gangrene Involving The Achilles Tendon Should Not Be An Indication For A BTK Amputation: How To Save Such A Limb
  Presenter(s):Mark G. Davies, MD  
4:15 PM - 4:20 PM Popliteal Artery-To-Distal Bypass For Limb Salvage; Status In 2020: Technical Tips And Value: When Is It Better Than Endovascular Treatments
  Presenter(s):Francesco Spinelli, MD  
4:20 PM - 4:25 PM Hybrid Lower Extremity Revascularizations: When And Why Are They Better Than Endo Approaches
  Presenter(s):Joseph S. Giglia, MD  
4:25 PM - 4:30 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) - ALL TALKS ARE 4 ¾ MINUTES
x
4:30 PM - 4:35 PM CLTI Is A Global Epidemic; How Can A CLTI Program Decrease Its Morbidity
  Presenter(s):Barry T. Katzen, MD  
4:35 PM - 4:40 PM What Is The Best Treatment For Young Patients With Symptomatic PAD: How Should Females Be Revascularized Differently From Males
  Presenter(s):William P. Robinson, MD  
4:40 PM - 4:45 PM Bare Metal Stents (BMSs) Still Have A Role In The Superficial Femoral Artery (SFA): In Precisely What Circumstances
  Presenter(s):Lawrence A. Garcia, MD  
4:45 PM - 4:50 PM Value Of External Duplex Ultrasound And Other Technical Factors In Optimizing BTK DCB Angioplasty
  Presenter(s):Francesco Liistro, MD  
4:50 PM - 4:55 PM How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): Why It Is Important
  Presenter(s):Jos C. van den Berg, MD, PhD  
4:55 PM - 5:00 PM Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: Its Costs, Value And Limitations
  Presenter(s):Ignacio Escotto, MD  
5:00 PM - 5:05 PM Panel Discussion
5:05 PM - 5:10 PM Patterns Of Calcification In BTK Arteries: How They Influence Endovascular Treatments
  Presenter(s):Jihad A. Mustapha, MD  
5:10 PM - 5:15 PM Best Treatment For Heavily Calcified Occlusive Lesions And When Are Re-Entry Devices Needed With Retrograde Recanalizations: Tips On How To Use Them
  Presenter(s):Erwin Blessing, MD  
5:15 PM - 5:20 PM How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries
  Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD  
5:20 PM - 5:25 PM Bailout Techniques For Problems Encountered With Subintimal Angioplasty For Chronic Total Occlusions (CTOs): Like Inability To Re-Enter The True Lumen
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
5:25 PM - 5:30 PM 2-Year Results With Sirolimus Coated Drug Eluting Stents (DES) For Fempop Lesions: The ILLUMINA Trial
  Presenter(s):Andrea Kahlberg, MD  
5:30 PM - 5:35 PM Early Failure Of Endovascular Treatment Of Tibial Disease With CLTI Is Associated With Increased Amputation Rates: How Can It Be Predicted And Is An Open Bypass A Solution
  Presenter(s):Mark G. Davies, MD  
5:35 PM - 5:40 PM Contemporary Comparative Results Of In Situ Versus Reversed Vein Bypasses: When Is One Better Than The Other
  Presenter(s):Carlo Pratesi, MD  
5:40 PM - 5:45 PM Distal Bypasses Under Nerve Block Without General Anesthesia Improves Results Of Bypasses For CLTI
  Presenter(s):Nobuyoshi Azuma, MD  
5:45 PM - 5:50 PM Alternate Approaches To Lower Extremity Arteries When Standard Approaches Are Blocked By Scarring Or Infection
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
5:50 PM - 5:55 PM Challenge Of Getting Endovascular Revascularization To Achieve Healing Of Ischemic Wounds: Value Of A Wound Center In A Limb Salvage Program
  Presenter(s):Robert B. McLafferty, MD, MBA  
5:55 PM - 6:00 PM Panel Discussion
End of Program C-3

END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
x
6:40 AM - 6:45 AM How Do Prior Endovascular Interventions Effect Future Lower Extremity Bypass Outcomes For CLTI
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
6:46 AM - 6:51 AM Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better
  Presenter(s):Katariina M. Noronen, MD, PhD  
6:52 AM - 6:57 AM Statins Decrease Rates Of Mortality, Amputation, MACE And Strokes And Increase Procedural Patency Rates In CLTI Patients: What Is The Best Drug And Dose
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
6:58 AM - 7:03 AM Key New Developments In Endovascular Treatments For CLTI
  Presenter(s):Sahil A. Parikh, MD  
7:04 AM - 7:09 AM Small Artery Disease (SAD) Medial Artery Calcification (MAC) And elow The Ankle (BTA) Disease: Major Causes Of CLTI With A Poor Prognosis: How Are They Best Treated Endovascularly
  Presenter(s):Roberto Ferraresi, MD  
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS
7:10 AM - 7:15 AM [SS] Optimal Different Techniques Of Vessel Prep For Plain Old Balloon Angioplasty (POBA), Drug Coated Balloon (DCB) Treatment And Drug Eluting Stent (DES) Treatment
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
7:15 AM - 7:20 AM [SS] Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple
  Presenter(s):Erwin Blessing, MD  
7:20 AM - 7:25 AM Thirteen Technical Tips For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated
  Presenter(s):Craig M. Walker, MD  
7:26 AM - 7:31 AM What Are The Downsides To Trans-Radial Or Pedal Access
  Presenter(s):Gary M. Ansel, MD  
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE
7:32 AM - 7:37 AM [SS] Guidewire Tips For Treating SFA And Popliteal Artery Lesions Including CTOs
  Presenter(s):Marco G. Manzi, MD  
7:37 AM - 7:42 AM [SS] Guidewire Tips For Treating BTK And Crural Artery Lesions
  Presenter(s):Craig M. Walker, MD  
7:42 AM - 7:47 AM [SS] Guidewire Tips For Treating Lesions Below the Ankle (BTA): Sliding, Piercing, Dissecting, Retrograde Maneuvers
  Presenter(s):Roberto Ferraresi, MD  
7:47 AM - 7:53 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) (ALL TALKS ARE 5 MINUTES)
x
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty
  Presenter(s):George L. Adams, MD  
7:59 AM - 8:04 AM Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Yea Results In CLTI Patients
  Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD  
8:05 AM - 8:10 AM Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial
  Presenter(s):Todd R. Vogel, MD, MPH  
8:11 AM - 8:16 AM Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View
  Presenter(s):James F. McKinsey, MD  
UPDATE ON THE SUPERA STENT
8:17 AM - 8:23 AM Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First
  Presenter(s):Peter C.J. Goverde, MD  
8:23 AM - 8:28 AM Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
DRUG ELUTING STENTS FOR BTK LESIONS
8:29 AM - 8:34 AM 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
8:35 AM - 8:40 AM Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Trial And A Meta-Analysis Of The Absorb Stent From Abbott
  Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
8:41 AM - 8:46 AM What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD / Sahil A. Parikh, MD / Brian G. DeRubertis, MD  
8:47 AM - 8:52 AM A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
8:53 AM - 9:00 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
x
9:00 AM - 9:05 AM Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: The More Recent Study Of DCBs In BTK Arteries Showed Increased Mortality And Amputation Rates After Only 1 Year
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
9:06 AM - 9:11 AM How Do Paclitaxel And Limus Drugs Work And Differ In Safety And Effectiveness In Inhibiting Intimal Hyperplasia Induced By Treatment
  Presenter(s):Juan F. Granada, MD  
9:12 AM - 9:17 AM Summary Of The Present Status Of The Paclitaxel Mortality Controversy With DCBs And DESs Treatments In The SFA And BTK Arteries
  Presenter(s):Andrew Holden, MBChB  
9:18 AM - 9:23 AM Alternatives To Paclitaxel Coated Devices For Limiting Intimal Hyperplasia After Treatment: Sirolimus Coating, Bioresorbables And Advential Drug Delivery With The Bullfrog Device: Is The Paclitaxel Mortality Signal Real
  Presenter(s):William A. Gray, MD  
9:24 AM - 9:29 AM Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients
  Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD  
9:30 AM - 9:35 AM Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices
  Presenter(s):Christian A. Behrendt, MD  
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS)
9:36 AM - 9:41 AM [SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data
  Presenter(s):Peter A. Schneider, MD  
9:41 AM - 9:46 AM [SS] Is The Paclitaxel Increased Mortality Signal Incorrect: The Updated Collected VIVA Data Do Not Confirm It
  Presenter(s):Gary M. Ansel, MD  
9:46 AM - 9:51 AM [SS] The Current Japanese View On The Paclitaxel Mortality Signal
  Presenter(s):Osamu Iida, MD  
9:51 AM - 9:56 AM [SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal
  Presenter(s):Daniel Bertges, MD / Jack L. Cronenwett, MD  
9:56 AM - 10:01 AM [SS] Progress And Problems With A Sustained Release Limus DCB: 2-Year Results With The Magic Touch DCB: From The SIRONA Study
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD  
10:01 AM - 10:08 AM Panel Discussion
10:08 AM - 10:18 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs
  Presenter(s):Stefan Müller-Hülsbeck, MD  
10:24 AM - 10:29 AM Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 4 Years In The ILLUMENATE RCT
  Presenter(s):Sean P. Lyden, MD  
10:30 AM - 10:35 AM Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD  
10:36 AM - 10:41 AM New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
  Presenter(s):Francesco Liistro, MD  
10:42 AM - 10:47 AM Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry
  Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD  
10:48 AM - 10:53 AM Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
  Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD  
10:54 AM - 10:59 AM Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA
  Presenter(s):Marianne Brodmann, MD  
11:00 AM - 11:05 AM New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment
  Presenter(s):Michael D. Dake, MD  
11:06 AM - 11:11 AM 3-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference
  Presenter(s):William A. Gray, MD / Stefan Müller-Hülsbeck, MD / Thomas Zeller, MD  
11:12 AM - 11:18 AM Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And Challenges With Treating CLTI Patients
  Presenter(s):Thomas Zeller, MD  
11:24 AM - 11:29 AM 1-Year Results Of The Lutonix 0.14 DCB (Becton Dickinson) RCT Versus POBA Mostly For CLTI: DCB Has Equal Safety But 6-Month Patency Advantage Not Present At 1 Year
  Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD / William A. Gray, MD / Dierk Scheinert, MD  
11:30 AM - 11:35 AM 2-Year Results Of Global Registry Of Lutonix BTK DCBs Mostly For CLTI Show Safety And Reasonable Effectiveness
  Presenter(s):Dierk Scheinert, MD / Michael K.W. Lichtenberg, MD  
11:36 AM - 11:41 AM 1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA
  Presenter(s):Wei Guo, MD / Francesco Liistro, MD  
11:42 AM - 11:47 AM Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter
  Presenter(s):Francesco Liistro, MD  
11:48 AM - 11:53 AM Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions
  Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
x
1:00 PM - 1:05 PM No Option CLTI: What Is It: What Are The Actual Options For Treatment
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
1:06 PM - 1:11 PM Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Worthwhile Saving Limbs Especially In Vascular Patients
  Presenter(s):Philip P. Goodney, MD, MS  
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
1:12 PM - 1:17 PM Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses: When A Single Autologous Vein Is Inadequate
  Presenter(s):Joseph L. Mills, MD  
1:18 PM - 1:23 PM PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Can Have Long-Term Patency And Limb Salvage And Are Worthwhile
  Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Neal S. Cayne, MD / Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Frank J. Veith, MD  
1:24 PM - 1:29 PM For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option
  Presenter(s):R. Clement Darling III, MD  
1:30 PM - 1:35 PM Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions
  Presenter(s):Matthew T. Menard, MD  
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
1:36 PM - 1:41 PM What Is The Real Prevalence Of No Option Anatomy Among The CLTI Population: What Is The Role For Foot Vein Arterialization: How Is It Best Done
  Presenter(s):Peter A. Schneider, MD  
1:42 PM - 1:47 PM Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
1:48 PM - 1:53 PM Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t
  Presenter(s):Roberto Ferraresi, MD  
1:54 PM - 1:59 PM 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing
  Presenter(s):Andrej Schmidt, MD  
2:00 PM - 2:05 PM How To Perform The LimFlow Procedure: Equipment Required And Technical Tips
  Presenter(s):Miguel F. Montero-Baker, MD  
2:06 PM - 2:11 PM Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results
  Presenter(s):Richard F. Neville, MD  
2:12 PM - 2:18 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
x
2:18 PM - 2:23 PM 3-Year Results From The BioMimics 3D Swirling Flow Stent In The MIMICS-2 Study: Who Needs Paclitaxel
  Presenter(s):Peter Gaines, MD / Michael K.W. Lichtenberg, MD / Timothy M. Sullivan, MD  
ARTERIAL PTFE BYPASSES
2:24 PM - 2:29 PM RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful
  Presenter(s):Yann Gouëffic, MD, PhD  
2:30 PM - 2:35 PM Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective
  Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD  
PERCUTANEOUS BYPASSES
2:36 PM - 2:41 PM Percutaneous (PQ) Tranvenous Fempop PTFE Bypasses With The Torus 2 Device: How It Works And Status Of The DETOUR And TORUS Trials In The US And Europe
  Presenter(s):Ehrin Armstrong, MD / Daniel G. Clair, MD / Peter A. Schneider, MD  
2:42 PM - 2:47 PM 3-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through The Femoral Vein: Will It Make Open Bypass Obsolete
  Presenter(s):Dainis K. Krievins, MD  
2:48 PM - 2:53 PM A Novel Technique For PQ Fempop Bypass Routing The PTFE Bypass Through The Soft Tissue Of The Thigh: How To Do It And Early Results
  Presenter(s):Pierre Saradon, MD / Jean-Pierre Becquemin, MD, FRCS  
2:54 PM - 2:58 PM Panel Discussion
NEW INFORMATION ON STENT-GRAFTS
2:58 PM - 3:03 PM 2-Year Results Of The SUPER B RCT Shows That Viabahn Stent-Grafts Have Patency Rates As Good As Open Fempop PTFE Bypasses But Require More Reinterventions: How To Make Viabahns Work Best
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
3:04 PM - 3:09 PM Advantages And Limitations Of The Gore Viabahn VBX Balloon Expandable (BE) Covered Stent For Treating Complex SFA Disease: Comparison With The Self-Expanding Viabahn: 1-Year Results From The IVORY Japanese Trial
  Presenter(s):Osamu Iida, MD  
3:10 PM - 3:15 PM Advantages, Limitations And Results Of Gore VBX BE Stent-Graft For Occlusive Disease In Various Vascular Beds And For F/B/EVAR Branches: Comparison With Other Stent-Grafts
  Presenter(s):Rocco Giudice, MD / Ciro Ferrer, MD, PhD  
TREATMENT OF IN STENT RESTENOSIS (ISR)
3:16 PM - 3:02 PM How Best To Treat Long Difficult ISR In Complex SFA Lesions
  Presenter(s):Sonia Ronchey, MD,PhD  
3:22 PM - 3:27 PM The Excimer Laser For Treating ISR: It Has A Role In Grossing And Debulking Difficult Lesions: Technical Tips
  Presenter(s):Craig M. Walker, MD  
3:28 PM - 3:33 PM Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
3:34 PM - 3:48 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
x
3:48 PM - 3:53 PM Update On The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Current Status, Challenges And What Will Be Its Value
  Presenter(s):Alik Farber, MD, MBA / Matthew T. Menard, MD / Kenneth Rosenfield, MD  
3:54 PM - 3:59 PM The Japanese SPINACH Registry Shows Why WIFI Wound Severity Helps To Select Open Versus Endovascular Treatment And Predicts Patient Survival
  Presenter(s):Nobuyoshi Azuma, MD  
4:00 PM - 4:05 PM The New Global Vascular Guidelines For CLTI Are Better Than Obsolete TASC Guidelines Because Treatment Recommendations, Revascularization Strategies And Needs For The Future Are Not Based On Lesion Anatomy But Are Nuanced By Other Factors
  Presenter(s):Michael S. Conte, MD  
METHODS FOR EVALUATING FOOT PERFUSION
4:06 PM - 4:11 PM Measuring Foot Perfusion After Endo Treatments For CLTI With Perfusion Angiography And Smart Software: Why It Is Important And How To Do It
  Presenter(s):Jim Reekers, MD, PhD  
4:12 PM - 4:17 PM Indocyanine Green Fluorescence (IGC-FL) Is A Good Way To Measure Foot Perfusion After Treatment: How It Explains Why The Angiosome Concept Is Important After Endo Treatments But Not After Bypasses
  Presenter(s):Maarit Venermo, MD, PhD  
4:18 PM - 4:23 PM How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not
  Presenter(s):Marianne Brodmann, MD  
4:24 PM - 4:29 PM What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters
  Presenter(s):Ido Weinberg, MD, MSc  
4:30 PM - 4:35 PM Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated
  Presenter(s):Hasan H. Dosluoglu, MD / Linda Harris, MD  
4:36 PM - 4:41 PM Foot Perfusion Measurements Show Why Open Bypasses Are Better Than Endovascular Treatments For CLTI
  Presenter(s):Werner Lang, MD  
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
x
INTERMITTENT CLAUDICATION (IC)
4:48 PM - 4:53 PM DEBATE: A RCT After 2 Years Shows That Stent Treatment For Intermittent Claudication (IC) Improves Quality Of Life More Than Medical Treatment And Exercise
  Presenter(s):Hans Lindgren, MD, PhD  
4:54 PM - 5:00 PM DEBATE: Interventions For IC Are Safe But Lead To Greater Decreased Function And Increased Limb Loss
  Presenter(s):Jeffrey J. Siracuse, MD  
5:00 PM - 5:05 PM Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined
  Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD  
5:06 PM - 5:11 PM Value Of Neuromuscular Electrical Stimulation (NMES) To Treat IC: It Works And How
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
5:12 PM - 5:16 PM Panel Discussion
ACUTE LIMB ISCHEMIA (ALI) (SEE ALSO SESSION 63)
5:16 PM - 5:21 PM Key Points From The New European Guidelines For Diagnosis And Treatment Of ALI In The Upper And Lower Limbs: When To Use Which Treatments
  Presenter(s):Martin Bjorck, MD, PhD  
5:22 PM - 5:27 PM Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
5:28 PM - 5:33 PM Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best When And Why
  Presenter(s):Patrick E. Muck, MD, FACS  
5:34 PM - 5:39 PM Aspiration Thrombectomy Devices And Techniques For ALI: Are Thrombolytics And Fogarty Balloon Catheters Obsolete
  Presenter(s):Maria A. Ruffino, MD, EBIR  
5:40 PM - 5:45 PM Penumbra Indigo Clot Aspiration System To Treat ALI: Why Is It A Game Changer: Technical Tips For Usage
  Presenter(s):James F. Benenati, MD  
5:46 PM - 5:51 PM Value And Technical Tips For Using The Indigo Clot Removal System Before Treating ISR And Other Lesions With Balloon And Stents
  Presenter(s):Frank R. Arko, MD  
5:52 PM - 5:57 PM How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD  
5:58 PM - 6:02 PM Panel Discussion
End of Program D

END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
x
6:40 AM - 6:45 AM What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There
  Presenter(s):Marianne Brodmann, MD  
6:46 AM - 6:51 AM When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
6:52 AM - 6:57 AM Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur
  Presenter(s):Peter Henke, MD  
6:58 AM - 7:03 AM Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins
  Presenter(s):J. David Spence, MD  
7:04 AM - 7:09 AM DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
7:10 AM - 7:15 AM DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
  Presenter(s):Ron Waksman, MD  
7:16 AM - 7:21 AM Low Dose Rivaroxaban (Bayer) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo and Open Treatments For PAD/CLTI: From The VOYAGER RCT
  Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD  
7:22 AM - 7:27 AM How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And Compass Trials
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
7:28 AM - 7:33 AM New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
7:34 AM - 7:42 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham)
  Presenter(s):Sahil A. Parikh, MD  
7:48 AM - 7:53 AM Updates On Other Methods Of Renal Denervation: Chemical (Alcohol) Infusion Via The Peregrine Catheter (Ablative Solutions) And Ultrasound Via The Paradise Catheter (ReCor Medical)
  Presenter(s):Horst Sievert, MD  
7:54 AM - 7:59 AM Preop Cardiac Evaluation With CT-Based Fractional Flow Reserve (FFRCT) And Selective Coronary Revascularization Saves Lives In Patients Undergoing Procedures For CLTI And Carotid Disease
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
8:00 AM - 8:05 AM The ISCHEMIA RCT Shows No Difference In Survival For Best Medical Treatment Versus Intervention In Patients With Stable Angina And Moderate Coronary Disease – Although Quality Of Life Is Better After Intervention: Will The Trial Change Practice
  Presenter(s):Judith S. Hochman, MD  
8:06 AM - 8:11 AM How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart
  Presenter(s):Frans L. Moll, MD, PhD  
8:12 AM - 8:17 AM When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks Because Duration Of Cessation Matters
  Presenter(s):Jeffrey J. Siracuse, MD  
8:18 AM - 8:23 AM Permissive Transfusion Strategies Increase Mortality And Serious Adverse Events After Major Vascular And General Surgery Operative Interventions
  Presenter(s):Panos Kougias, MD, MSc  
8:25 AM - 8:29 AM How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Decision Making And What To Do About It Other Than Treating ACS Patients Non-Invasively
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
8:30 AM - 8:35 AM Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat
  Presenter(s):Michael E. Barfield, MD  
8:36 AM - 8:41 AM Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment
  Presenter(s):Roxana Mehran, MD  
8:42 AM - 8:50 AM Panel Discussion
8:50 AM - 9:06 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
x
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS
9:06 AM - 9:11 AM Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
TREATING TYPE 1 ENDOLEAKS
9:12 AM - 9:17 AM Type 1A Endoleaks After EVAR Are Predictable And Preventable: How To Do So
  Presenter(s):Michael J. Singh, MD  
9:18 AM - 9:23 AM When And How To Treat Type 1 Endoleaks With Embolization: Technical Tips
  Presenter(s):Robert A. Morgan, MD  
9:24 AM - 9:29 AM When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately
  Presenter(s):Sigrid Nikol, MD  
9:30 AM - 9:35 AM How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How To Treat Them When They Occur: When Not To Treat Them
  Presenter(s):Konstantinos P. Donas, MD  
9:36 AM - 9:41 AM Fibrin Glue Sac Filling Technique During EVAR To Prevent All Endoleaks: It Should Be Routine And Is A Game Changer Based On A Multicenter Trial: How To Do It
  Presenter(s):Qingsheng Lu, MD  
ROLE OF INFLAMMATION
9:42 AM - 9:47 AM The Role Of Inflammation In Causing Late Endoleaks: How To Evaluate It And How Should It Influence Treatment
  Presenter(s):Furuzan Numan, MD  
9:48 AM - 9:53 AM Panel Discussion
PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
9:53 AM - 9:58 AM A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: Confirmed By A Japanese RCT: When And How To Do It
  Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD  
9:59 AM - 10:04 AM Preventing Threatening Type 2 Endoleaks By IMA Embolization When AAA Sac And IMA Are Large: Indications And Technical Tips And Evidence
  Presenter(s):Toru Kuratani, MD, PhD  
10:05 AM - 10:10 AM With A Large IMA (> 3mm), When Should It Be Embolized; When Should It Be Revascularized And Why
  Presenter(s):Piotr M. Kasprzak, MD  
10:11 AM - 10:16 AM Selective Coiling Of IMA And Lumbar Arteries Decrease Harmful Type 2 Endoleaks: When And How To Do It
  Presenter(s):Götz M. Richter, MD, PhD  
10:17 AM - 10:22 AM Panel Discussion
TREATMENT OF TYPE 2 ENDOLEAKS AFTER EVAR
10:22 AM - 10:27 AM How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips
  Presenter(s):Ross Milner, MD  
10:28 AM - 10:33 AM Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It
  Presenter(s):Neal S. Cayne, MD  
10:34 AM - 10:39 AM Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
  Presenter(s):Adam Beck, MD  
10:40 AM - 10:45 AM How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access
  Presenter(s):Mark W. Mewissen, MD, RVT  
10:46 AM - 10:51 AM Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions
  Presenter(s):James F. McKinsey, MD  
10:52 AM - 10:57 AM Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique
  Presenter(s):Zvonimir Krajcer, MD, FACC  
10:58 AM - 11:03 AM With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is Not Occult Type 1 Leak
  Presenter(s):Zachary M. Arthurs, MD  
11:04 AM - 11:12 AM Panel Discussion
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: TCT RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
x
11:12 AM - 12:00 PM PROGRAM TO BE DETERMINED
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: VIDEO SESSION: RECORDED LIVE CHALLENGING ENDOVASCULAR CASES AND INNOVATIVE TECHNIQUES
Moderators:TBD
x
PART 1 – PLINIO ROSSI’S RECORDED LIVE CASE SESSION
Moderator(s): Fabrizio Fanelli, MD, EBIR / Andrew Holden, MBChB / Carlo Setacci, MD  
1:00 PM - 1:25 PM PROGRAM TO BE DETERMINED
PART 2 – RECORDED LIVE CASES FROM LINC AND LEIPZIG
Moderator(s): Dierk Scheinert, MD / Giancarlo Biamino, MD, PhD / Andrej Schmidt, MD  
1:25 PM - 1:50 PM PROGRAM TO BE DETERMINED
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: ISSUES IMPORTANT TO HISTORY, VASCULAR SURGICAL LEADERSHIP, SCIENCE, TRAINING AND CAREERS
x
HISTORICAL NOTE
1:50 PM - 1:55 PM What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today
  Presenter(s):Cynthia K. Shortell, MD  
1:56 PM - 2:01 PM How To Succeed In Academic Vascular Surgery: Don’t Be A Revolutionary
  Presenter(s):Ronald L. Dalman, MD  
2:02 PM - 2:07 PM How To Become President Of A Major Vascular Society Or The SVS
  Presenter(s):Anil P. Hingorani, MD  
2:08 PM - 2:13 PM Vascular Surgery In The Democratic Republic Of The Congo: An Amazing Story
  Presenter(s):Jesse M. Manunga, MD  
2:14 PM - 2:19 PM RCTs And Meta-Analyses Can Be Flawed And Biased: They Should Only Be Viewed With Other Evidence And Common Sense
  Presenter(s):George S. Lavenson, MD  
2:20 PM - 2:25 PM Why Systematic Reviews And Meta-Analyses Can Be Misleading: What To Do About It
  Presenter(s):Janet T. Powell, MD, PhD  
ISSUES IN VASCULAR TRAINING
2:26 PM - 2:31 PM Coming Crisis In Vascular Surgical Training – In Both 5+2 And 0+5 Programs: What Can Be Done About It
  Presenter(s):Michael B. Silva, Jr., MD  
2:32 PM - 2:37 PM How To Remedy The Deficiency Vascular Fellows And Residents Have In Numbers Of Open Vascular Surgical Operations
  Presenter(s):Malachi Sheahan, MD  
2:38 PM - 2:43 PM Ten Golden Rules To Train Vascular Surgeons In Distal Bypass Procedures In 2020
  Presenter(s):Francesco Spinelli, MD  
2:44 PM - 2:49 PM Ten Top Tips For Establishing An Independent Research Initiative In Vascular Surgery After Training
  Presenter(s):Philip P. Goodney, MD, MS  
2:50 PM - 2:58 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: MORE ISSUE RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
x
2:58 PM - 3:03 PM Heart And Vascular Centers Are Artificial Entities That Disadvantage Vascular Surgeons
  Presenter(s):Malachi Sheahan, MD  
3:04 PM - 3:09 PM The Wellness Of Vascular Surgeons: Physical And Mental: How To Monitor It And How To Promote It And Prevent Burnout
  Presenter(s):Samuel R. Money, MD, MBA  
3:10 PM - 3:15 PM Unfilled Promises With Devices, Drugs And Treatments: Initial Hype That Is Not Fulfilled: It Is Often Hidden: More Transparency Is Needed: A Few Examples
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
3:16 PM - 3:21 PM Advances In Telecare For Vascular Surgeons: What Is The Best Technology: What Does The Future Hold And What Was The Impact Of The COVID-19 Shutdowns
  Presenter(s):John (Jeb) W. Hallett, MD  
3:22 PM - 3:27 PM How To Improve Operating Room Efficiency For Vascular Surgical Operations: Why It Is So Widespread And Hard To Fix
  Presenter(s):Panos Kougias, MD, MSc  
3:28 PM - 3:33 PM Why Is The Per Capita Use Of EVAR And TAVR Dramatically Higher In New York State, USA Than Ontario, Canada
  Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD  
3:34 PM - 3:39 PM How To Avoid Lawsuits In Vascular Surgery And Other Vascular Specialties
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
3:40 PM - 3:45 PM Panel Discussion
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
3:45 PM - 3:50 PM Why And How Do Outpatient Angio Suites And OBLs Fail
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
3:51 PM - 3:56 PM Tips And Tricks For Performing High Risk Lower Extremity Endovascular Procedures Safely And Successfully In An Outpatient Setting
  Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD  
3:57 PM - 4:02 PM A Balanced View Of Atherectomy In Outpatient Facilities And OBLs In 2020: Is The Procedure Overused And Why
  Presenter(s):Krishna Jain, MD  
4:03 PM - 4:08 PM Inherent Conflicts Of Interest In OBLs: Why They Occur And Are Bad For Patients: How To Counteract Them
  Presenter(s):O. William Brown, MD, JD  
4:09 PM - 4:13 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF INSURANCE; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
x
4:13 PM - 4:18 PM What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2021: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements
  Presenter(s):Sean P. Roddy, MD  
4:19 PM - 4:24 PM How Can Vascular Surgeons Identify High Risk, High Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients
  Presenter(s):Lee Kirksey, MD  
4:25 PM - 4:30 PM Update On Valuable New Information From The International Consortium of Vascular Registries (ICVR)
  Presenter(s):Adam Beck, MD  
4:31 PM - 4:36 PM The Role And Value Of Guidelines In Vascular Practice; Why Guidelines Can Be Misleading; How Should They Be Written To Not Be
  Presenter(s):Anders Wanhainen, MD, PhD  
4:37 PM - 4:42 PM The Ethics Of The Health Insurance Business Models To Reduce Costs: Patients Are Not Being Well Served: What Can Be Done About It
  Presenter(s):James W. Jones, MD, PhD, MHA  
4:43 PM - 4:48 PM Importance Of Clinical Endpoints (Like Wound Healing, Amputation) Rather Than Proxy Endpoints (Like TLR) In Evaluating New Endovascular Technology And Its Incremental Benefits
  Presenter(s):Jim Reekers, MD, PhD  
4:49 PM - 4:54 PM Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not
  Presenter(s):Mohammad H. Eslami, MD, MPH  
4:55 PM - 5:00 PM Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Ethical And Beneficial To Patients And Society: Pitfalls To Avoid
  Presenter(s):Bruce A. Perler, MD, MBA  
5:01 PM - 5:06 PM Panel Discussion
5:06 PM - 5:11 PM Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses
  Presenter(s):Charles C. Miller, PhD  
REGULALTORY ISSUES
5:12 PM - 5:17 PM Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications
  Presenter(s):Dorothy B. Abel, BSBME  
5:18 PM - 5:23 PM The New (2020) European Regulations For Medical Device Approval: Will They Impede Approval Of Endovascular Treatments
  Presenter(s):Jim Reekers, MD, PhD  
5:24 PM - 5:29 PM Are The Quality, Safety And Effectiveness Of Generic Drugs Equating Those Of The Patented Original Drugs: How Is The FDA Assuring Equivalence; Should The FDA Do More
  Presenter(s):Valerie M. Merkle, PhD  
JOURNAL ISSUES
5:30 PM - 5:35 PM How To Get A Paper Accepted In A High Impact Journal Like The JVS: Does Bias Ever Matter
  Presenter(s):Peter Gloviczki, MD  
5:36 PM - 5:41 PM Non-Compliance With The SVS AAA Practice Guidelines Is Common: How Does It Impact On Outcomes
  Presenter(s):Elliot L. Chaikof, MD, PhD  
VQI TOPICS
5:42 PM - 5:47 PM Recent Challenges And Accomplishments Of The SVS VQI: A Worthy Organization
  Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD  
5:48 PM - 5:53 PM Using The SVS VQI To Improve The Practice Of Vascular Surgery: What Is The Concept Of CAPT And How Can It Help
  Presenter(s):Fred A. Weaver, MD, MMM  
5:54 PM - 6:00 PM Panel Discussion
End of Program E

END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), PENETRATING AORTIC ULCERS (PAU) AND THEIR TREATMENT
x
6:50 AM - 6:55 AM Aortic Arch Type And Adequacy Of The Proximal Seal Zone Are Important Determinants Of TEVAR Outcomes In Treatment Of TBADs
  Presenter(s):Firas F. Mussa, MD  
6:56 AM - 7:01 AM False Lumen Area >50% Of Total Aortic Cross-Section Area At The Tracheal Bifurcation At Time Of TEVAR For TBAD Is A Predictor Of Early Death: How To Decrease This Mortality
  Presenter(s):Johnny Steuer, MD, PhD  
7:02 AM - 7:07 AM Value Of Stent-Grafts In Genetically Triggered Aortopathy
  Presenter(s):Cherrie Z. Abraham, MD  
7:08 AM - 7:13 AM How Best To Deal With A Persistent Or Enlarging False Lumen After TEVAR For TBAD
  Presenter(s):Nicola Mangialardi, MD  
7:14 AM - 7:19 AM Update On Use And Value Of The Candy Plug Endovascular Device To Treat Chronic TBADs With A TAAA
  Presenter(s):Tilo Koelbel, MD, PhD  
7:20 AM - 7:25 AM Panel Discussion
7:25 AM - 7:30 AM Staged Hybrid Single Lumen Reconstruction Is The Best Treatment For Complex Chronic TBAD With Visceral Segment Involvement Of The Aorta: How To Do It, Advantages And Results
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
7:31 AM - 7:36 AM Reinterventions After TEVAR For TBADs: How To Decrease Them At The Index Procedure And How Planning Helps
  Presenter(s):Bijan Modarai, PhD, FRCS  
7:37 AM - 7:42 AM Adjunctive Peripheral And Visceral Interventions During TEVAR For Complicated TBADs: Indications, Technical Tips And Results
  Presenter(s):Mark K. Eskandari, MD  
7:43 AM - 7:48 AM Update On Intramural Hematoma (IMH): Etiology, Natural History And Indications For TEVAR
  Presenter(s):Frank J. Criado, MD  
7:49 AM - 7:54 AM Natural History And Optimal Treatment For Penetrating Aortic Ulcers (PAUs) When To Observe And When To Treat With TEVAR
  Presenter(s):Colin D. Bicknell, MD, FRCS  
7:55 AM - 8:00 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE ADVANCES RELATED TO SESSIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
x
8:00 AM - 8:05 AM Value Of Transcranial Doppler (TCD) For TEVAR And Endo Procedures Involving The Ascending Aorta And Aortic Arch
  Presenter(s):Alan B. Lumsden, MD, FACS  
8:06 AM - 8:11 AM Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
8:12 AM - 8:17 AM Role Of Bare Metal Stents (Ascyrus Medical) For Repair Of Acute Type A Dissections: Indications And Results
  Presenter(s):Grayson H. Wheatley, MD  
8:18 AM - 8:23 AM Caval Balloon Occlusion: A Better Way Than Rapid Pacing To Permit Precise Stent-Graft Placement In The Proximal Aorta: How To Do It And Is It Better For The Heart
  Presenter(s):Bjõrn Sonesson, MD, PhD  
8:24 AM - 8:29 AM For Precise TEVAR In The Aortic Arch Rapid Pacing And Caval Occlusion Are NOT Needed: Valsalva And PEEP By Anesthesiologist Do Just As Well And Are Simple: Technical Tips
  Presenter(s):Nikolaos Tsilimparis, MD; PhD  
8:30 AM - 8:35 AM Panel Discussion
8:35 AM - 8:40 AM Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why
  Presenter(s):Gustavo S. Oderich, MD, FACS  
8:41 AM - 8:46 AM Chimney Technique For Dealing With Total Arch Lesions And Dissections: How To Make It Work, Limitations And Results
  Presenter(s):Ivo Petrov, MD, PhD  
8:47 AM - 8:52 AM Laser Fenestration Option For TEVAR Involving The Great Arch Branches: When Is It Better Than Branched Endografts: Technique And Results
  Presenter(s):Timothy A. Resch, MD, PhD  
8:53 AM - 8:58 AM For Aortic Arch Repairs In Situ Fenestration Is Superior To Chimney TEVAR: New Technology From Life Tech For Doing It
  Presenter(s):Ralf R. Kolvenbach, MD  
8:59 AM - 9:04 AM For Distal Aortic Arch Pathology Custom Fenestrated Grafts (From Cook) Are The Best Repair Technique: Why
  Presenter(s):Nikolaos Tsilimparis, MD; PhD  
9:05 AM - 9:11 AM Panel Discussion
9:11 AM - 9:24 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
x
COMPLEX AAAs AND TAAAs
9:24 AM - 9:29 AM Open Repair Is The Best Way To Treat Short Neck, No Neck And Pararenal AAAs: Why Is This So
  Presenter(s):Laurent Chiche, MD, FEBVS  
9:30 AM - 9:35 AM Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated
  Presenter(s):Matthew J. Eagleton, MD  
9:36 AM - 9:41 AM How To Make 3 Chimney EVAR With Involvement Of The SMA Safe And Effective
  Presenter(s):Konstantinos P. Donas, MD  
9:42 AM - 9:47 AM Value Of Ch/EVAR For Juxtarenal AAAs: They Are As Safe And Effective As Any Other Procedure And Simpler
  Presenter(s):Joost A. van Herwaarden, MD, PhD  
9:48 AM - 9:53 AM Advances In Endovascular TAAA Repair In Canada: Making The Procedure Safe And Diagnosing And Fixing Late Type 3 Endoleaks
  Presenter(s):Thomas F. Lindsay, MDCM, FRCS, FACS  
9:54 AM - 9:59 AM Comparison Of Endo And Open Repair Of Post Dissection TAAAs: Which Procedure Is Best And When
  Presenter(s):Fabio Verzini, MD, PhD  
10:00 AM - 10:05 AM Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions
  Presenter(s):Gilbert R. Upchurch, MD / Dean Arnaoutakis, MD / Salvatore T. Scali, MD  
10:06 AM - 10:12 AM Panel Discussion
TOPICS RELATED TO INTERESTING NEW DEVICES
10:12 AM - 10:17 AM A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Early Clinical Experience And Advantages
  Presenter(s):Sebastian E. Debus, MD, PhD  
10:18 AM - 10:23 AM How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur
  Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS  
10:24 AM - 10:29 AM Why AAA Sac Shrinkage Is Better After EVAR With The Treo (From Terumo Aortic) Endograft
  Presenter(s):Michael C. Stoner, MD  
10:30 AM - 10:35 AM Update On The Colt Manifold Device For TAAAs, Complex AAAs, Failed EVARs And Failed EVAS Procedures: How Does It Work And Results
  Presenter(s):Piotr Szopinski, MD, PhD  
10:36 AM - 10:41 AM We Flow Device For Juxtarenal AAA Repair: A New Approach: How Does It Work And Early Results
  Presenter(s):Wei Guo, MD  
10:42 AM - 10:48 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
x
TREATMENT OF ILIAC ANEURYSMS AND IBDs
10:48 AM - 10:53 AM DEBATE: How Best To Treat Iliac Aneurysms In 2020: There Is Not Much Of A Need For Open Surgery
  Presenter(s):Stefan Müller-Hülsbeck, MD  
10:54 AM - 10:59 AM DEBATE: There Is A Role For Open Surgery In The Treatment Of Iliac Aneurysms: What Is It And Technical Tips
  Presenter(s):Heron E. Rodriguez, MD  
11:00 AM - 11:05 AM Long-Term Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Advantages And Limitations
  Presenter(s):Giovanni B. Torsello, MD  
11:06 AM - 11:11 AM Terumo Aortic Customized Iliac Branched Device: How Is It Different From Other IBDs: Advantages And Limitations
  Presenter(s):Afshin Assadian, MD  
11:12 AM - 11:17 AM Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
11:18 AM - 11:23 AM Long-Term Comparison Of The Cook Zenith And Gore Excluder IBDs: Advantages And Limitations Of Both
  Presenter(s):Giovanni Pratesi, MD  
11:24 AM - 11:30 AM Panel Discussion
UPDATE ON MULTILAYER FLOW MODULATING (MLFM) BARE STENTS
11:30 AM - 11:35 AM Why MLFM Bare Stents Should Be The Treatment Of Choice For Visceral, Peripheral And Iliac Aneurysms: Advantages And Has Rupture Been Universally Prevented
  Presenter(s):Michel C. Henry, MD  
11:36 AM - 11:41 AM MLFM Bare Stent (From Cardiatis) Is A Promising Treatment For Acute Aortic Dissections: What Is the Evidence In Support
  Presenter(s):Rodney A. White, MD  
11:42 AM - 11:47 AM Improved Outcomes Of Type A Aortic Dissections With Use Of Bare Stents (Cardiatis And Ascyrus): They Decrease Malperfusion, Promote Aortic Remodeling And Prevent Strokes: How Do They Work
  Presenter(s):Ralf R. Kolvenbach, MD  
11:48 AM - 11:53 AM Update On The Long-Term Results Of The MLFM Bare Stents (Cardiatis) In The Treatment Of TAAAs: Are They Proving Safe And Effective Mid And Long-Term: What Is Their Role
  Presenter(s):Claude D. Vaislic, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break -2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
x
1:00 PM - 1:05 PM A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results
  Presenter(s):Venkatesh G. Ramaiah, MD  
AAA NECK BEHAVIOR AFTER EVAR
1:06 PM - 1:11 PM Impact Of Oversizing And Level Of Fixation (Infra Versus Supra-Renal) On Aortic Neck Behavior: How Do These Variables Affect EVAR Outcomes: From A 10-Year Study
  Presenter(s):Carlos F. Bechara, MD  
1:12 PM - 1:17 PM Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes
  Presenter(s):Thomas S. Maldonado, MD  
1:18 PM - 1:23 PM Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAN RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts
  Presenter(s):Jan D. Blankensteijn, MD  
1:24 PM - 1:29 PM Do AAA Necks Dilate After F/EVAR For Juxtarenal AAAs: What Are The Good Or Bad Consequences For Procedural Outcomes
  Presenter(s):Benjamin W. Starnes, MD  
1:30 PM - 1:35 PM DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
1:36 PM - 1:41 PM DEBATE: Not So: Ovation Stent-Graft (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft
  Presenter(s):Mahmoud B. Malas, MD, MHS  
1:42 PM - 1:47 PM Current Status Of The Link Between EVAR And Cancer: Is It Real And What Is Its Etiology
  Presenter(s):Janet T. Powell, MD, PhD  
1:48 PM - 1:53 PM Why 3D Ultrasound Should Replace CTA For AAA Post EVAR Surveillance And Other Purposes: Advantages And Limitations
  Presenter(s):Henrik Sillesen, MD, DMSc  
1:54 PM - 1:59 PM Presenting AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed, Inaccurate And Harmful
  Presenter(s):Frank J. Criado, MD  
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
x
AAA NECK AND SAC THROMBUS LOAD
2:06 PM - 2:11 PM Impact Of Thrombus In AAA Sac And Neck On AAA Behavior And EVAR Outcomes: How To Quantitate Thrombus Load And Distribution
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
2:12 PM - 2:17 PM DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And Rupture: What Is The Mechanism And How To Quantitate Thrombus Load
  Presenter(s):David H. Deaton, MD, FACS  
2:18 PM - 2:23 PM DEBATE: Large Flow Lumenal Space In AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
2:24 PM - 2:29 PM Graft Infolding: A Unique EVAR Complication: How To Prevent It and How To Treat It
  Presenter(s):Ashraf Mansour, MD  
2:30 PM - 2:35 PM Large AAA Necks (> 29 mm) Increase Migration And Leak Risks After EVAR With Self-Expanding Endografts Due To Neck Dilatation: Not So With Anatomically Adaptive (Polymer) Sealing Endografts (Ovation) Which Are Not Followed With Neck Dilatation
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
2:36 PM - 2:41 PM Does Doxycycline Stabilize AAA Neck Diameter: From The NTACT Trial
  Presenter(s):Jon S. Matsumura, MD  
2:42 PM - 2:47 PM EVAS With Sac Filling Technology (Nellix) Has Lower Late Mortality Than EVAR With Other Endografts – Especially With Large AAAs: What Is The Mechanism Thought To Be
  Presenter(s):Marc L. Schermerhorn, MD  
2:48 PM - 2:53 PM Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries
  Presenter(s):Barend M.E. Mees, MD, PhD  
2:54 PM - 2:59 PM 4X Increased 18F FDG Uptake On PET CT In Female AAA Patients Compared To Males Indicates Increased Aortic Wall Inflammation: Does This Explain Increased Rupture Risk In Females: Implications For Treatment
  Presenter(s):Natzi Sakalihasan, MD, PhD  
3:00 PM - 3:06 PM Panel Discussion
3:06 PM - 3:15 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: SHORT HOT AORTIC TOPICS (4 ¾-MINUTE FAST PACED TALKS)
x
3:15 PM - 3:20 PM Large Diameter AAAs Negatively Impacts Patient Survival After EVAR: Is Inflammation Involved And What Can Be Done About It
  Presenter(s):Matt M. Thompson, MD  
3:20 PM - 3:25 PM A Large Proportion Of EVARs Are Performed On Small AAAs: What Are The Implications And What Should Be Done About It
  Presenter(s):Salvatore T. Scali, MD  
3:25 PM - 3:30 PM Late Delayed Renal Artery Revascularization After Inadvertent Occlusion During Complex EVAR Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced
  Presenter(s):Nikolaos Tsilimparis, MD; PhD  
3:30 PM - 3:35 PM Global Trends In AAA Mortality: What Reasons Explain These Trends
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
3:35 PM - 3:40 PM How Can A Long-Term Aortic Risk (LEAR) Model Predict Mortality And Complication Risks And Guide Surveillance: Can The Model Be Made Device Specific
  Presenter(s):Pete Holt, MD, PhD  
3:40 PM - 3:45 PM Update On Status Of Retrograde And Prograde In Situ Fenestration For Arch Aneurysms And TAAAs: How To Do Them
  Presenter(s):Jean M. Panneton, MD  
3:45 PM - 3:50 PM Long-Term Propensity Matched Comparison Of Open Repair And F/B/EVAR For Pararenal And Paravisceral AAAs
  Presenter(s):Giovanni G.T. Tinelli, MD, PhD  
3:50 PM - 3:55 PM Panel Discussion
3:55 PM - 4:00 PM Safe Anticoagulation In F/B/EVAR Patients Requiring Spinal Fluid Drainage
  Presenter(s):Afshin Assadian, MD  
4:00 PM - 4:05 PM Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat TAAAs In Good Risk Patients: How To Do It Safely
  Presenter(s):Guillermo A. Escobar, MD  
4:05 PM - 4:10 PM Update On Maintaining Euglycemia To Decrease Spinal Cord Ischemia With Complex AAA And TAAA Repairs
  Presenter(s):Jade S. Hiramoto, MD  
4:10 PM - 4:15 PM Incidence And Etiology Of Cerebrovascular Injuries With Acute TBADs With And Without Treatment
  Presenter(s):Loay S. Kabbani, MD, MHSA  
4:15 PM - 4:20 PM EVAR, F/EVAR And B/EVAR Results In Females: Are There Still Differences
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
4:20 PM - 4:25 PM Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 3-Year Results
  Presenter(s):Jörg Tessarek, MD  
4:25 PM - 4:30 PM Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation >6 Years After EVAR With Self-Expanding Endografts: Does The Neck Keep Dilating After The Spring Is Gone: What Are The Differences Between Excluder And Endurant Endografts
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
4:30 PM - 4:35 PM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT (4 ¾-MINUTE FAST PACED TALKS)
x
4:35 PM - 4:40 PM Role Of Endovascular And Open Treatment For Mid Aortic Syndrome In Children, Teenagers And Young Adults
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
4:40 PM - 4:45 PM Endovascular Repair Of Thoracic Aneurysms With TEVAR Outside IFUs: Value And Limitations: From A Multicenter Study
  Presenter(s):Fabio Verzini, MD, PhD  
4:45 PM - 4:50 PM A New Gene Family In AAA Smooth Muscle Is Related To Aneurysm Diameter And Rupture: Could It Be A Screening Tool
  Presenter(s):Kak Khee Yeung, MD, PhD  
4:50 PM - 4:55 PM Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs
  Presenter(s):Matthew J. Eagleton, MD  
4:55 PM - 5:00 PM How To Make Ch/EVAR Work: A Standard Protocol Helps: What Are The Best Endografts For The Aorta; For The Branches: How To Prevent Gutter Endoleaks
  Presenter(s):Konstantinos P. Donas, MD  
5:00 PM - 5:05 PM How To Treat AAAs With Large (>34 mm Diameter) Necks: When EVAR; When F/EVAR; When Open
  Presenter(s):Rabih A. Chaer, MD  
5:05 PM - 5:10 PM 3-Stage Concept For Treating Mega-Aortic Syndrome: Frozen Elephant Trunk (FET), TEVAR, Distal Open Repair: Results
  Presenter(s):Martin Czerny, MD  
5:10 PM - 5:15 PM Panel Discussion
5:15 PM - 5:20 PM How Should Intramural Hematomas (IMHs) In The Ascending Aorta And Arch Be Treated
  Presenter(s):Jennifer L. Perri, MD, MBA / Timothy A.M. Chuter, DM  
5:20 PM - 5:25 PM How To Set Up A Large Multispecialty Acute Aortic Disease Network: How Does It Improve Results
  Presenter(s):Jean-Marc Alsac, MD, PhD  
5:25 PM - 5:30 PM How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results
  Presenter(s):Luis A. Sanchez, MD  
5:30 PM - 5:35 PM An Unrecognized Mechanism For Causing Aortic Dissections: Shock Wave Energy Rather Than Increased Arterial Pressure Causes The Tear: How Does It Work And How To Decrease The Risk
  Presenter(s):Erno Remsey-Semmelweis, MD  
5:35 PM - 5:40 PM Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Outcomes
  Presenter(s):Naoki Fujimura, MD, PhD  
5:40 PM - 5:45 PM The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It
  Presenter(s):Sukgu Han, MD  
5:45 PM - 5:50 PM Comparison Of Endo And Open (Carotid-Subclavian Bypass) Treatments For Subclavian Artery Stenosis And Occlusions: Safety, Durability And Costs
  Presenter(s):Ali F. AbuRahma, MD  
5:50 PM - 5:55 PM Panel Discussion
End of Program F

END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
x
6:50 AM - 6:55 AM Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It
  Presenter(s):Matthew T. Menard, MD  
6:56 AM - 7:01 AM Update On Remote Monitoring Of Vascular Grafts: Where Is It At And Where Is It Going
  Presenter(s):Richard F. Neville, MD  
7:02 AM - 7:07 AM New Wearable Technologies For Telemonitoring Vascular Diseases And Their Treatments: They Will Improve Care And Decrease Hospitalization And Office Visits
  Presenter(s):Celia Riga, MD, FRCS  
7:08 AM - 7:13 AM Value Of Digital Health In Vascular Disease Management: Virtual And Otherwise
  Presenter(s):Tony S. Das, MD  
7:14 AM - 7:19 AM Vascular Surgical Risks Of Shoulder Reconstructive Surgery: What Are They And How Should They Be Managed
  Presenter(s):Jacques Busquet, MD  
7:20 AM - 7:25 AM Why Carotid Plaque Morphology Differ In Patients With An Acute MI And Those With Intermittent Claudication: Why It Matters
  Presenter(s):Henrik Sillesen, MD, DMSc  
7:26 AM - 7:31 AM Panel Discussion
7:31 AM - 7:36 AM Relining Occluded Vein Grafts With Viabahn (Gore) Stent-Grafts Or Supera (Abbott) Bare Stents Can Restore Patency And Avoid Thrombolysis: Techniques And Results
  Presenter(s):Hans Lindgren, MD, PhD  
7:37 AM - 7:42 AM Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: What Are The Implications
  Presenter(s):Janet T. Powell, MD, PhD  
7:43 AM - 7:48 AM The Temporary Perfuse Dual Chamber Stent-Graft For Clamp Free Aortic Surgery, Drug Delivery And Other Uses: How Does It Work
  Presenter(s):Bryan W. Tillman, MD, PhD  
7:49 AM - 7:54 AM Provider Skill Is Not Getting Appropriate Attention In The Health Care Value Equation Of Value = Outcome/Cost: What To Do About It
  Presenter(s):Lars B. Lonn, MD, PhD  
7:55 AM - 8:00 AM Effect Of Increased Hydration And Protein Intake On Lower Extremity Arteriosclerotic Ischemia With IC And CLTI: What Is the Evidence And The Mechanism: Will It Change The Game And Decrease The Need For Stents And Bypasses
  Presenter(s):Juan C. Parodi, MD  
8:01 AM - 8:06 AM Update On Isolated Limb Perfusion To Enable Amputated Limb Reimplantation
  Presenter(s):Zachary M. Arthurs, MD  
8:07 AM - 8:12 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
8:12 AM - 8:17 AM Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them
  Presenter(s):Thomas S. Maldonado, MD  
8:18 AM - 8:23 AM F/B/EVAR Treatment Of FAILED EVAR: A Safer Better Way To Treat: How Has The Aortic Research Consortium Helped To Promote Solutions To This And Other Problems
  Presenter(s):Andres Schanzer, MD  
8:24 AM - 8:29 AM When Is Ch/EVAR Indicated And Equally Effective To F/EVAR For Juxta And Pararenal AAAs In Terms Of Outcomes And Cost: Why Are Opinions On Ch/EVAR So Divergent
  Presenter(s):Konstantinos P. Donas, MD  
8:30 AM - 8:35 AM Status Of Automated Planning Software For F/EVAR Endografts From Aortica (Terumo Aortic): Design Features And Advantages Of A F/EVAR Dedicated Bridging Stent-Graft
  Presenter(s):Benjamin W. Starnes, MD  
8:36 AM - 8:41 AM Mortality From Aneurysm Rupture While Waiting For A Customized F/B/EVAR Endograft: Strategy To Prevent: Are There Reasons For Open Repairs In A High Volume F/B/EVAR Center
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
8:42 AM - 8:47 AM Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective
  Presenter(s):Mark A. Farber, MD  
8:48 AM - 8:53 AM Why Balloon Expandable Bridging Stents-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A European Perspective
  Presenter(s):Mauro Gargiulo, MD  
8:54 AM - 8:59 AM What Is The Best Bridging Covered Stent (Stent-Graft) For F/B/EVAR Based On An In Vitro Fatigue Testing Model And Other Considerations
  Presenter(s):Martin J. Austermann, MD  
9:00 AM - 9:05 AM With Complex AAAs, When F/B/EVAR; When Parallel Grafts; When Open Repair: All Have Their Pros And Cons
  Presenter(s):Chang Shu, MD  
9:06 AM - 9:11 AM Technical Tips For F/B/EVAR Repairs Of TAAAs Complicating TBADs
  Presenter(s):Götz M. Richter, MD, PhD  
9:12 AM - 9:17 AM How To Safely And Effectively Treat TAAAs With Off-The-Shelf (OTS) Devices Including Chimney And Sandwich Stent-Grafts: The Docking Station Approach: How To Do It And Midterm Results
  Presenter(s):Manish Mehta, MD, MPH  
9:18 AM - 9:26 AM Panel Discussion
9:26 AM - 9:38 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
9:38 AM - 9:43 AM Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Safely Do It Safely And To Downsize Femoral Sheaths To Restore Lower Extremity Flow
  Presenter(s):Darren B. Schneider, MD  
9:44 AM - 9:49 AM Present Status Of Parallel Grafts For Complex AAAs And TAAAs: How To Do These Repairs Safely And Effectively: Results To Date
  Presenter(s):Armando C. Lobato, MD, PhD  
9:50 AM - 9:55 AM Value And Advantages Of Preloaded Wires And Catheters For F/B/EVAR: How Do They Work; Are There Pitfalls
  Presenter(s):Mark A. Farber, MD  
9:56 AM - 10:01 AM DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better
  Presenter(s):Adam Beck, MD  
10:02 AM - 10:07 AM DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper
  Presenter(s):Edward Y. Woo, MD  
10:08 AM - 10:13 AM F/EVAR Is Sometimes Justified In Patients >80: How About >90
  Presenter(s):Clark J. Zeebregts, MD, PhD  
10:14 AM - 10:19 AM DEBATE: Increasing The Number Of Fenestrations In F/EVAR Beyond 2 Improves Outcomes Without Increasing Downsides
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
10:20 AM - 10:25 AM DEBATE: Not So! 2 Branch F/EVAR Is Sometimes Better And Has Fewer Complications And Downsides In Some Cases: Which Ones
  Presenter(s):Timothy A. Resch, MD, PhD  
10:26 AM - 10:31 AM Technical Tips To Deploy F/EVAR Endografts Precisely With Tortuous Anatomy: How To Compensate For Endograft Rotation And Still Match Fenestrations To Branch Orifices Perfectly
  Presenter(s):Bjõrn Sonesson, MD, PhD  
10:32 AM - 10:37 AM Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them
  Presenter(s):W. Anthony Lee, MD  
10:38 AM - 10:43 AM Technical Tips And Precautions For Using Steerable (Variable Curve) Sheaths For B/EVAR: Why They May Not Work And How To Make Them Work
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
10:44 AM - 10:52 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
x
10:52 AM - 11:03 AM The Vietnam Battle Of Ia Drang (November 14-16, 1965): Why Was It Fought And Why Was It Significant (11-Minute Talk)
  Presenter(s):Wayne F. Yakes, MD  
11:04 AM - 11:09 AM Department of Defense Effort To Support Vascular Surgery Research And US National Preparedness For Mass Casualties
  Presenter(s):Todd E. Rasmussen, MD, FACS  
11:10 AM - 11:15 AM Update On Endovascular Resuscitation And Control Of Bleeding: What Is New And Different: What Is The EVTM Society
  Presenter(s):Tal M. Hörer, MD, PhD  
11:16 AM - 11:21 AM Update On Civilian REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta) For Treatment Of Hemorrhage And Trauma: What Is New And Different: When And Where Should It Be Used And By Whom
  Presenter(s):Joseph J. DuBose, MD  
11:22 AM - 11:27 AM Is REBOA A Panacea For Battlefield Hemorrhage Or Not Yet Ready For Prime Time Use
  Presenter(s):Brandon Propper, MD / Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
11:28 AM - 11:33 AM Current Advances In The Treatment Of Blast And High Velocity Gun Shot Injuries
  Presenter(s):Paul W. White, MD  
11:34 AM - 11:39 AM Update On The Retrievable Rescue Stent Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work And Present Status
  Presenter(s):Bryan W. Tillman, MD, PhD  
11:40 AM - 11:45 AM Major Amputation Prosthetics Can Be Fixed Into Bone: How Does Osteointegration Work And How Is Infection Avoided
  Presenter(s):Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
11:46 AM - 11:51 AM Update On Tissue Engineered Biological Arterial Grafts (Humacyte): How Well Are They Working In Patients And In What Vascular Bed
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
x
1:00 PM - 1:05 PM Value, Limitations And Technical Tips For Using The Nellix Endograft For Ruptured AAAs
  Presenter(s):Tal M. Hörer, MD, PhD  
1:06 PM - 1:11 PM The Incidence Of Ruptured AAAs Is Decreasing And So Is Their Mortality: Why Are These 2 Facts So
  Presenter(s):Ross Milner, MD  
1:12 PM - 1:17 PM Statins Decrease The Growth Rate And Rupture Risk Of AAAs As Well As The Perioperative Mortality: Who Should Receive Them, When And At What Dose
  Presenter(s):Thomas L. Forbes, MD  
1:18 PM - 1:23 PM Impact Of Weekends On Treatment Method (Endo Versus Open Repair) And Outcomes (Early And Late) Of Treatment For Ruptured AAAs
  Presenter(s):Sebastian E. Debus, MD, PhD  
1:24 PM - 1:29 PM Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Wins In The End – Especially In Patients >80
  Presenter(s):Willem Wisselink, MD  
1:30 PM - 1:35 PM Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done
  Presenter(s):Martin Malina, MD, PhD  
1:36 PM - 1:41 PM EVAR Should Be The Standard Of Care For Most Ruptured AAAs: Reasons Why It Is Not So And How To Overcome Them
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
1:42 PM - 1:47 PM EVAR Is A Better Treatment For Ruptured AAAs Than Open Repair In Most Patients: The Mortality Benefit Of EVAR Is Increasing More Recently: Based On A Meta-Analysis
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
1:48 PM - 1:53 PM DEBATE: With Ruptured Complex AAAs And TAAAs, Off-The-Shelf F/B/EVAR Is The Best Treatment
  Presenter(s):Mark A. Farber, MD  
1:54 PM - 1:59 PM DEBATE: Not So: With Ruptured Complex AAAs And TAAAs Parallel Grafts Are Simpler, More Effective And Less Costly
  Presenter(s):Konstantinos P. Donas, MD  
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
x
NEW DEVELOPMENTS IN AAA SCREENING
2:06 PM - 2:11 PM Why The Current US PSTF Guidelines For AAA Screening Are Insufficient: Many At Risk Patients Are Not Screened
  Presenter(s):Malachi Sheahan, MD  
2:12 PM - 2:17 PM Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed
  Presenter(s):Marc L. Schermerhorn, MD  
2:18 PM - 2:23 PM Flaws In AAA Screening In Finland Result In AAA Ruptures In Patients Too Young For Screening And Whose AAAs Are Too Small To Reach Threshold For Repair
  Presenter(s):Maarit Venermo, MD, PhD  
2:24 PM - 2:29 PM Why AAA Screening Should Be Expanded To More Females, Younger Men And Older Men
  Presenter(s):Thomas F.X. O'Donnell, MD  
MORE ABOUT AAA RUPTURES AND THEIR TREATMENT
2:30 PM - 2:35 PM AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures
  Presenter(s):Piotr Szopinski, MD, PhD  
2:36 PM - 2:41 PM Update On Treating All (100%) Ruptured AAAs With EVAR: The Orebro Experience Shows It Is The Best Treatment And Lowers The Turndown Rate
  Presenter(s):Thomas Larzon, MD, PhD / Mario L. Lachat, MD / Zoran Rancic, MD, PhD / Tal M. Hörer, MD, PhD  
2:42 PM - 2:47 PM Experience With Cook t-Branched OTS Endograft To Treat Ruptured Pararenal AAAs And TAAAs: Advantages, Limitations And Results
  Presenter(s):Ciro Ferrer, MD, PhD / Rocco Giudice, MD  
2:48 PM - 2:53 PM In Situ Laser Fenestration To Facilitate Endograft Treatment Of Ruptured TAAAs: When Is It Needed; How To Do It And Results
  Presenter(s):Stephan Haulon, MD / Dominique Fabre, MD, PhD  
2:54 PM - 2:59 PM Open Repair For AAAs Should Not Be Used In Patients >80 Unless Their AAA Is >6 cm And They Are At Risk Of Rupture Or Ruptured: These Restrictions Do Not Apply To EVAR
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
3:00 PM - 3:05 PM Emergency Treatment Of Aortic Rupture From Chronic TBAD Using The Candy Plug Technique: Technical Tips And Results
  Presenter(s):Andrej Schmidt, MD / Daniela Branzan, MD  
3:06 PM - 3:11 PM Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen
  Presenter(s):Martin Bjorck, MD, PhD  
3:12 PM - 3:20 PM Panel Discussion
3:20 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
x
3:30 PM - 3:35 PM The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair
  Presenter(s):Janet T. Powell, MD, PhD  
3:36 PM - 3:41 PM Transradial Approaches For Complex Lower Extremity Interventions: CTSOs, Iliac, Fempop And BTK Lesions Can Be Treated: How To Make Them Work And Precautions: Advantages Of The Terumo R2P System
  Presenter(s):David O'Connor, MD  
3:42 PM - 3:47 PM New Endovascular Treatments For Pulsatile Tinnitus: What Are The Options
  Presenter(s):Athos Patsalides, MD, MPH  
3:48 PM - 3:53 PM The Spur Stent System (Reflow Medical): A Temporary Stent With Pins To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date
  Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
3:54 PM - 3:59 PM The Serrenator Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations And Prevents Dissections With PTA: Current Status: The PRELUDER Trial
  Presenter(s):Andrew Holden, MBChB  
4:00 PM - 4:05 PM What Is The OR Black Box System For Measuring Endovascular Operator Performance: How Does It Work And Should It Be In Every Hybrid Angio Suite
  Presenter(s):Isabelle van Herzeele, MD, PhD  
4:06 PM - 4:11 PM Update On A Clampless Sutureless Technique For Performing Aorto-Iliac Anastomosis Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Control And Suturing Is Impossible
  Presenter(s):Mario L. Lachat, MD  
4:12 PM - 4:17 PM Technical Tips For Safe Endovascular Treatment Of Hepatic Artery Stenosis After Liver Transplantation
  Presenter(s):W. Charles Sternbergh III, MD  
4:18 PM - 4:23 PM Current Status Of Left Gastric Embolization To Treat Obesity: Where Is It And What Will Its Role Be
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
4:24 PM - 4:29 PM The Many Possible Uses Of Femoral Veins For Arterial Procedures: How To Harvest Them Safely
  Presenter(s):Timur P. Sarac, MD  
4:30 PM - 4:38 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
x
PROGRESS IN RADIATION SAFETY
4:38 PM - 4:43 PM Endovascular Team Radiation Safety Performance: How To Monitor It: It Is More Than Dose Measurement
  Presenter(s):Isabelle van Herzeele, MD, PhD  
4:44 PM - 4:49 PM Myths And Facts Regarding Radiation Protection And Safety
  Presenter(s):Lindsay Machan, MD  
4:50 PM - 4:55 PM New ESVS Radiation Safety Guidelines: Why Are They Needed And How Will They Be Helpful
  Presenter(s):Bijan Modarai, PhD, FRCS  
4:56 PM - 5:01 PM Simple Radiation Protection Techniques For All Interventionalists To Use
  Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR  
5:02 PM - 5:05 PM Panel Discussion
NEW CONCEPTS, ETC.
5:05 PM - 5:10 PM With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula
  Presenter(s):I-Hui Wu, MD, PhD  
5:11 PM - 5:16 PM Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential
  Presenter(s):Michael B. Silva, Jr., MD  
5:17 PM - 5:22 PM Value Of Repetitive Digital Photo Documentation Of The Ischemic Foot: It Improves Decisions And Outcomes
  Presenter(s):Martin Malina, MD, PhD  
5:23 PM - 5:28 PM Minimizing Contrast Induced Nephropathy With EVAR By Contrast Dilution
  Presenter(s):Naoki Fujimura, MD, PhD  
5:29 PM - 5:34 PM What Is The Cut Needle: How Does It Work And Why Does It Facilitate Difficult Vascular Access: Clinical Experience And Cost
  Presenter(s):Vicente Riambau, MD, PhD  
5:35 PM - 5:40 PM Current Status Of AFX-3 And Ovation (With Anatomy Adaptive Sealing) Endografts (Both From Endologix) For AAA Repairs: Advantages And Limitations Of Each
  Presenter(s):Francesco Speziale, MD  
5:41 PM - 5:46 PM TBD
5:47 PM - 5:54 PM Panel Discussion
End of Program G

END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
x
6:50 AM - 6:55 AM Treo Endograft (From Terumo Aortic) For Standard Infrarenal EVAR: Characteristics, Advantages And Status Of US IDE
  Presenter(s):Matthew J. Eagleton, MD  
6:56 AM - 7:01 AM Value Of Treo Endograft (From Terumo Aortic)) In Highly Angled Necks: What Makes It Different And Results
  Presenter(s):Vicente Riambau, MD, PhD  
7:02 AM - 7:07 AM Status In The US Of The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs With Imperfect Necks
  Presenter(s):Robert Y. Rhee, MD  
7:08 AM - 7:13 AM Status Of The Gore Conformable Excluder For EVAR In Europe: Results From The EXCEL And BSET Registries
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Colin D. Bicknell, MD, FRCS  
7:14 AM - 7:19 AM When Does The Gore Conformable Excluder For EVAR Really Make A Difference: How Does It Work
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
7:20 AM - 7:25 AM Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Experience With 150 Patients And Up To 5-Year Follow-Up
  Presenter(s):Dainis K. Krievins, MD  
7:26 AM - 7:31 AM Advantages And Limitations Of The Cook ZENITH Alpha Endograft For EVAR: Based On European Multicenter Experience
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Philippe W.M. Cuypers, MD, PhD  
7:32 AM - 7:38 AM Panel Discussion
7:38 AM - 7:43 AM How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
7:44 AM - 7:49 AM AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
7:50 AM - 7:55 AM Head To Head Comparison Of Endurant And Excluder Endografts For EVAR In Challenging Asian AAA Anatomy
  Presenter(s):Naoki Fujimura, MD, PhD  
7:56 AM - 8:01 AM Update LEOPARD RCT Results Show That AFX Endografts Compare Favorably To Standard Proximally Fixed Endografts For AAA Repair
  Presenter(s):Christopher J. Kwolek, MD, MBA  
8:02 AM - 8:07 AM AFX Endografts Work Well In Conical (Flared) AAA Necks: Why And Results
  Presenter(s):Naoki Fujimura, MD, PhD  
8:08 AM - 8:14 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
x
8:14 AM - 8:19 AM Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages
  Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB  
8:20 AM - 8:25 AM Combination Of Ovation Endograft And Bare Metal Renal Stent For Difficult AAA Neck Unsuitable For F/EVAR
  Presenter(s):Gianmarco de Donato, MD  
8:26 AM - 8:31 AM Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Devices’ Future
  Presenter(s):Dainis K. Krievins, MD  
8:32 AM - 8:37 AM Current Status And Value Of Chimney EVAS (Ch/EVAS): From The ASCEND Trial Data: Status Of The CHEVAS ONE IDE Trial Of Ch/EVAS In Complex AAA Repairs
  Presenter(s):Joseph V. Lombardi, MD / Pete Holt, MD, PhD / Ian Loftus, MD / Michel M.P. Reijnen, MD, PhD  
8:38 AM - 8:43 AM Comparison Of Ch/EVAS And Ch/EVAR: When Is Ch/EVAS Indicated: Advantages And Limitations
  Presenter(s):Barend M.E. Mees, MD, PhD  
8:44 AM - 8:49 AM Update On Multicenter Results With F/EVAR Using The Fenestrated Anaconda Endograft: From The Global FACT Registry: Advantages And Limitations
  Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD  
8:50 AM - 8:55 AM Value Of The Fenestrated Anaconda Endograft For Treating Failed EVAR
  Presenter(s):Afshin Assadian, MD  
8:56 AM - 9:01 AM Update On The Incraft Endograft For Standard Infrarenal EVAR: Is Its Low Profile An Advantage
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
9:02 AM - 9:07 AM Long-Term Outcomes Of The Cook pBranch OTS Device For F/EVAR: Advantages And Limitations
  Presenter(s):Timothy A. Resch, MD, PhD  
9:08 AM - 9:15 AM Panel Discussion
9:15 AM - 9:26 AM Break – Visit Pavilions And Exhibits (2nd and 3rd Floors)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
x
9:26 AM - 9:31 AM Nexus OTS Endograft From Endospan For Treating Zone 1 Lesions Of The Aortic Arch: How Does It Work And 2-Year Clinical Results: Status In The US
  Presenter(s):Andrew Holden, MBChB / Daniel G. Clair, MD  
9:32 AM - 9:37 AM Update On The Status Of The Custom Relay Branch Endograft (Terumo Aortic) For Arch TEVAR: The European Experience: What Are The Advantages For Deployment, Apposition And Sealing
  Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR  
9:38 AM - 9:43 AM Status In The US Of The RelayBranch Investigational Device For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations
  Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD  
9:44 AM - 9:49 AM Long-Term Safety And Durable Effectiveness Of Relay (Terumo Aortic) Scalloped Endograft For TEVAR Treatment Of Lesions In Or Near The Aortic Arch
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR / Jean-Marc Alsac, MD, PhD  
9:50 AM - 9:55 AM Status In The US Of The Gore Conformable CTAG Endograft With Variable Angulation Control In The Aortic Arch: How Does It Work And Advantages
  Presenter(s):Jean Bismuth, MD  
9:56 AM - 10:01 AM When And How To Use The Gore Conformable CTAG Endograft Optimally: Are There Downsides
  Presenter(s):Sukgu Han, MD  
10:02 AM - 10:07 AM Indications, Value And Limitations Of Single Branched TEVAR Devices For Revascularizing The Left Subclavian Artery: Are They Worth The Effort And Cost
  Presenter(s):Gustavo S. Oderich, MD, FACS  
10:08 AM - 10:15 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
x
DEVICES FOR TEVAR
10:15 AM - 10:20 AM Low Profile Devices for TEVAR: Advantages And Disadvantages Based On Long-Term Results
  Presenter(s):Giovanni B. Torsello, MD  
10:20 AM - 10:25 AM 6-Year Experience With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In 400 Patients: How To Achieve Long-Term Durably Good Results
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
10:25 AM - 10:30 AM Current Status Of Valiant Nation Low Profile Endograft For TEVAR: Features And Advantages
  Presenter(s):Ali Azizzadeh, MD  
10:30 AM - 10:35 AM Value Of Valiant Navion Endograft For TEVAR In Fragile Aortas: Why It Is Better
  Presenter(s):Ross Milner, MD  
10:35 AM - 10:40 AM Real World Results, Advantages And Limitations Of The Valiant Navion Endograft For TEVAR From A Multicenter Study
  Presenter(s):Giovanni G.T. Tinelli, MD, PhD / Yamume Tshomba, MD  
10:40 AM - 10:46 AM Panel Discussion
10:46 AM - 10:51 AM The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device
  Presenter(s):Edward Y. Woo, MD  
10:51 AM - 10:56 AM Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances
  Presenter(s):David M. Williams, MD  
10:56 AM - 11:01 AM Relay Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing
  Presenter(s):Afshin Assadian, MD  
11:01 AM - 11:06 AM European Experience With The Gore CTAG Conformable Endograft For TEVAR With Variable Angulation Control Proximally: When And How Does It Improve Results
  Presenter(s):Vicente Riambau, MD, PhD  
11:06 AM - 11:11 AM New Polymer Filled Low Profile Endograft Device With O-Ring Sealing: How Does It Work And Why Is It Better
  Presenter(s):Piotr Szopinski, MD, PhD  
11:11 AM - 11:17 AM Panel Discussion
NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS
11:17 AM - 11:22 AM To Treat Complex TAAAs A Combination Of A Relay (Terumo Aortic) TEVAR And A Fenestrated Anaconda Is Best: How Are The SMA And Celiac Axis Revascularized
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR  
11:22 AM - 11:27 AM Status Of The Cook t-Branch OTS Endograft For TAAA Repairs: Advantages And Limitations Based On A Meta-Analysis
  Presenter(s):Nikolaos Tsilimparis, MD; PhD  
11:27 AM - 11:32 AM Experience With The Cook t-Branch OTS Endograft Device For Juxta- And Pararenal AAAs: Advantages And Limitations
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
11:32 AM - 11:37 AM Comparison Of 3 OTS Endografts For Urgent TAAA Repairs: TAMBE (Gore) Versus E-nside (Jotec) Versus t-Branch (Cook): Advantages And Disadvantages Of Each
  Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD  
11:37 AM - 11:42 AM Valiant Manifold OTS Endograft (Medtronic) Device For Repairing TAAAs: How Does It Work And Early Clinical Experience In The US
  Presenter(s):Murray L. Shames, MD  
11:42 AM - 11:47 AM Unitary Manifold Endograft System For Complex Type 4 TAAAs And Failed EVARs: How Does It Work And 2-Year Results
  Presenter(s):Patrick W. Kelly, MD  
11:47 AM - 11:52 AM Novel OTS Life Tech Endograft For TAAA Repair: How Does It Work And What Makes It Different
  Presenter(s):Ralf R. Kolvenbach, MD  
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR UPDATED INFORMATION ON BALLOON EXPANDABLE COVERED STENTS, LOWER EXTREMITY PROSTHETIC GRAFTS, BIORESORBABLE GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH [SEE ALSO SESSION 28] PATCH (ALL TALKS ARE 5 MINUTES)
x
STENT-GRAFTS
1:00 PM - 1:05 PM Why Are VBX Balloon Expandable Stent-Grafts (From Gore) Different And Better Than Other Covered Stents In Various Vascular Beds
  Presenter(s):James F. McKinsey, MD  
1:06 PM - 1:11 PM Safety Of MRI EarlyAfter Deployment Of Various Bridging Covered Stents In Complex AAA Repairs
  Presenter(s):Maria A. Ruffino, MD, EBIR  
PROSTHETIC GRAFTS
1:12 PM - 1:17 PM Final 3-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Should Open Prosthetic Bypass Be Abandoned
  Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD  
1:18 PM - 1:23 PM The 3DH Spiral Flow Prostheti Graft: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access
  Presenter(s):Hosam F. El Sayed, MD  
1:24 PM - 1:29 PM Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: Are The Heparin Coated Grafts Worth The Cost
  Presenter(s):David J. Dexter, MD  
1:30 PM - 1:35 PM Bioabsorbable Arterial Grafts (Xeltis Grafts): How Do They Work And What Is Their Potential
  Presenter(s):Frans L. Moll, MD, PhD  
1:36 PM - 1:41 PM Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them
  Presenter(s):Jae S. Cho, MD  
1:42 PM - 1:47 PM Update On External Sirolimus Patch Wrap-Around For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia
  Presenter(s):Sriram S. Iyer, MD, FACC  
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
x
ATHERECTOMY RELATED TOPICS
1:54 PM - 1:59 PM Value Of Directional Or Rotational Atherectomy And DCBs With Complex Lesions And CLTI: Which Lesions And How Do We Know This Combination Helps
  Presenter(s):Venita Chandra, MD  
2:00 PM - 2:05 PM Value And Limitations Of 355 nm Auryon B-Laser™ (From AngioDynamics): It Enables Safe Crossing Of Difficult Lesions Not Crossed With A Guidewire: How Does It Work And Clinical Results
  Presenter(s):Luis R. Leon, MD, RVT, FACS  
2:06 PM - 2:11 PM Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above Knee BTK De Novo Lesions And ISR
  Presenter(s):Craig M. Walker, MD  
2:12 PM - 2:17 PM Value Of Atherectomy And DCBs: Interim Results Of The REALITY Trial
  Presenter(s):Brian G. DeRubertis, MD  
ANCILLARY TECHNIQUES
2:18 PM - 2:23 PM Value of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results
  Presenter(s):John R. Laird, MD  
2:24 PM - 2:29 PM Value of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
2:30 PM - 2:36 PM Panel Discussion
NEW INFORMATION ON STENTS
2:36 PM - 2:41 PM Advantages Of Supera (Vasculomimetic – VMI) Stent For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position
  Presenter(s):Erwin Blessing, MD  
2:42 PM - 2:47 PM Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 2-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery)
  Presenter(s):Koen R. Deloose, MD  
2:48 PM - 2:53 PM Value Of Multiloc Ministents To Treat Post Balloon Dissections: How Do They Work And How Do They Compare To Tacks
  Presenter(s):Thomas Zeller, MD  
2:54 PM - 2:59 PM Value And Advantages Of Eluvia DESs (Boston Scientific) For Lower Extremity Occlusive Lesions: When To Use Them And How To Optimize Their Results
  Presenter(s):Steven Kum, MD  
3:00 PM - 3:05 PM RCT Comparing A New Bare Metal Stent – Misago Versus Zilver PTX DESs For Fempop Lesions: 2-Year Results Of The BATTLE Trial: Misago Stents Can Be Deployed Via Radial Access
  Presenter(s):Yann Gouëffic, MD, PhD  
3:06 PM - 3:12 PM Panel Discussion
3:12 PM - 3:24 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
x
3:24 PM - 3:29 PM Chocolate Touch DCBs (From TriReme Medical): How Do They Work, Advantages And Updated Clinical Results
  Presenter(s):Andrew Holden, MBChB  
3:30 PM - 3:35 PM Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips
  Presenter(s):Steven Kum, MD  
3:36 PM - 3:41 PM Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Results
  Presenter(s):Ehrin Armstrong, MD  
3:42 PM - 3:47 PM Value Of The Passeo-18Lux DCB For Treating BTK Lesions With Or Without Bare Metal Stents
  Presenter(s):Gunnar Tepe, MD  
3:48 PM - 3:53 PM Unfavorable Balloon Wrap (Candy) Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: The Chocolate DCB Is One Way
  Presenter(s):Jos C. van den Berg, MD, PhD  
3:54 PM - 3:59 PM The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work
  Presenter(s):Andrew Holden, MBChB  
4:00 PM - 4:05 PM 12-Month Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 80% Patency
  Presenter(s):Patrick J. Geraghty, MD  
4:06 PM - 4:12 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
x
4:12 PM - 4:17 PM Prophylactic Endoanchors (Medtronic) With TEVAR For Complex Anatomy Improves Outcomes: Technical Tips For Their Use In TEVAR
  Presenter(s):Jean M. Panneton, MD  
4:18 PM - 4:23 PM New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: What Are Those Indications
  Presenter(s):William D. Jordan Jr., MD  
4:24 PM - 4:29 PM New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof
  Presenter(s):Jean-Paul de Vries, MD, PhD  
4:30 PM - 4:35 PM Vesteck – The Next Generation Of Endoanchor Technology: How Does It Work And Where Does It Stand
  Presenter(s):David H. Deaton, MD, FACS  
4:36 PM - 4:41 PM Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks and Migration
  Presenter(s):David J. Minion, MD  
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
x
CLOT REMOVING DEVICES
4:48 PM - 4:53 PM Percutaneous Embolectomy Or Thrombectomy With The Indigo System (From Penumbra): What Makes It Different, Technical Tips, Results And Limitations
  Presenter(s):David J. Dexter, MD  
4:54 PM - 4:59 PM Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use
  Presenter(s):Guillermo A. Escobar, MD  
5:00 PM - 5:05 PM Catheter Based Vacuum Assisted Thrombectomy For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study
  Presenter(s):Carlo Setacci, MD / Gianmarco de Donato, MD  
VASCUAR OCCLUSIVE DEVICES
5:06 PM - 5:11 PM Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Coils With Fibers Versus Plain Metal Coils; Value And Indications For Different Coils
  Presenter(s):James F. Benenati, MD / Constantino Pena, MD  
5:12 PM - 5:17 PM Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing
  Presenter(s):Sean P. Lyden, MD  
5:18 PM - 5:23 PM Caterpillar™ Embolic Plug (From Bard): How Does It Work: Advantages And Clinical Results
  Presenter(s):Andrew Holden, MBChB  
5:24 PM - 5:29 PM How To Treat Type 1A Endoleaks With Ruby Coils: When Will They Work; When Will They Not: Technical Tips
  Presenter(s):Mazin Foteh , MD  
5:30 PM - 5:35 PM How To Insert Large Vessel Embolization Devices (PODs) Through Low Profile Access
  Presenter(s):Frank R. Arko, MD  
5:36 PM - 5:44 PM Panel Discussion
End of Program H

END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:00 AM - 7:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:05 AM - 7:10 AM AVF CEAP Revision 2020
  Presenter(s):Marc A. Passman, MD  
7:11 AM - 7:16 AM CEAP, VCSS, HASTI: Their Significance And How To Utilize
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
7:17 AM - 7:22 AM Physiology Of Venous Return
  Presenter(s):Brajesh K. Lal, MD  
7:23 AM - 7:28 AM What Are The Causes Of Symptoms In CEAP C Zero Class Of Patients: Implications For Therapy
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
7:29 AM - 7:34 AM How To Measure DUS Venous Reflux Volume: Is It More Important Than Reflux Time
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
7:35 AM - 7:40 AM Status Of The Evidence For C2 Intervention
  Presenter(s):Peter Gloviczki, MD  
7:41 AM - 7:46 AM An Algorithm To Predict Disease Severity In C2 Patients
  Presenter(s):Mikel Sadek, MD  
7:47 AM - 7:52 AM Evidence Summary On The Pathophysiology Of Varicose Veins
  Presenter(s):Thomas W. Wakefield, MD  
7:53 AM - 7:58 AM CVD: A Clinical Approach Algorithm
  Presenter(s):Seshadri Raju, MD  
7:59 AM - 8:04 AM Understanding Venous Physiology Helps Guide Therapy
  Presenter(s):Fedor Lurie, MD, PhD  
8:05 AM - 8:10 AM Non-Venous Causes Of The Swollen Extremity
  Presenter(s):Andrea T. Obi, MD  
8:11 AM - 8:16 AM Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: VENOUS IMAGING AND BIOLOGY
x
8:23 AM - 8:28 AM Identifying Reflux Pathways With Duplex Ultrasound Mapping
  Presenter(s):Neil M. Khilnani, MD  
8:29 AM - 8:34 AM Are They Venous Ulcers
  Presenter(s):Raghu Kolluri, MD  
8:35 AM - 8:40 AM Venous Consensus Project Update
  Presenter(s):Lawrence V. Hofmann, MD  
8:41 AM - 8:46 AM Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease
  Presenter(s):Seshadri Raju, MD  
8:47 AM - 8:52 AM Role Of Foot Static Disorders In Chronic Venous Disease
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
8:53 AM - 8:58 AM Inflammation And CVD
  Presenter(s):Joseph D. Raffetto, MD  
8:59 AM - 9:04 AM Does Deep Venous Reflux Matter With Superficial Ablation
  Presenter(s):Peter Henke, MD  
9:05 AM - 9:10 AM Genetics Involving VV And VLU
  Presenter(s):Joseph D. Raffetto, MD  
9:11 AM - 9:16 AM A New Noninvasive Method To Measure Lower Limb Venous Outflow Resistance
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
9:17 AM - 9:22 AM Value Of Coordinated Registry Network: Information Obtained
  Presenter(s):Steve Elias, MD  
9:23 AM - 9:28 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:29 AM - 9:34 AM Results Of Randomized Controlled Trial MOCA Versus Cyanoacrylate
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
9:35 AM - 9:40 AM “Choosing Wisely” Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence
  Presenter(s):Claudine M. Hamel-Desnos, MD  
9:41 AM - 9:46 AM Rethinking Endovenous Techniques To Define Cost-Effectiveness
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
9:47 AM - 9:52 AM Saphenous Sparing: Instructions For Users
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
9:53 AM - 9:58 AM Important Factors And Misconceptions In Skin End Organ Damage
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
9:59 AM - 10:04 AM What Drugs Do I Recommend For Symptomatic Venous Disease
  Presenter(s):Jorge H. Ulloa, MD, FACS  
10:05 AM - 10:10 AM Ablative Procedures And Cost Effectiveness
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
10:11 AM - 10:16 AM SVT Treatment During Pregnancy: Treatment Choices
  Presenter(s):Ellen D. Dillavou, MD  
10:17 AM - 10:22 AM Vein Histopathology: 5.5 Years After Cyanoacrylate Closure
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
10:23 AM - 10:28 AM Saphenous Ablation On Anticoagulation; Is It Safe, Effective And Durable
  Presenter(s):Glenn Jacobowitz, MD  
10:29 AM - 10:34 AM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: THERMAL AND NON-THERMAL ABLATION
x
THERMAL AND NON-THERMAL ABLATION I
10:35 AM - 10:40 AM Decision Making In Saphenous Ablation: What To Use When
  Presenter(s):Ellen D. Dillavou, MD  
10:41 AM - 10:46 AM HIFU: Is It Ready For Prime Time
  Presenter(s):Mark S. Whiteley, MS, FRCS  
10:47 AM - 10:52 AM Tips, Tricks And Limitations: HIFU
  Presenter(s):Mark S. Whiteley, MS, FRCS  
10:53 AM - 10:58 AM Tips, Tricks And Limitations: Perforator Ablation
  Presenter(s):Steve Elias, MD  
10:59 AM - 11:04 AM Tips, Tricks And Limitations: Varithena
  Presenter(s):Edward G. Mackay, MD  
11:05 AM - 11:10 AM Tips, Tricks, And Limitations: Ultrasound Guided Foam Sclerotherapy
  Presenter(s):Jean Luc Gerard, MD  
11:11 AM - 11:16 AM Panel Discussion
THERMAL AND NON-THERMAL ABLATION II
Moderator(s): Alan M. Dietzek, MD, RPVI, FACS / Steve Elias, MD  
11:17 AM - 11:22 AM Tips, Tricks, And Limitations: Liquid Sclerotherapy
  Presenter(s):Victor M. Canata, MD  
11:23 AM - 11:28 AM Tips, Tricks And Limitations: Clarivein
  Presenter(s):Steve Elias, MD  
11:29 AM - 11:34 AM Tips, Tricks And Limitations: Laser Truncal Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:35 AM - 11:40 AM Tips, Tricks And Limitations: Radiofrequency Ablation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
11:41 AM - 11:46 AM Tips, Tricks And Limitations: Brazilian Phlebectomy
  Presenter(s):Gutenberg A. Gurgel, MSc, MD  
11:47 AM - 11:52 AM Tips, Tricks And Limitations: Phlebogrif
  Presenter(s):Lorena Grillo, MD  
11:53 AM - 11:58 AM Tips, Tricks And Limitations: VenaSeal
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, F  
11:59 AM - 12:04 PM Safety And Efficacy Of Endovenous Ablations In Octogenarians, Nonagenarians, And Centenarians
  Presenter(s):Enrico Ascher, MD  
12:05 PM - 12:10 PM SVT Management In 2020: Anything New
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
12:11 PM - 12:16 PM Panel Discussion
12:16 PM - 12:45 PM Lunch Break – 2nd Floor Promenade
Visit Exhibit And Pavilions (2nd and 3rd Floors)

END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
x
12:45 PM - 12:50 PM Foam Therapies (PCF Versus PEM): When To Use And Does It Make A Difference
  Presenter(s):Edward G. Mackay, MD  
12:51 PM - 12:56 PM Patient Preferences For Thermal Ablation Versus Non-Thermal, Non-Tumescent Varicose Vein Treatments: A Choice-Based Conjoint (CBS) Analysis
  Presenter(s):Peter J. Pappas, MD  
12:57 PM - 1:02 PM Randomized Controlled Study Of EVLA And Foam In the SSV-Fovelass Study: 3-Year Results
  Presenter(s):Claudine M. Hamel-Desnos, MD  
1:03 PM - 1:08 PM CLACS In Paraguay Results Of The Aesthetic Phlebology Trial
  Presenter(s):Victor M. Canata, MD  
1:09 PM - 1:14 PM Superficial Ablation Outcomes (5 Years) In 13,000 Patients
  Presenter(s):Peter J. Pappas, MD  
1:15 PM - 1:20 PM Labial Varices: Choices And How I Do It
  Presenter(s):Ellen D. Dillavou, MD  
1:21 PM - 1:26 PM Which Saphenous Vein Recanalization Should Be Treated
  Presenter(s):Kathleen D. Gibson, MD  
1:27 PM - 1:32 PM Is Combination Therapy Laser And Sclerotherapy More Efficacious For Telangiectatic Treatment
  Presenter(s):Gutenberg A. Gurgel, MSc, MD  
1:33 PM - 1:38 PM Panel Discussion
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: VENOUS SOCIETAL AND GOVERNANCE
x
1:39 PM - 1:44 PM CMS Policy Update On Non-Thermal Ablation
  Presenter(s):Harold J. Welch, MD  
1:45 PM - 1:50 PM The Future Of Venous Reimbursement In A Non-Fee For Service Environment
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
1:51 PM - 1:56 PM What Evidence Is There For Compression Prior To Insurance Approval
  Presenter(s):Saum A. Rahimi, MD  
1:57 PM - 2:02 PM Can We Use The Data From VQI VVR To Advocate For Coverage Of Venous Procedures
  Presenter(s):Nicholas H. Osborne, MD, MS  
2:03 PM - 2:08 PM Who Should Fund The Management Of C2 Disease And Why
  Presenter(s):Sarah Onida, MD, PhD  
2:09 PM - 2:14 PM The Irony Of Overtreatment And Undertreatment In Venous Disease: What Can Be Done
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
2:15 PM - 2:20 PM Results Of Appropriateness Criteria (AVF) I
  Presenter(s):Elna M. Masuda, MD  
2:21 PM - 2:26 PM Results Of Appropriateness Criteria (AVF) II
  Presenter(s):Kathleen J. Ozsvath, M.D.  
2:27 PM - 2:32 PM Shifting From Overutilization To Underutilization: Deeper Dive Into Improving Wisely
  Presenter(s):Margaret Mann, MD  
2:33 PM - 2:38 PM Focused Practice Designation – Venous Disease Treatment
  Presenter(s):Brajesh K. Lal, MD  
2:39 PM - 2:44 PM Prior Authorization As A Utilization Management Tool For Elective Superficial Venous Procedures Is Worthless
  Presenter(s):Todd Berland, MD  
2:45 PM - 2:50 PM Panel Discussion
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
2:51 PM - 2:56 PM From The AVF And SVS: EHIT Recommendations
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
2:57 PM - 3:02 PM Physician Compounded Foam Sclerotherapy
  Presenter(s):Margaret Mann, MD  
3:03 PM - 3:08 PM Saphenous Incompetence With Post-Thrombotic Deep Veins
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
3:09 PM - 3:14 PM Which Factors Increase VTE Risk For Superficial Venous Procedures
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
3:15 PM - 3:20 PM Ablation Outcomes In Obese Patients
  Presenter(s):Peter J. Pappas, MD  
3:21 PM - 3:26 PM Varithena® VLU Registry: The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence
  Presenter(s):Raghu Kolluri, MD  
3:27 PM - 3:32 PM Varicose Veins Among Klippel Trenaunay Syndrome: What You Should Know About
  Presenter(s):Byung-Boong Lee, MD  
3:33 PM - 3:38 PM Radiofrequency Ablation Increases The Incidence Of Endothermal Heat Induced Thrombosis
  Presenter(s):Anil P. Hingorani, MD  
3:39 PM - 3:44 PM European College Of Phlebology Guideline for Truncal Ablation
  Presenter(s):Kursat A. Bozkurt, MD  
3:45 PM - 3:50 PM Risk Factors For EHIT And Recanalization: An Analysis Of 10,000 Patients
  Presenter(s):Anil P. Hingorani, MD  
3:50 PM - 3:55 PM Panel Discussion
END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: VENOUS CLINICAL TRIALS, LYMPHATIC, VEIN TREATMENT STRATEGIES
x
3:56 PM - 4:01 PM Thermal Ablation RCTs: Summary
  Presenter(s):Bo G. Eklof, MD, PhD  
4:02 PM - 4:07 PM What Venous Trials Do We Need
  Presenter(s):Mark H. Meissner, MD  
4:08 PM - 4:13 PM Unilateral, Bilateral, Staged Endovenous Ablation – VQI Data
  Presenter(s):Nicholas H. Osborne, MD, MS  
4:14 PM - 4:19 PM The Recalcitrant Ulcer: Our 52-Week Analysis
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
4:20 PM - 4:25 PM First Experience: Russian Glue “Cyanoacrylate”
  Presenter(s):Evgeny Shaydakov, MD, PhD  
4:26 PM - 4:31 PM VenaSeal Spectrum Study: RCT Study Overview
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
4:32 PM - 4:37 PM Treating Low And Moderate Severity Venous Disease Is Beneficial – Data From The VQI VVR
  Presenter(s):Nicholas H. Osborne, MD, MS  
4:38 PM - 4:43 PM A Newer Laser Fiber: All Fibers Are Not The Same
  Presenter(s):Evgeny Shaydakov, MD, PhD  
4:44 PM - 4:49 PM What Articles Are JVS-VL Looking For and How Can You Write A Paper That Will Be Accepted And Published
  Presenter(s):Peter Gloviczki, MD  
4:50 PM - 4:55 PM Panel Discussion
LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
Moderator(s): Joseph A. Caprini, MD / Thomas F. O'Donnell, Jr., MD  
4:56 PM - 5:01 PM Diagnosis Of Lipedema And Treatment
  Presenter(s):Steven M. Dean, DO  
5:02 PM - 5:07 PM Overview Of Lymphatic Anatomy, Physiology And Imaging Techniques
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
5:08 PM - 5:13 PM Clinical Characteristics Of Lower Extremity Lymphedema
  Presenter(s):Steven M. Dean, DO  
5:14 PM - 5:19 PM Evidence Based Compression Recommendations For Lymphedema
  Presenter(s):Joseph A. Caprini, MD  
5:20 PM - 5:25 PM Venolymphatic Edema And Its Treatment Options
  Presenter(s):Raghu Kolluri, MD  
5:26 PM - 5:31 PM Phlebolymphedema: Hallmark Of Combined Insufficiency Of Venous-Lymphatic System
  Presenter(s):Byung-Boong Lee, MD  
5:32 PM - 5:37 PM Moel Lavallee Syndrome
  Presenter(s):Lourdes Reina, MD  
5:38 PM - 5:43 PM Advanced Pneumatic Compression: Continued Improvement In Quality Of Life
  Presenter(s):Thomas S. Maldonado, MD  
5:44 PM - 5:49 PM Panel Discussion
EXAMINING THE EVIDENCE
Moderator(s): Jean Luc Gerard, MD / Lorena Grillo, MD  
5:50 PM - 5:55 PM Bone Perforator: What Is The Significance
  Presenter(s):Jean Luc Gerard, MD  
5:56 PM - 6:01 PM Is Saphenous Vein Stripping A Cost-Effective Treatment
  Presenter(s):Lourdes Reina, MD  
6:02 PM - 6:07 PM Ablative Risks Prior And After Flying: What Do You Tell Your Patients
  Presenter(s):Sarah Onida, MD, PhD  
6:08 PM - 6:13 PM 1470mm Laser And Wound Care Trial
  Presenter(s):Lorena Grillo, MD  
6:14 PM - 6:20 PM Panel Discussion
End of Program I

END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: ACUTE STROKE IMAGING AND TRIAGE
Moderators:TBD
x
8:00 AM - 8:05 AM Introduction
  Presenter(s):Allan L. Brook, MD  
8:06 AM - 8:16 AM Which Stroke Patients Need A CT Perfusion Study
8:17 AM - 8:27 AM MRI Has Unique Benefits: Let Me Explain
8:28 AM - 8:38 AM Perfusion Imaging For Dummies
8:39 AM - 8:49 AM Latest Stroke Trial Updates
8:50 AM - 9:00 AM Stroke Triage Direct To CSC
9:01 AM - 9:11 AM Stroke Triage Direct To The Angio Suite
9:12 AM - 9:22 AM Innovative And Novel Stroke Therapies That Are In The Pipeline
9:23 AM - 9:33 AM Lessons Learned On Patient Selection
9:34 AM - 9:44 AM Stroke Devices And Nuances
9:45 AM - 9:55 AM Robotics Are Here To Stay And What To Expect
9:56 AM - 10:01 AM DEBATE: A VIZ AI Is The Best Triage System
10:02 AM - 10:07 AM DEBATE: RAPID Is The Best Triage System
10:08 AM - 10:15 AM Panel Discussion
10:15 AM - 10:26 AM Break – Visit Exhibits And Exhibits (2nd and 3rd Floors)
END OF SESSION 72
 
SESSION 73 SCHEDULE
Thursday
SESSION 73: COVID AND OTHER INFECTIOUS RELATED CEREBROVASCULAR ISSUES
Moderators:TBD
x
10:26 AM - 10:36 AM COVID-19: Overview Of What Happened
10:37 AM - 10:47 AM COVID-19: An Ischemic Stroke
10:48 AM - 10:58 AM COVID-19 And Hemorrhagic Stroke
10:59 AM - 11:09 AM COVID-19: Practice Workflows And Systems Of Care
11:10 AM - 11:20 AM Vasculitis: Imaging And Diagnosis
11:21 AM - 11:31 AM Mycotic Aneurysms: Treatment Strategies
11:32 AM - 11:42 AM Improving Outcomes Is Based Solely On Brain Physiology, Clot Type, Intrinsic Vessel Pathology, And Collaterals
11:43 AM - 11:53 AM How CSC Organized Medicine Helped Prepare Us For The COVID Onslaught
11:54 AM - 12:04 PM Panel Discussion
12:04 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 73
 
SESSION 74 SCHEDULE
Thursday
SESSION 74: CAROTID AND CEREBROVASCULAR HOT TOPICS AND LITERATURE REVIEW
Moderators:TBD
x
1:00 PM - 1:10 PM TCAR: Technical Pearls And Why It’s The Latest Trending Vascular Procedure
1:11 PM - 1:21 PM TCAR: Why Not Just Do An Endarterectomy
1:22 PM - 1:32 PM Hemicraniectomy: Why It Is Not a Lost Art
1:33 PM - 1:43 PM Have We Finally Figured Out Who Needs Carotid Revascularization
END OF SESSION 74
 
SESSION 75 SCHEDULE
Thursday
SESSION 75: BRAIN ANEURYSM
Moderators:TBD
x
1:44 PM - 1:54 PM Update On Latest Literature
1:55 PM - 2:05 PM Next Generation Flow Diverters
2:06 PM - 2:16 PM State-Of-The-Art Imaging Of Aneurysms
2:17 PM - 2:27 PM Intrasaccular Devices: Overview And Indications
2:28 PM - 2:38 PM Unruptured Aneurysms: Why Do We Treat These
2:39 PM - 2:49 PM What Aneurysms Are Best For Open Surgery And Why
END OF SESSION 75
 
SESSION 76 SCHEDULE
Thursday
SESSION 76: COMPLICATION, AVOIDANCE AND TECHNIQUES
Moderators:TBD
x
2:49 PM - 2:59 PM The SAH I Learned The Most From
3:00 PM - 3:10 PM Improving Thrombectomy: How To Avoid Embolic Strokes In Different Territories
3:11 PM - 3:21 PM Carotid Blowout: How To Treat And How To Avoid
3:22 PM - 3:32 PM Lessons Learned On Using Flow Diverters In SAH, And Getting Out Of Tough Situations
END OF SESSION 76
 
SESSION 77 SCHEDULE
Thursday
SESSION 77: NEUROINTERVENTIONAL ONCOLOGY
Moderators:TBD
x
3:32 PM - 3:43 PM Anatomy Of The Skull Base For Dummies
3:44 PM - 3:54 PM Collateral Physiologic Flow: Connections You Must Know To Avoid Disasters
3:55 PM - 4:05 PM Subdural Hematoma Theory And Percutaneous Treatment
4:06 PM - 4:16 PM Tinnitus: The Endovascular Specialist And Their Role
4:17 PM - 4:27 PM Intracranial Atherosclerosis: Is It Prime Time For The Next Prospective Trial
4:28 PM - 4:38 PM Dural Sinus Thrombosis/Stenosis: When And Why I Treat
4:39 PM - 4:49 PM Intraarterial Head And Neck Chemotherapy: Its Role 2020
END OF SESSION 77
 
SESSION 78 SCHEDULE
Thursday
SESSION 78: LATEST SCIENCE, LITERATURE AND NEWEST DEVICES
Moderators:TBD
x
4:50 PM - 5:00 PM Anatomic Variations And The True Meaning Of Basic Knowledge
5:01 PM - 5:11 PM Venous Anatomy And Why It Is Important To Review
5:12 PM - 5:22 PM Disparities In The Five Boroughs
5:23 PM - 5:40 PM Panel Discussion
End of Program J

END OF SESSION 78
 
SESSION 79 SCHEDULE
Friday
SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
x
6:40 AM - 6:45 AM A Multidisciplinary Approach To Prevent SCI During Endovascular TAAA Repairs
  Presenter(s):Patrick W. Kelly, MD  
6:46 AM - 6:51 AM Strategies To Minimize Paraplegia After TAAA Repairs: How A Biomarker Can Help
  Presenter(s):Bijan Modarai, PhD, FRCS / Adam Beck, MD  
6:52 AM - 6:57 AM New Developments In Preventing SCI With Endo And Open TAAA Repairs
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
6:58 AM - 7:03 AM Update On The Value Of Motor Evoked Potentials To Decrease SCI With TAAA Repairs: What Is The Difference Between Peripheral And Central SCI
  Presenter(s):Barend M.E. Mees, MD, PhD / Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD  
7:04 AM - 7:09 AM Cerebrospinal Fluid (CSF) Drainage (To Decrease SCI) Is Not A Benign Procedure: Why: When Not And When To Use It
  Presenter(s):Gustavo S. Oderich, MD, FACS  
7:10 AM - 7:15 AM SCI Is More Severe And Resolves Less When Routine CSF Drainage Is Used With TAAA Repairs: When Should It Be Used Selectively And With What Precautions
  Presenter(s):Adam Beck, MD  
7:16 AM - 7:21 AM Status Of CSF Drainage With TAAA Repairs In Europe: Evidence Is Lacking: What Is The Standard Practice
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
7:22 AM - 7:27 AM Near Infrared Spectrometry (NIRS) Monitoring Is Helpful In Decreasing SCI With TAAA Repairs: How To Do It: Why Is There Controversy
  Presenter(s):Carlos H. Timaran, MD  
7:28 AM - 7:33 AM The Intraspinal Collateral Arterial Network And Its Importance In Preventing SCI And Paraplegia With Complex Aortic Repairs
  Presenter(s):Martin Czerny, MD  
7:34 AM - 7:39 AM Current Strategies To Minimize SCI With TAAA Repairs, Endo And Open: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Status Of PAPA-ARTIS RCT
  Presenter(s):Christian D. Etz, MD, PhD  
7:40 AM - 7:45 AM Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair
  Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD / Christian D. Etz, MD, PhD  
7:46 AM - 7:53 AM Panel Discussion
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
x
MESH COVERED STENTS
7:53 AM - 7:58 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD  
7:59 AM - 8:04 AM Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better
  Presenter(s):Laura Capoccia, MD  
8:05 AM - 8:10 AM 7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results
  Presenter(s):Stefan Müller-Hülsbeck, MD  
8:11 AM - 8:16 AM Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications
  Presenter(s):Francesco Speziale, MD / Wassim Mansour, MD / Pasqualino Singnano, MD / Carlo Setacci, MD  
TCAR RELATED TOPICS
8:17 AM - 8:22 AM TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD  
8:23 AM - 8:28 AM TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD  
8:29 AM - 8:34 AM Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show
  Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / Giancarlo Biamino, MD, PhD  
8:35 AM - 8:40 AM DEBATE: For TFCAS Reversal/ Of Flow With Gore/MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So
  Presenter(s):Marc L. Schermerhorn, MD  
8:41 AM - 8:46 AM DEBATE: Not So: In Some Specific Circumstances Reversal/Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection
  Presenter(s):Giancarlo Biamino, MD, PhD / William A. Gray, MD  
8:47 AM - 8:52 AM Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View
  Presenter(s):Vikram S. Kashyap, MD  
8:53 AM - 8:58 AM TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks
  Presenter(s):Wesley S. Moore, MD  
8:59 AM - 9:07 AM Panel
9:07 AM - 9:17 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
x
9:17 AM - 9:22 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions
  Presenter(s):Peter A. Schneider, MD  
9:23 AM - 9:28 AM DEBATE: TCAR Is Not Hard To Learn: Results Are Unrelated To Operator Experience In ROADSTER 2 Trial
  Presenter(s):Vikram S. Kashyap, MD  
9:29 AM - 9:34 AM DEBATE: Not So: TCAR Has A Steeper Learning Curve Than Commonly Thought: Some Precautions To Prevent Adverse Events
  Presenter(s):Michael B. Silva, Jr., MD / Charles Thang, MD  
9:35 AM - 9:40 AM Learning And Optimizing The TCAR Procedure
  Presenter(s):Edward Y. Woo, MD  
9:41 AM - 9:46 AM Complications Of TCAR: How To Avoid Them And Fix Those That Occur
  Presenter(s):Thomas S. Maldonado, MD  
9:47 AM - 9:52 AM Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How
  Presenter(s):Todd R. Vogel, MD, MPH  
9:53 AM - 9:58 AM Mini-Incision CEA Is Better And Less Costly Than TCAR
  Presenter(s):Enrico Ascher, MD  
9:59 AM - 10:04 AM TCAR Can Be Performed Under Local Anesthesia With Outcomes Equal To TCAR Under General Anesthesia: From A VQI Study: How To Do It Safely
  Presenter(s):Dipankar Mukherjee, MD  
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS
10:05 AM - 10:10 AM DEBATE: How Size And Number Of Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Affect Cognitive Changes: They Really Do Matter
  Presenter(s):Wei Zhou, MD  
10:11 AM - 10:16 AM DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter
  Presenter(s):Thomas G. Brott, MD  
10:17 AM - 10:22 AM Why Asymptomatic Carotid Stenosis (ACS) Is Associated With Impaired Cognitive Function And Silent Infarcts: However, CEA And CAS For ACS Cause More Cognitive Impairment Than They Prevent
  Presenter(s):J. David Spence, MD  
10:23 AM - 10:30 AM Panel Discussion
END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
x
10:30 AM - 10:35 AM Comparative Cost Effectiveness: TCAR Versus CEA Versus TFCAS
  Presenter(s):Mohammad H. Eslami, MD, MPH  
10:36 AM - 10:41 AM Transcranial Doppler (TCD) Hits During TCAR: When Do They Occur And What Is Their Significance
  Presenter(s):Cynthia K. Shortell, MD  
10:42 AM - 10:47 AM Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions
  Presenter(s):Max Amor, MD  
10:48 AM - 10:53 AM Value Of Mesh Covered Stents With TCAR: Is It The Best Of All Worlds: Limitations
  Presenter(s):Ralf R. Kolvenbach, MD  
10:54 AM - 10:59 AM OCT Proves CAS Is Rendered Safer Because Emboli Are Decreased By Mesh Covered Stents: The Evidence
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
11:00 AM - 11:05 AM TCAR Versus Minimal Incision CEA: Cost Effectiveness, Advantages And Limitations Of Both
  Presenter(s):Robert M. Proczka, MD, PhD  
11:06 AM - 11:12 AM Panel Discussion
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET
11:12 AM - 11:17 AM Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On Large National Database Study
  Presenter(s):Mahmoud B. Malas, MD, MHS  
11:18 AM - 11:23 AM DEBATE: It’s Reasonable To Perform CEA Within 48 Hours After A Stroke’s Symptoms Start: Under What Conditions And What Precautions Should Be Taken
  Presenter(s):R. Clement Darling III, MD  
11:24 AM - 11:29 AM DEBATE: Patients With Moderate To Severe Strokes Do Poorly With Both CEA And CAS Done Within 48 Hours Of Symptom Onset: Both Procedures Should Be Avoided During This Period: How Long Should One Wait
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
11:30 AM - 11:35 AM When Is CEA Within 48 Hours Of Stroke Symptom Onset Necessary: What Are The Risks: How To Make It Reasonably Safe: When Is It Totally Contraindicated
  Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed) ,FEBVS  
11:36 AM - 11:41 AM What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Asymptomatic): Can High Risk Plaques Be Made Low Risk And Can They Be Made Smaller: Are Some Plaques Resistant To Medical Treatment And Why
  Presenter(s):J. David Spence, MD  
11:42 AM - 11:47 AM Technical Tips and Maneuvers To make Treatment Of High Carotid Lesions Safe And Relatively Simple
  Presenter(s):Richard J. Powell, MD  
11:48 AM - 11:53 AM Getting Non-Compliant Carotid Patients To Comply With Best Medical Treatment By Showing Them Their Duplex Scans And Pictures Of Hemorrhagic And Ulcerated Plaques
  Presenter(s):J. David Spence, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
x
UPDATE ON CAROTID RCTs
1:00 PM - 1:05 PM Update On ACST 2: CEA Versus CAS For ACS: What Is It Telling Us And When Will We Have All The Answers
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
1:06 PM - 1:11 PM Update On SPACE 2: CEA Versus Best Medical Treatment (BMT); CAS Versus BMT For ACS: Updated And Interesting Findings From A Stopped RCT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
1:12 PM - 1:17 PM Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Findings To Date And When Will We Have Final Results
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
1:18 PM - 1:23 PM Why Is BMT With Clopidogrel Different In The Arms Of CREST and CREST 2 And Why This Difference Could Invalidate The RCTs Results (Power Point Presentation With Synched Audio)
  Presenter(s):Timothy M. Sullivan, MD  
TANDEM CAROTID LESIONS
1:24 PM - 1:30 PM DEBATE: Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
1:30 PM - 1:35 PM DEBATE: Tandem Carotid Lesions: Treatment Risks Need Not Be Increased: Based On A Meta-Analysis: How Best To Treat To Minimize Risk
  Presenter(s):Ross Naylor, MD, FRCS  
1:36 PM - 1:41 PM CEA And Retrograde Stenting Of A Tandem Proximal Lesion: Technical Tips To Make It Safe And Effective
  Presenter(s):Christopher J. Smolock, MD  
1:42 PM - 1:47 PM Optimal Management Of Extracranial Carotid Aneurysms In 2020: When Open; When Endo: Technical Tips And Results
  Presenter(s):Samuel R. Money, MD, MBA  
1:48 PM - 1:53 PM How Best To Treat Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: What Skills Are Needed
  Presenter(s):Gert J. de Borst, MD, PhD  
1:54 PM - 2:02 PM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: MORE HOT CAROTID TOPICS: TREATMENT IN 2020 OF STRING SIGN, BIG CAROTID BODY TUMORS, AND CAROTID DISSECTIONS; OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS; VALUE OF LOCAL ANESTHESIA; STROKE RISK WITH ACS PLAQUES - A WAY TO PREDICT HIGH RISK PLAQUES
x
2:02 PM - 2:07 PM Current Optimal Treatment For Carotid Artery Dissections: When Medical Treatment (Anticoagulation And BP Control); When Open Surgery; When Stenting With Proximal Protection: Precautions
  Presenter(s):Felice Pecoraro, MD  
2:08 PM - 2:13 PM How Best To Diagnose And Treat Near Occlusion Of The Internal Carotid Artery (ICA) In 2020: Based On A Meta-Analysis: Is This The ICA String Sign Of Past Descriptions
  Presenter(s):Gert J. de Borst, MD, PhD  
2:14 PM - 2:19 PM Technical Tips For Treating Large Shamblin III Carotid Body Tumors Safely; From An Ecuadorian Team Who Treats Many
  Presenter(s):Oscar L. Ojeda, MD, FACS  
2:20 PM - 2:25 PM Optimal Anti-Platelet Strategy Before And After CEA
  Presenter(s):Ross Naylor, MD, FRCS  
2:26 PM - 2:31 PM Value Of Protamine Use During CEA: How Should It Be Used And With What Precautions
  Presenter(s):David H. Stone, MD  
2:32 PM - 2:38 PM Panel Discussion
2:38 PM - 2:43 PM Restenosis After CEA And CAS Is Benign And Should Rarely Be Treated: When Can It Cause Strokes Justifying Prophylactic Treatment
  Presenter(s):Ross Naylor, MD, FRCS  
2:44 PM - 2:49 PM DEBATE: Local Anesthesia And Intraoperative Control With Duplex Or Angiography Is Key To Safe CEA: How To Do Them
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
2:50 PM - 2:55 PM DEBATE: Not So: CEA Can Be Performed Safely And Optimally Under General Anesthesia And Without Completion Duplex Or Angio Control: What Is Required To Do So And Are There Downsides To Duplex Or Angio Controls
  Presenter(s):Ali F. AbuRahma, MD  
2:56 PM - 3:01 PM Are Symptomatic And Asymptomatic Carotid Stenosis Really 2 Different Diseases As Some Suggest
  Presenter(s):Thomas G. Brott, MD  
3:02 PM - 3:07 PM What Percent Of Carotid Plaques Are Really High Stroke Risk: How To Detect Them With Ultrasound To See Neovascularization: Can High Risk Plaques Be Made Low Risk By Lipid Lowering
  Presenter(s):Henrik Sillesen, MD, DMSc  
3:08 PM - 3:13 PM When An Asymptomatic Carotid Stenosis (ACS) Patient Has A Stroke What Is Its Magnitude: Does It Make The Case For More Or Less Prophylactic CEAs And CASs
  Presenter(s):Gianluca Faggioli, MD  
3:14 PM - 3:20 PM Panel Discussion
3:20 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: MORE HOT AND CONTROVERSIAL CAROTID TOPICS AND NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS
x
HOT CAROTID TOPICS
3:30 PM - 3:35 PM Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
3:36 PM - 3:41 PM Unnecessary Redundant Testing/Imaging Prior To CEA: What Is The Reason For This Needless Addition To Health Care Costs
  Presenter(s):Reese A. Wain, MD  
3:42 PM - 3:47 PM Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting
  Presenter(s):Juan C. Parodi, MD  
3:48 PM - 3:53 PM What Is Carotid Near Occlusion And How Is It Best Treated Currently: Conservatively, CEA, CAS
  Presenter(s):Weiguo Fu, MD  
3:54 PM - 3:59 PM DEBATE: CAS Is The Best Treatment For Young Patients With A High Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):Giancarlo Biamino, MD, PhD  
4:00 PM - 4:05 PM DEBATE: Not So: Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
4:06 PM - 4:12 PM Panel Discussion
NEW OR UPDATED CONCEPTS OR ENDO TREATMENTS
4:12 PM - 4:17 PM Clinical Judgment Is Required In The Application Of Evidence Based Medicine: RCTs Can Have Flaws Leading To Misleading Conclusions
  Presenter(s):J. David Spence, MD  
4:18 PM - 4:23 PM How Should Left Subclavian Artery Stenosis Be Treated In Patients Before Coronary Artery Bypass: Stent Versus Carotid Subclavian Bypass Versus Ignore But Don’t Use The Left Internal Mammary Artery
  Presenter(s):Jennifer L. Perri, MD, MBA  
4:24 PM - 4:29 PM Progress In Open And Endovascular Treatment For Erectile Dysfunction: Diagnosis And Treatment Of Cavernous Leak And Other Pathology: A New Horizon
  Presenter(s):Eric Allaire, MD, PhD  
4:30 PM - 4:35 PM Embolic Treatment Of Hemorrhoids: How To Do It And How Well Does It Work
  Presenter(s):Gloria Salazar, MD  
4:36 PM - 4:41 PM Transfemoral Transcaval Liver Biopsy: A Better Way And How To Do It
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE, ENDOVASCULAR SUTURING AND WOUND CARE
x
4:48 PM - 4:53 PM Update On Large Bore Percutaneous Access Closure Devices: Key New Devices And Developments: How To Prevent Failure And Complications
  Presenter(s):Zvonimir Krajcer, MD, FACC  
4:54 PM - 4:59 PM Endovascular Suturing Devices At The Tip Of An 8-9 French Catheter To Close Large Bore Sheath Access From Inside: The NovelRad Device: How Does It Work And Present Status
  Presenter(s):Elchanan Bruckheimer, MBBS  
PROGRESS IN WOUND CARE
5:00 PM - 5:05 PM Access Complications Despite Modern Closure Devices And Endovascular Suturing: Strategies And Wound Care
  Presenter(s):Martin Storck, MD, PhD / Peter Reimer, MD, PhD  
5:06 PM - 5:11 PM Best Treatment Strategies For Complex Infected Groin Wounds After Vascular Surgery: When To Do What: Wide Debridement, Antibiotics, Muscle Flap Reconstruction Or Graft Removal
  Presenter(s):Jan-Willem Elshof, MD  
5:12 PM - 5:17 PM Optimal Treatment For Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg
  Presenter(s):Hosam F. El Sayed, MD  
5:18 PM - 5:23 PM New Developments In The Treatment Of Mixed Arterial And Venous Wounds And Ulcers
  Presenter(s):Katherine A. Gallagher, MD  
5:24 PM - 5:29 PM Value Of A Wound Care Center To A Vascular Practice: Who Should Staff It And How To Make It Revenue Positive
  Presenter(s):Venita Chandra, MD  
5:30 PM - 5:36 PM Panel Discussion
End of Program K

END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
x
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS
7:00 AM - 7:05 AM High Points Of New SVS Guidelines For The Treatment Of Popliteal Aneurysms: Roles Of Endo And Open Repairs
  Presenter(s):Alik Farber, MD, MBA / Patrick J. Geraghty, MD  
7:06 AM - 7:11 AM Contemporary Treatment Of Popliteal Aneurysms In 14 Countries: There Is Great Variation In Treatment, Techniques, Complications And Outcomes: The Take Home Message Is . . .
  Presenter(s):Martin Bjorck, MD, PhD  
7:12 AM - 7:17 AM DEBATE: Endovascular Repair Is The Best Option For Most Popliteal Aneurysms Requiring Repair: Recent Progress In The Procedure: When Is Open Repair Indicated
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
7:18 AM - 7:23 AM DEBATE: Open Repair With Prosthetic Bypass Graft Is Better Than Endovascular Treatment For Popliteal Aneurysms Requiring Repair
  Presenter(s):Laurent Chiche, MD, FEBVS  
7:24 AM - 7:30 AM Update On Optimal Treatment For Popliteal Aneurysms: When Observation; When Endo Repair; When Open Repair And How
  Presenter(s):Fred A. Weaver, MD, MMM  
7:30 AM - 7:36 AM Panel Discussion
7:36 AM - 7:41 AM What Are Complex Popliteal Aneurysms And How Should They Be Fixed: When Endo; When Open
  Presenter(s):Jacques Busquet, MD  
7:42 AM - 7:47 AM Rescue Procedures For Failed Endovascular Repairs Of Popliteal Aneurysms: Observation May Be Enough: If Not, Hybrid Versus Open Repair: Technical Tips
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS,FESC,FEBVS  
POPLITEAL ENTRAPMENTS
7:48 AM - 7:53 AM What’s New In The Treatment Of Popliteal Entrapments
  Presenter(s):Niten Singh, MD  
POPLITEAL ARTERY INJURY
7:54 AM - 7:59 AM Surgical Approach And Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation
  Presenter(s):Charles J. Fox, MD, FACS  
POPLITEAL ARTERY ATHERECTOMY
8:00 AM - 8:05 AM Value Of Orbital Atherectomy For Popliteal Artery Occlusive Lesions: Indications, Results, Precaution
  Presenter(s):Konstantinos P. Donas, MD  
8:06 AM - 8:12 AM Panel Discussion
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) AND ARTERIAL GRAFT INFECTIONS
x
8:12 AM - 8:17 AM Update On Deep Vein Use For Arterial Procedures: The NAIS Operation For Infections: Recent Technical Improvements
  Presenter(s):Patrick A. Stone, MD  
TREATMENT OF MYCOTIC ANEURYSMS
8:18 AM - 8:23 AM Optimal Treatment Of Mycotic AAAs In 2020: Value Of And Precautions With EVAR: Is It Ever A Stand-Alone Treatment
  Presenter(s):Timur P. Sarac, MD  
8:24 AM - 8:29 AM Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques
  Presenter(s):Guillermo A. Escobar, MD  
8:30 AM - 8:35 AM Why Open Repair Is The Best Treatment For Mycotic AAAs: Is EVAR Ever Of Value
  Presenter(s):Yamume Tshomba, MD  
8:36 AM - 8:41 AM Best Treatment For Mycotic Aortic Aneurysms In The Thorax And Abdomen Based On Long-Term Results
  Presenter(s):Samy S. Nitecki, MD  
8:42 AM - 8:48 AM Panel Discussion
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS
8:48 AM - 8:53 AM Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment, Outcomes
  Presenter(s):Mohammad H. Eslami, MD, MPH  
8:54 AM - 8:59 AM Optimal Techniques For Treating Aorto-Iliac Graft And Endograft Infections In 2020
  Presenter(s):Anders Wanhainen, MD, PhD  
9:00 AM - 9:05 AM Update Of Surgical Treatment For Infected Aortic Grafts And Aortic-Enteric And Aortic-Bronchial Fistulas: Current Results In A Committed Center
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
9:06 AM - 9:11 AM Update On Progress In The Optimal Treatment Of Aortic And Arterial Graft Infections: What’s New In 2020
  Presenter(s):Jean-Paul de Vries, MD, PhD  
9:12 AM - 9:17 AM DEBATE: Semi-Conservative Therapy May Be Best For Some Aortic Graft Infections: What Is It And When Will Saving All Or Part Of An Infected Graft Work
  Presenter(s):Zoran Rancic, MD, PhD  
9:18 AM - 9:23 AM DEBATE: Not So: Aggressive Graft Removal Is Always Necessary In Treating Infections Involving Aortic Grafts
  Presenter(s):Franco Grego, Vascular Surgery  
9:24 AM - 9:29 AM Open Repair Of Suprarenal Aortic Graft Infections: Technical Tips And Long-Term Results
  Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS  
9:30 AM - 9:37 AM Panel Discussion
9:37 AM - 9:52 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
x
VASCULAR HOLOGRAPHY
9:52 AM - 9:57 AM How Will The Microsoft Hololens Look Through Patients’ Bodies And Facilitate Endovascular Interventions: The ARCUS System Of Augmented Reality And Its Value In Vascular Surgery
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
9:58 AM - 10:03 AM Real View Holographic Imaging: How Will It Help In Endovascular Treatments: Is It Available In The US
  Presenter(s):Elchanan Bruckheimer, MBBS  
10:04 AM - 10:09 AM Holographic Guidance Of Endovascular Procedures: What Is Possible And What Is Not
  Presenter(s):Claude Mialhe, MD  
DUPLEX AND INTRAVASCULAR ULTRASOUND
10:10 AM - 10:15 AM Duplex Ultrasound Guidance: How, Where And When Can It Replace Fluoroscopy For Endovascular Procedures: Advantages, Limitations, And Why Its Use Is Increasing
  Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM  
10:16 AM - 10:21 AM Intravascular Ultrasound (IVUS) Assistance In EVAR And TEVAR: Advantages And Limitations - Based On A Multicenter Study
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
10:22 AM - 10:28 AM Panel Discussion
IMPROVED IMAGING
10:28 AM - 10:33 AM Contrast Induced Nephropathy Is Over-Exaggerated: When Patients Need A Contrast Study, They Should Get It: How To Minimize Consequences
  Presenter(s):Lindsay Machan, MD  
10:34 AM - 10:39 AM CO2 As A Contrast Agent For Endo Treatment Of PAD And CLTI: How To Use It Safely And Effectively
  Presenter(s):Jim Caridi, MD, FSIR  
10:40 AM - 10:45 AM Dual Fluoroscopy With Live Image Digital Zooming: How Does It Work And Why Does It Decrease Radiation During Complex AAA Repairs: What Is Its Cost
  Presenter(s):Carlos H. Timaran, MD  
10:46 AM - 10:51 AM The Cydar System Deformation Tool For Improving Image Fusion Accuracy: How Does It Work And Why Does It Help
  Presenter(s):Cynthia K. Shortell, MD  
10:52 AM - 10:57 AM Cydar Medical System’s Evolution To Facilitate Fusion With All Digital Fluoroscopes: How The System Uses AI To Improve EVAR Planning, Guidance And Deployment
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
10:58 AM - 11:03 AM The Cydar System’s Value In Standard And Complex EVAR
  Presenter(s):Venkatesh G. Ramaiah, MD  
11:04 AM - 11:12 AM Panel Discussion
END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC AND THE UNIVERSITY OF TEXAS, HOUSTON
x
11:12 AM - 12:00 PM PROGRAM TBD
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 90
 
SESSION 91 SCHEDULE
Friday
SESSION 91: ONE PRESENTATION AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
x
1:00 PM - 1:44 PM Complex Cases From Münster With Questions And Discussion
  Presenter(s):Giovanni B. Torsello, MD / Martin J. Austermann, MD  
END OF SESSION 91
 
SESSION 92 SCHEDULE
Friday
SESSION 92: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
x
1:44 PM - 1:49 PM New Developments In The Treatment Of Neurogenic TOSs: What Preop Factors Correlate With Good Outcomes; With Bad Outcomes
  Presenter(s):Karl A. Illig, MD  
1:50 PM - 1:55 PM Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation)
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
VENOUS TOSs
1:56 PM - 2:01 PM Venous TOSs: Lessons Learned After Treating >1000 Cases
  Presenter(s):Robert W. Thompson, MD  
2:02 PM - 2:07 PM Spectrum Of Treatment Options For Venous TOS: What Are The Outcomes And How Do They Differ
  Presenter(s):Jason T. Lee, MD  
2:08 PM - 2:13 PM Patients With Symptomatic Venous TOS With And Without Venous Thrombosis May Not Need Surgical (1st Rib Resection) Treatment: Antiplatelet Drugs And Anticoagulation May Resolve Symptoms: Which Patients Require Rib Resection
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
2:14 PM - 2:19 PM Technical Tips For Optimal Surgical Treatment For Venous TOS
  Presenter(s):Robert W. Thompson, MD  
2:20 PM - 2:26 PM Panel Discussion
2:26 PM - 2:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 92
 
SESSION 93 SCHEDULE
Friday
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
x
ANTIPLATELET REGIMENS
2:36 PM - 2:41 PM Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs
  Presenter(s):David H. Stone, MD  
2:42 PM - 2:47 PM Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE
  Presenter(s):Peter Henke, MD  
2:48 PM - 2:53 PM Most Effective Antiplatelet After Lower Extremity Interventional Treatments For CLTI – POBA, DCBs, Stents, Etc.
  Presenter(s):Maciej L. Dryjski , MD, PhD  
2:54 PM - 2:59 PM Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem
  Presenter(s):Karthikeshwar Kasirajan, MD  
NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS
3:00 PM - 3:05 PM Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Shockingly These Treatments Are Underutilized – Especially In Women: Why Is This So
  Presenter(s):Christian A. Behrendt, MD  
3:06 PM - 3:11 PM Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality
  Presenter(s):Adam Beck, MD  
3:12 PM - 3:17 PM The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
3:18 PM - 3:24 PM Panel Discussion
3:24 PM - 3:29 PM Elevated Neutrophil To Lymphocyte Ratio Predicts Poor Outcomes And Mortality After Elective EVAR And CEA: What Is The Mechanism
  Presenter(s):Jae S. Cho, MD  
3:30 PM - 3:35 PM The Justification For Carotid Screening Is To Promote Medical Treatment To Decrease Stroke And MI Risks, Not To Push Patients To Have Unnecessary Invasive Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
3:36 PM - 3:41 PM Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
3:42 PM - 3:47 PM Current (2020) Status Of Diagnosis And Treatment Of Buerger’s Disease: Does It Exist Or Is It Just A Variant Of Atherosclerosis
  Presenter(s):Kamphol Laohapensang, MD  
3:48 PM - 3:53 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
3:54 PM - 4:00 PM Panel Discussion
END OF SESSION 93
 
SESSION 94 SCHEDULE
Friday
SESSION 94: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
x
4:00 PM - 4:05 PM Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions
  Presenter(s):Gilbert R. Upchurch, MD  
4:06 PM - 4:11 PM Value Of REBOA For Pending And Actual Cardiac Arrest: What Is Partial And Intermittent REBOA And How Is It Helpful
  Presenter(s):Tal M. Hörer, MD, PhD  
4:12 PM - 4:17 PM Value Of Simulator Based Training For REBOA: How Does It Work: Can It Improve Results And Decrease Mishaps
  Presenter(s):Lars B. Lonn, MD, PhD  
4:18 PM - 4:23 PM Transexamic Acid – An Antifibrinolytic Drug: Does It Reduce Mortality With Mild To Moderate Traumatic Brain Injuries: Based On A RCT
  Presenter(s):Todd E. Rasmussen, MD, FACS  
4:24 PM - 4:29 PM Why One Should Have A Stock On Hand Of Balloon-Expandable And Self-Expandable Covered Stents To Deal With Emergencies From Iatrogenic And Other Traumatic Vascular Injuries: What Should Be In The Stock
  Presenter(s):Maria A. Ruffino, MD, EBIR  
4:30 PM - 4:35 PM Radial Access Techniques And Technology For Embolotherapy To Treat Vascular Trauma: Indications And Results
  Presenter(s):Jonathan J. Morrison, PhD, FRCS  
4:36 PM - 4:41 PM For Major Venous Injuries: Repair Versus Ligation – Which Is Currently Best When
  Presenter(s):Samy S. Nitecki, MD  
4:42 PM - 4:47 PM Update On Best Current Management Of Pediatric Vascular Injuries: When Conservative; When Open; When Endo And Precautions
  Presenter(s):Michael C. Dalsing, MD  
4:48 PM - 4:54 PM Panel Discussion
BLUNT THORACIC AORTIC INJURY (BTAI)
4:54 PM - 4:59 PM Endovascular Repairs Of Traumatic Aortic Injuries – Civilian And Military: Technology, Technical Tips And Results
  Presenter(s):James W. Dennis, MD  
5:00 PM - 5:05 PM When Can Minor BTAI Be Treated By Observation Without TEVAR: What Precautions Are Necessary
  Presenter(s):Elina Quiroga, MD, MPH  
5:06 PM - 5:11 PM DEBATE: Are We Overtreating BTAI – Especially Lesser Injuries
  Presenter(s):Joseph J. DuBose, MD  
5:12 PM - 5:17 PM DEBATE: Why Many Patients With Lesser Degrees Of BTAI Require TEVAR
  Presenter(s):Ali Azizzadeh, MD  
5:18 PM - 5:23 PM Why Rapid And Complete Aortic Healing After TEVAR For BTAI Should Influence The Length And Diameter Of The Endograft Used: Oversizing And Length Of Seal Zone Can Be Minimized: Technical Tips
  Presenter(s):Shang Loh, MD  
5:24 PM - 5:29 PM How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing
  Presenter(s):Charles J. Fox, MD, FACS  
5:30 PM - 5:35 PM With TBAI Requiring TEVAR, When Can The Left Subclavian Artery Be Covered And When Not: Tips On Endograft Sizing
  Presenter(s):Elina Quiroga, MD, MPH  
5:36 PM - 5:42 PM Panel Discussion
End of Program L

END OF SESSION 94
 
SESSION 95 SCHEDULE
Friday
SESSION 95: PELVIC VENOUS DISORDERS, FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
x
7:00 AM - 7:04 AM Introduction: Deep System
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
7:05 AM - 7:10 AM Iliocaval Duplex Ultrasound With Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
7:11 AM - 7:16 AM PTS Patients: Identifying Patients Most Likely To Fail Stenting
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
7:17 AM - 7:22 AM Venographic Techniques To Identify Pelvic Anatomy And Escape Points
  Presenter(s):Mark H. Meissner, MD  
7:23 AM - 7:28 AM Ovarian Vein Embolization: Which Patient Benefits And Reimbursement
  Presenter(s):Kathleen D. Gibson, MD  
7:29 AM - 7:34 AM Open Surgery For Nutcracker: Techniques And Results
  Presenter(s):Cynthia K. Shortell, MD  
7:35 AM - 7:40 AM We Need Dedicated Venous Stents For Nutcracker Syndrome And We Need Them Now
  Presenter(s):Peter Gloviczki, MD  
7:41 AM - 7:46 AM Panel Discussion
CHRONIC VENOUS OBSTRUCTION
Moderator(s): Jose I. Almeida, MD, FACS, RPVI, RVT / Patrick E. Muck, MD, FACS  
7:47 AM - 7:52 AM Recanalizing Occluded Venous Stents
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:53 AM - 7:58 AM Deep Reflux: What Happens After Concomitant Obstruction Correction
  Presenter(s):Marzia Lugli, MD  
7:59 AM - 8:04 AM Contralateral Limb Improvement After Unilateral Iliac Vein Stenting: Argument Against Simultaneous Bilateral Stenting
  Presenter(s):Seshadri Raju, MD  
8:05 AM - 8:10 AM Precise Positioning Of Venous Stents Using Anatomical Landmarks Only
  Presenter(s):Gerard J. O'Sullivan, MD  
8:11 AM - 8:16 AM Utilizing The Radiofrequency Power Wire To Vaporize A Channel Through Chronic Iliocaval Venous Obstructions (CICVO)
  Presenter(s):Patrick E. Muck, MD, FACS  
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 95
 
SESSION 96 SCHEDULE
Friday
SESSION 96: FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
x
8:23 AM - 8:28 AM Impact Of Stent Structure On Venous Flow (In Vitro Investigations With A Designed Fluid Dynamic Model)
  Presenter(s):Houman Jalaie, MD  
8:29 AM - 8:34 AM Does Vein Stenting Reduce Great And Small Saphenous Venous Reflux
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
8:35 AM - 8:40 AM Misconceptions Regarding Elastic Compression For Prevention Of Post-Thrombotic Changes
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
8:41 AM - 8:46 AM Best Anticoagulation After Deep Venous Stenting
  Presenter(s):Ellen D. Dillavou, MD  
8:47 AM - 8:52 AM Appropriate Iliofemoral Venous Stent Sizing
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
8:53 AM - 8:58 AM Outcomes And Predictors Of Failure Of Iliac Vein Stenting
  Presenter(s):Rabih A. Chaer, MD  
8:59 AM - 9:04 AM Reinterventions Following Vein Stent Placements – Lessons Learned From 166 Cases
  Presenter(s):Windsor Ting, MD  
9:05 AM - 9:10 AM Panel Discussion
END OF SESSION 96
 
SESSION 97 SCHEDULE
Friday
SESSION 97: HYBRID TECHNIQUES, STENT PROBLEMS, POST-IMPLANTATION
x
9:11 AM - 9:16 AM Endovascular Remote Endovenectomy For Chronic Venous Disease Using The Inari CloTriever
  Presenter(s):Steven D. Abramowitz, MD  
9:17 AM - 9:22 AM Neointima Formation Following Venous Placement Of Self-Expanding Nitinol Stents Of Different Porosity: Clinical And Experimental Results
  Presenter(s):Houman Jalaie, MD  
9:23 AM - 9:28 AM Biopsy Of Venous In-Stent Stenosis: Histopathology And Treatment
  Presenter(s):David M. Williams, MD  
9:29 AM - 9:34 AM Utilizing Indigo System To Extract Thrombus Prior To ISR Ballooning And Stenting: Our Institution’s Experience
  Presenter(s):Frank R. Arko, MD  
9:35 AM - 9:40 AM Predilating A Chronic Thrombotic Obstructive Lesion: Balloon Size And What Pressure-Nominal Or Burst Pressure
  Presenter(s):Gerard J. O'Sullivan, MD  
9:41 AM - 9:46 AM Endovectomy And Iliac Vein Stent Placement: How I do It (Video Technique Demonstration)
  Presenter(s):Houman Jalaie, MD  
9:47 AM - 9:52 AM Iatrogenic Balloon Laceration O Central Vein: Now What
  Presenter(s):Gerard J. O'Sullivan, MD  
9:53 AM - 9:58 AM Techniques For Endovenectomy And Concomitant Iliocaval Stenting With And Without Adjuvant Arteriovenous Fistula Creation
  Presenter(s):Steven D. Abramowitz, MD  
9:59 AM - 10:04 AM Panel Discussion
END OF SESSION 97
 
SESSION 98 SCHEDULE
Friday
SESSION 98: STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS, MEDICINES, AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
x
10:05 AM - 10:10 AM What To Do When Iliac Vein Stenting As Well As Endovenous Ablation Fail To Heal The Venous Ulcer: Tips And Tricks
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
10:11 AM - 10:16 AM When Deep Venous Reflux Repair Is Not Effective: What Next
  Presenter(s):Marzia Lugli, MD  
10:17 AM - 10:22 AM Evolution Of Endovenous Treatment Options For Acute DVT
  Presenter(s):Antonios P. Gasparis, MD  
10:23 AM - 10:28 AM Femoral-Popliteal Intervention For Post-Thrombotic Syndrome: ACCESS Trial: EKOS And TPA Overnight
  Presenter(s):Mark J. Garcia, MD  
10:29 AM - 10:34 AM Management Options Of Infrainguinal Disease: Indications And Options
  Presenter(s):Steve Elias, MD  
10:35 AM - 10:40 AM Panel Discussion
WOUNDS AND NEW HORIZONS
Moderator(s): Peter F. Lawrence, MD / William A. Marston, MD  
10:41 AM - 10:46 AM What Is The Standard Of Care For Venous Wounds
  Presenter(s):William A. Marston, MD  
10:47 AM - 10:52 AM Skin Substitutes To Promote Venous Leg Ulcer Healing
  Presenter(s):Sarah Onida, MD, PhD  
10:53 AM - 10:58 AM Treatment Of Superficial And Perforator Reflux And Deep Venous Stenosis Improves Healing Of Chronic Venous Leg Ulcers
  Presenter(s):Peter F. Lawrence, MD  
10:59 AM - 11:04 AM Do The EVRA Study Results Apply For Ulcers <6 Months Chronicity
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
11:05 AM - 11:10 AM The Economic Impact Of Infections In Venous Leg Ulcer Patients
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
11:11 AM - 11:16 AM Panel Discussion
END OF SESSION 98
 
SESSION 99 SCHEDULE
Friday
SESSION 99: VENOUS STENT TRIALS AND CONCEPTS
x
11:17 AM - 11:22 AM Differences Between Elgiloy And Nitinol Stents
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:23 AM - 11:28 AM Virtus Trial - 3-Year Update
  Presenter(s):William A. Marston, MD  
11:29 AM - 11:34 AM Vernacular Trial - 3-Year Update
  Presenter(s):Gerard J. O'Sullivan, MD  
11:35 AM - 11:40 AM Abre Trial Results
  Presenter(s):Stephen A. Black, MD  
11:41 AM - 11:46 AM Zilver Vena Stent Trial
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
11:47 AM - 11:52 AM What Can The Arnsberg Registry Tell Us
  Presenter(s):Michael K.W. Lichtenberg, MD  
11:53 AM - 11:58 AM What Is Aspect Ratio And What Does The Clinical Data Reveal
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:59 AM - 12:04 PM Aspect Ratio Of Iliac Stenosis: Does It Matter
  Presenter(s):Seshadri Raju, MD  
12:05 PM - 12:10 PM Panel Discussion
12:10 PM - 12:40 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 99
 
SESSION 100 SCHEDULE
Friday
SESSION 100: MORE ILIOFEMORAL FLOW AND PELVIC ISSUES
x
12:40 PM - 12:45 PM Do Venous Stent Fractures Matter
  Presenter(s):David J. Dexter, MD  
12:46 PM - 12:51 PM Treatment Algorithm For Pelvic Venous Reflux
  Presenter(s):Antonios P. Gasparis, MD  
12:52 PM - 12:57 PM Which Is More Important: Pelvic Venous Insufficiency Or Iliac Vein Obstruction
  Presenter(s):Peter J. Pappas, MD  
12:58 PM - 1:03 PM Male Pelvic Congestion And Varicose Veins: How Much Of A Problem
  Presenter(s):Mark S. Whiteley, MS, FRCS  
1:04 PM - 1:09 PM Diagnosis And Treatment Of Pelvic Congestion Syndrome: UIP Consensus Document
  Presenter(s):Neil M. Khilnani, MD  
1:10 PM - 1:15 PM A Novel Technique And Outcomes For Iliocaval Extravascular Reconstruction (TIER) For Iliocaval Agenesis
  Presenter(s):Steven D. Abramowitz, MD  
1:16 PM - 1:21 PM Deep Venous Reconstruction: Is It Safe And Profitable In An OBL
  Presenter(s):Paul J. Gagne, MD  
1:22 PM - 1:27 PM Panel Discussion
END OF SESSION 100
 
SESSION 101 SCHEDULE
Friday
SESSION 101: STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
x
VTE INTERVENTIONAL
1:28 PM - 1:33 PM DVT Removal Without Thrombolytics – Mechanical Thrombectomy Is Now The Standard Of Care For Both Upper And Lower Extremity DVT
  Presenter(s):Constantino Pena, MD  
1:34 PM - 1:39 PM P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex
  Presenter(s):Michael K.W. Lichtenberg, MD  
1:40 PM - 1:45 PM Thrombolysis For Acute DVT: Utilization And Guidance From Current Clinical Trials
  Presenter(s):Brian G. DeRubertis, MD  
1:46 PM - 1:51 PM A Comparison Of Angiojet Versus CDT For The Treatment Of Iliofemoral DVT
  Presenter(s):Stephen A. Black, MD  
1:52 PM - 1:57 PM Angiovac Venous Thrombectomy: Where, When, And How
  Presenter(s):David J. Dexter, MD  
1:58 PM - 2:03 PM Venous Aneurysms: Should They Be Treated
  Presenter(s):Peter F. Lawrence, MD  
2:04 PM - 2:09 PM Renal Failure In Acute DVT Treatment: Incidence And Strategies For Prevention
  Presenter(s):Stephen A. Black, MD  
2:10 PM - 2:15 PM Clot Registry For The Inari CloTriever
  Presenter(s):David J. Dexter, MD  
2:16 PM - 2:21 PM Panel Discussion
CENTRAL VENOUS THROMBOSIS; COVID-19
Moderator(s): Ian J. Franklin, MS, FRCS(Gen Surg) / Jinsong Wang, MD  
2:22 PM - 2:27 PM Investigation And Treatment Of Pelvic Vein Reflux Associated With Varicose Veins: Current Views And Practice Of 100 UK Vascular Specialists
  Presenter(s):Ian J. Franklin, MS, FRCS(Gen Surg)  
2:28 PM - 2:33 PM Does PMT Now Lead To Over-Stenting
  Presenter(s):Stephen A. Black, MD  
2:34 PM - 2:39 PM Outcome Of Venous Stents In Adolescents, Teenagers, And Pregnancy
  Presenter(s):Mahmood Razavi, MD  
2:40 PM - 2:45 PM COVID-19: What Have We Learned – China Experience
  Presenter(s):Jinsong Wang, MD  
2:46 PM - 2:51 PM COVID-19 Treatment Of Venous Thrombosis In Hospitalized Patients
  Presenter(s):Mikel Sadek, MD  
2:52 PM - 2:57 PM COVID-19 Outpatient Experience With Anticoagulation
  Presenter(s):Steve Elias, MD  
2:58 PM - 3:03 PM COVID-19 And Thrombotic Or Thromboembolic Disease: Implications For Prevention, Antithrombotic Therapy, And Follow-Up
  Presenter(s):Joseph A. Caprini, MD  
3:04 PM - 3:09 PM Panel Discussion
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Peter Henke, MD  
3:10 PM - 3:15 PM Using The Femoral Vein As A Tunneling Conduit For An Arterial Bypass: Venous Outcomes In PQ Bypass
  Presenter(s):Mark A. Adelman, MD  
3:16 PM - 3:21 PM Duration Of Anticoagulation
  Presenter(s):Rachel Rosovsky, MD, MPH  
3:22 PM - 3:27 PM Should All Patients With Acute VTE Be Treated With A Statin: When And Dose
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
3:28 PM - 3:33 PM Update On Reversal Agents For The DOACs
  Presenter(s):Timothy K. Liem, MD, MBA  
3:34 PM - 3:39 PM Thrombus Aging Using MRI
  Presenter(s):Stephen A. Black, MD  
3:40 PM - 3:45 PM Role Of Thrombophilia Testing
  Presenter(s):Rachel Rosovsky, MD, MPH  
3:46 PM - 3:51 PM Update In Experimental DVT Pathogenesis And Resolution
  Presenter(s):Peter Henke, MD  
3:52 PM - 3:57 PM DOAC Revolution – Which Drug For What Disease: Review Of Ongoing Trials
  Presenter(s):Andrea T. Obi, MD  
3:58 PM - 4:03 PM Pediatric DVT: An Evidence Summary
  Presenter(s):Dawn M. Coleman, MD  
4:04 PM - 4:09 PM Inflammation And Venous Thrombosis: An Evidence Summary
  Presenter(s):Thomas W. Wakefield, MD  
4:10 PM - 4:15 PM Family History Of Thrombosis: The Forgotten Risk Factor
  Presenter(s):Joseph A. Caprini, MD  
4:16 PM - 4:21 PM Current Strategy Of VTE Prevention In China
  Presenter(s):Jinsong Wang, MD  
4:22 PM - 4:27 PM Mesenteric Vein Thrombosis: What Is The Best Strategy
  Presenter(s):Mark G. Davies, MD  
4:28 PM - 4:33 PM Thoracic Outlet Acute VTE: What To Do And When
  Presenter(s):Saum A. Rahimi, MD  
4:34 PM - 4:39 PM Closed Plication Is A Safe And Effective Method For Treating Popliteal Venous Aneurysm
  Presenter(s):Thomas W. Wakefield, MD  
4:40 PM - 4:45 PM Panel Discussion
END OF SESSION 101
 
SESSION 102 SCHEDULE
Friday
SESSION 102: DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION
x
DEEP VALVE PROGRESS
4:46 PM - 4:51 PM The Need For A Deep Venous Valve For Severe CVI Patients With DVT
  Presenter(s):Mikel Sadek, MD  
4:52 PM - 4:57 PM Safety And Efficacy Report On The Venovalve (First In Man) IDE Feasibility Study
  Presenter(s):Jorge H. Ulloa, MD, FACS  
4:58 PM - 5:03 PM US Experience Of The BlueLeaf®Endovenous Valve Formation: Update
  Presenter(s):William A. Marston, MD  
5:04 PM - 5:09 PM Implantable Bicuspid Valve: Early Preclinical Results
  Presenter(s):Paul J. Gagne, MD  
5:10 PM - 5:15 PM Surgical Creation Of A Monocusp Valve
  Presenter(s):Marzia Lugli, MD  
5:16 PM - 5:21 PM Panel Discussion
CAVAL INTERRUPTION
Moderator(s): Timothy K. Liem, MD, MBA / Constantino Pena, MD  
5:22 PM - 5:27 PM The Novate Sentry Trial With A Novel Bio-Convertible IVC Filter: Follow-Up At 2 Years
  Presenter(s):Michael D. Dake, MD  
5:28 PM - 5:33 PM Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
5:34 PM - 5:39 PM IVC Management In Pregnant Patients
  Presenter(s):Joann Lohr, MD  
5:40 PM - 5:45 PM Surgical Removal Of IVC Filters: Perforation Or Infiltration
  Presenter(s):Timothy K. Liem, MD, MBA  
5:46 PM - 5:51 PM Why Temporary Filters Are Not Removed: Clinical Predictors In 1,000 Consecutive Cases
  Presenter(s):Heron E. Rodriguez, MD  
5:52 PM - 5:57 PM What To Do With Fractured Filters And Embolic Filter Fragments
  Presenter(s):Constantino Pena, MD  
5:58 PM - 6:03 PM Panel Discussion
End of Program M

END OF SESSION 102
 
SESSION 103 SCHEDULE
Saturday
SESSION 103: LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
7:00 AM - 7:05 AM Optimal Vessel Prep Is Key To Successful BTK And Tibial Angioplasty (PTA): How To Do It
  Presenter(s):Peter A. Schneider, MD  
7:05 AM - 7:10 AM Why Endovascular Treatments Should Be The First Choice For Common Femoral Artery (CFA) Occlusive Lesions
  Presenter(s):Koen R. Deloose, MD  
7:10 AM - 7:15 AM Technical Tips For Retrograde Tibial And Pedal Access Under Ultrasound (Duplex) Guidance: Contraindications When Fluoro Is Better
  Presenter(s):Steven Kum, MD  
7:15 AM - 7:20 AM What Is The Real Complication Rate With Retrograde Tibial And Pedal Access: How To Minimize These Complications
  Presenter(s):Michael H. Wholey, MD, MBA  
7:20 AM - 7:25 AM DEBATE: An Endo First Approach Is Best For Treating CLTI In All Patients: Is There Any Role For Open Bypasses
  Presenter(s):Christopher J. Abularrage, MD  
7:30 AM - 7:35 AM Panel Discussion
7:35 AM - 7:40 AM Complications Of Atherectomy: How To Prevent Some, How To Treat The Others
  Presenter(s):Theodosios Bisdas, MD  
7:40 AM - 7:45 AM Are Isolated Pedal Interventions For CLTI Worthwhile
  Presenter(s):Mark G. Davies, MD  
7:45 AM - 7:50 AM DEBATE: Multivessel Tibial Revascularization Does Not Improve Limb Salvage In CLTI Patients: From A VQI Study
  Presenter(s):Venita Chandra, MD  
7:50 AM - 7:55 AM DEBATE: Not So: In Some Circumstances Multivessel Tibial Revascularization Does Improve Outcomes In CLTI Patients: Which Circumstances
  Presenter(s):Brian G. DeRubertis, MD  
7:55 AM - 8:00 AM Panel Discussion
8:00 AM - 8:05 AM Indication And Technical Tips For Performing Retrograde Popliteal Artery Access
  Presenter(s):Jeffrey J. Siracuse, MD  
8:05 AM - 8:10 AM Prograde SFA Access Can Be Safe And Effective For Lower Extremity Endo Procedures; When And How To Do It
  Presenter(s):Todd Berland, MD  
8:10 AM - 8:15 AM Technical Tips For Open Tibial And Pedal Artery Exposures In Virginal And Redo Situations
  Presenter(s):William P. Robinson, MD  
8:15 AM - 8:20 AM When Are Oral Antibiotics Without Excision Of Infected Bone Adequate Treatment For Osteomyelitis In The Foot
  Presenter(s):Wayne J. Caputo, DPM  
8:20 AM - 8:25 AM Panel Discussion
END OF SESSION 103
 
SESSION 104 SCHEDULE
Saturday
SESSION 104: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
8:25 AM - 8:30 AM Technical Tips For Retrograde Access Via The SFA, Popliteal And BTK Arteries: When And How To Do It
  Presenter(s):Lorenzo Patrone, MD  
8:30 AM - 8:35 AM Dangers And Pitfalls Of Retrograde Lower Extremity Access Distal To The Common Femoral Artery
  Presenter(s):Venita Chandra, MD  
8:35 AM - 8:40 AM Impact Of A Dedicated Limb Preservation/Limb Salvage Service On Amputation Rates: Must It Include An Open Bypass Surgery Component
  Presenter(s):Niten Singh, MD  
8:40 AM - 8:45 AM Importance Of Functional And Ambulatory Status In Decision Making In CLTI Patients: Why Limbs Should Be Saved In Patients Who Are Not Ambulatory
  Presenter(s):Vincent L. Rowe, MD  
8:45 AM - 8:50 AM Endo Versus Open Reinterventions To Assist In Maintaining Patency Of Distal Vein Grafts: Both Are Needed
  Presenter(s):Francesco Spinelli, MD  
8:50 AM - 8:55 AM Panel Discussion
8:55 AM - 9:00 AM Relationship Between Zinc Deficiency And The Outcomes Of Lower Extremity Bypasses For CLTI: Should All CLTI Patients Be Given Zinc
  Presenter(s):Kimihiro Komori, MD, PhD  
9:00 AM - 9:05 AM Open Versus Endo Revascularizations In Dialysis Patients With CLTI: What Is The Role Of Each
  Presenter(s):Rabih A. Chaer, MD  
9:05 AM - 9:10 AM What Is The Best Vessel Prep For Endo Treatments Of Heavily Calcified Lesions: Technical Tips And Precautions
  Presenter(s):Theodosios Bisdas, MD  
9:10 AM - 9:15 AM How To Correct The “No Flow” Phenomenon After Lower Extremity Endovascular Interventions: What Is The Etiology And How To Fix
9:15 AM - 9:20 AM Real World Outcomes With Zilver PTX DESs For Complex Fempop Disease: Why Do They Differ From Trial Results
  Presenter(s):Ali F. AbuRahma, MD  
9:20 AM - 9:25 AM Panel Discussion
9:25 AM - 9:30 AM Value Of Duplex Gray Scale In Predicting Successful SFA CTO Crossing, Re-Entry And The Need For Distal Access
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
9:30 AM - 9:35 AM Effect Of Short-Term Complications Of Lower Extremity Revascularizations On Long-Term Outcomes And Patient Survival
  Presenter(s):Joseph L. Mills, MD  
9:35 AM - 9:40 AM Endovascular Diagnosis And Control f Hemorrhage After Fempop Open Operations: It Is A Better Way And How To Do It
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
9:40 AM - 9:45 AM Longer Procedure Times Are Predictive Of Worse Outcomes With Endovascular Treatments Of Lower Extremity Occlusive Lesions
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
9:45 AM - 9:50 AM Panel Discussion
9:50 AM - 10:00 AM Break – Visit Exhibits And Pavilions (3rd Floors)
END OF SESSION 104
 
SESSION 105 SCHEDULE
Saturday
SESSION 105: AORTIC TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
10:00 AM - 10:05 AM Improved System For Evaluating Aortic Neck Anatomy And Suitability For EVAR And F/EVAR
  Presenter(s):David J. Minion, MD  
10:05 AM - 10:10 AM Top 10 Clinical Trials That Are Needed In AAA Disease
  Presenter(s):Ronald L. Dalman, MD  
SPINE EXPOSURE SURGERY
10:10 AM - 10:17 AM Technical Tips And Tools For The Vascular Surgeon To Provide Anterior Exposure For Spine Procedures (7-Minute Presentation)
  Presenter(s):Jeffrey Jim, MD, MPHS  
10:18 AM - 10:25 AM Vascular Complications Of Anterior Spine Exposures; How To Avoid Them And How To Treat Them If They Occur (7-Minute Presentation)
  Presenter(s):William P. Robinson, MD  
10:25 AM - 10:30 AM EVAR Outside The IFUs Of Commercial Devices Is Sometimes Justified And Does Not Negatively Impact On Midterm Outcomes: When Is This So
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
10:30 AM - 10:35 AM The Aortyx Aortic Patch For Repairing Focal Aortic Defects: How Does It Work And Current Status
  Presenter(s):Vicente Riambau, MD, PhD  
10:35 AM - 10:40 AM Panel Discussion
10:40 AM - 10:45 AM How To Avoid Axillary Artery Complications After Large Sheath Use In Complex AAA Repairs
  Presenter(s):Michael C. Stoner, MD  
10:45 AM - 10:50 AM Late Complications Of F/B/EVAR In An Experience Of >1000 Cases
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
10:50 AM - 10:55 AM With F/EVAR Intraoperative Endoleaks Do No Predict Midterm Failure
  Presenter(s):Michael J. Singh, MD  
10:55 AM - 11:00 AM Left Subclavian Revascularization With TEVAR: Technical Tips And Tools To Make In Situ Fenestration Easy
  Presenter(s):Wayne W. Zhang, MD  
11:00 AM - 11:05 AM Variable Curve Directional Sheaths Will Eliminate The Need For Upper Extremity Access With F/B/EVAR: Which Sheath Is Best And Pitfalls
  Presenter(s):James F. McKinsey, MD  
11:05 AM - 11:10 AM How Can Computer Modeling Help To Improve The Treatment Of TBADs
  Presenter(s):Ross Milner, MD  
11:10 AM - 11:15 AM Panel Discussion
END OF SESSION 105
 
SESSION 106 SCHEDULE
Saturday
SESSION 106: AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
AORTIC TOPICS
11:15 AM - 11:20 AM Options For Managing The Left Subclavian Artery When Performing Endovascular Treatment Of Zone 2 Lesions
  Presenter(s):Edward Y. Woo, MD  
11:20 AM - 11:25 AM Carotid-To-Axillary Bypass Is Better Than Carotid-Subclavian Bypass For Revascularizing Subclavian Arteries With TEVAR: Why And How To Do It
  Presenter(s):Frank J. Criado, MD  
11:25 AM - 11:30 AM When Is A Left Subclavian Chimney Graft Better Than A Carotid-Subclavian Bypass For Preserving Subclavian Artery Flow
  Presenter(s):R. Clement Darling III, MD  
11:30 AM - 11:35 AM Upper Extremity Access For Complex Endo AAA Repairs Is Associated With A High Rate Of Stroke: From A VQI Study
  Presenter(s):Marc L. Schermerhorn, MD  
11:35 AM - 11:40 AM DEBATE: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
11:40 AM - 11:45 AM DEBATE: Not So: Many Failed EVARs Are Best Repaired By Open Conversion
  Presenter(s):Michel Makaroun, MD  
11:45 AM - 11:50 AM AAAs With Large Diameter Necks (>34 mm) Do Poorly With EVAR: How Should Such Patients Be Treated
  Presenter(s):Matt M. Thompson, MD  
11:50 AM - 11:55 AM Value Of 3D Flow Models To Analyze The Cause Of Failure After F/EVAR And TEVAR
  Presenter(s):Maciej L. Dryjski , MD, PhD  
11:55 AM - 12:00 PM Panel Discussion
CAROTID TOPICS
12:00 PM - 12:05 PM Optimal Anticoagulant And Antiplatelet Treatment For Patients With Asymptomatic Carotid Stenosis
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
12:05 PM - 12:10 PM How To Use The Silk Road TCAR Device In The Treatment Of Tandem Carotid Lesions: Technical Tips And Results
  Presenter(s):Michael C. Stoner, MD  
12:10 PM - 12:15 PM Update On Isolated Carotid Webs As A Cause Of Cryptogenic Stroke: How To Diagnose And Treat
  Presenter(s):W. Charles Sternbergh III, MD / Clayton Brinster, MD  
12:15 PM - 12:20 PM Mini-Incision CEA With Standard Or Eversion Techniques: How To Do It Safely: It’s Better Than Transfemoral CAS Or TCAR
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
12:20 PM - 12:25 PM TCAR With Flow Reversal Versus Transcervical CAS With Distal Protection: TCAR’s Benefit Is Not Just Due To Its Avoidance Of Having To Traverse The Aortic Arch
  Presenter(s):Mahmoud B. Malas, MD, MHS  
12:25 PM - 12:30 PM Panel Discussion
End of Program N

The A-V Access Program Continues in the Grand Ballroom West.

END OF SESSION 106
 
SESSION 107 SCHEDULE
Saturday
SESSION 107: IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
x
8:00 AM - 8:05 AM Introduction
  Presenter(s):Anton N. Sidawy, MD, MPH / Larry A. Scher, MD  
8:06 AM - 8:13 AM What Vascular Access Issues Are Important To Patients
  Presenter(s):Dori R. Schatell, MS  
8:14 AM - 8:21 AM Where Should Patients And Physicians Get Information About Hemodialysis Access
  Presenter(s):Ellen D. Dillavou, MD  
8:22 AM - 8:29 AM Kickstarting Your Peritoneal Dialysis Program
  Presenter(s):Sean D. Kalloo, MD  
8:30 AM - 8:37 AM Selecting The Right Access In The Chronically Hypotensive Patient
  Presenter(s):Aisha Shaikh, MD  
8:38 AM - 8:45 AM TBD
8:46 AM - 8:53 AM Cardiovascular Implantable Electronic Devices In Hemodialysis Patients: Prevalence And Strategies For Management
  Presenter(s):Theodore F. Saad, MD  
8:54 AM - 9:04 AM Panel Discussion
9:05 AM - 9:12 AM Body Image, Sexuality And Hemodialysis Access
  Presenter(s):Dori R. Schatell, MS  
9:13 AM - 9:20 AM Wearable Technology For Remote Patient Monitoring During Home Hemodialysis
  Presenter(s):Richard F. Neville, MD  
9:21 AM - 9:28 AM Managing The Pulsatile AV Access: How To Prolong Access Life
  Presenter(s):Surendra Shenoy, MD, PhD  
9:29 AM - 9:36 AM Use Of Drug Eluting Balloons And Stents: What Does The Data Tell Us
  Presenter(s):Theodore F. Saad, MD  
9:37 AM - 9:44 AM LIMA Steal Syndrome After Ipsilateral AV Fistula: Is It Real
  Presenter(s):Jeffrey E. Indes, MD  
9:45 AM - 9:52 AM Early Banding For High Flow AV Fistulas
  Presenter(s):Moro Salifu, MD  
9:53 AM - 10:03 AM Panel Discussion
10:04 AM - 10:25 AM Break – Visit Exhibits And Pavilions (3rd Floor)
END OF SESSION 107
 
SESSION 108 SCHEDULE
Saturday
SESSION 108: MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
x
10:26 AM - 10:33 AM Performance Of Vascular Access Procedures During A Global Pandemic
  Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN  
10:34 AM - 10:41 AM Surgeon’s Perspective On Management Of Acute Kidney Injury During The COVID-19 Pandemic
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
10:42 AM - 10:49 AM How Has COVID-19 Impacted Medicare Reimbursement
  Presenter(s):Evan C. Lipsitz, MD, MBA  
10:50 AM - 10:57 AM Telemedicine For Vascular Access Patients: Preoperative Planning, Postoperative Visits, Access Maintenance
  Presenter(s):Aisha Shaikh, MD  
10:58 AM - 11:05 AM Accelerating Technology Development During A Pandemic To Bring More People With Kidney Failure Home
  Presenter(s):Prabir Roy-Chaudhury, MD, PhD  
11:06 AM - 11:16 AM Panel Discussion
THE USE OF ULTRASOUND IN CONTEMPORARY DIALYSIS ACCESS PRACTICE
Moderator(s): John E. Aruny, MD / Clifford M. Sales, MD, MBA, FACS  
11:17 AM - 11:24 AM Preoperative Vessel Mapping: Did KDOQI Really Make This Optional
  Presenter(s):Charmaine Lok, MD  
11:25 AM - 11:32 AM Economic And Clinical Impact Of Changes In Reimbursement For Predialysis Duplex Planning
  Presenter(s):Jason K. Wagner, MD  
11:33 AM - 11:40 AM Incorporating Point Of Care Ultrasound Into The Practice Of Nephrology
  Presenter(s):Vandana D. Niyyar, MD  
11:41 AM - 11:48 AM Use Of IVUS For Evaluation And Sizing Of Central Vein Stenosis
  Presenter(s):John E. Aruny, MD  
11:49 AM - 11:59 AM Panel Discussion
12:00 PM - 12:50 PM Lunch – 3rd Floor Foyer
Visit Exhibits And Pavilions (3rd Floor)

END OF SESSION 108
 
SESSION 109 SCHEDULE
Saturday
SESSION 109: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7- 10-MINUTE TALKS)
x
12:50 PM - 12:57 PM Creating AV Fistulas For Children In Guatamala
  Presenter(s):William Jennings, MD  
12:58 PM - 1:05 PM How Will Government Initiatives Move Patients From Dialysis Centers To Home Dialysis
  Presenter(s):Sean D. Kalloo, MD  
1:06 PM - 1:13 PM Implementing The Results Of A Randomized Trial Comparing Early Cannulation Grafts To Catheters Into Practice
  Presenter(s):David Kingsmore, Mr, MD, FRCS (Ed), MBChB, BMedBiol  
1:14 PM - 1:24 PM How Artificial Kidneys And Miniaturized Dialysis Could Save Millions Of Lives
  Presenter(s):Buddy D. Ratner, PhD  
1:25 PM - 1:35 PM Keynote Speaker: Health And Human Services Initiatives To Improve Management Of Kidney Disease: A $35 Billion Innovation Black Hole
  Presenter(s):Ed Simcox, JD  
1:36 PM - 1:46 PM Panel Discussion
END OF SESSION 109
 
SESSION 110 SCHEDULE
Saturday
SESSION 110: NEW TECHNOLOGIES FOR AV ACCESS CREATION (7-MINUTE TALKS)
x
1:47 PM - 1:54 PM Use Of External Support Devices To Improve AV Fistula Maturation
  Presenter(s):Ellen D. Dillavou, MD  
1:55 PM - 2:02 PM Use Of Pharmacologic Adjuncts To Improve AV Fistula Maturation
  Presenter(s):Alan Dardik, MD, PhD  
2:03 PM - 2:10 PM DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: EndoAV Fistula Is Better Than Surgery
  Presenter(s):Neghae Mawla, MD, FASDIN  
2:11 PM - 2:18 PM DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: Surgery Is Still The Gold Standard
  Presenter(s):John R. Ross, Sr., MD  
2:19 PM - 2:26 PM Cannulation Issues With Endovascular Fistulas
  Presenter(s):Deborah Brouwer-Maier, RN, CNN  
2:27 PM - 2:37 PM Panel Discussion
END OF SESSION 110
 
SESSION 111 SCHEDULE
Saturday
SESSION 111: UPDATE ON CLINICAL CHALLENGES IN HEMODIAYLSYS (7-MINUTE TALKS)
x
2:38 PM - 2:45 PM Options For Management Of Deep AV Fistulas
  Presenter(s):William Jennings, MD  
2:46 PM - 2:53 PM Surgical Management Of The Mega Fistula
  Presenter(s):John R. Ross, Sr., MD  
2:54 PM - 3:01 PM TBD
3:02 PM - 3:09 PM Why Choose A Biologic Conduit For Hemodialysis Access
  Presenter(s):Matthew J. Dougherty, MD  
3:10 PM - 3:17 PM What Is The Best Option For Cephalic Arch Stenosis
  Presenter(s):Mark G. Davies, MD  
3:18 PM - 3:25 PM Management Of The Abandoned HeRO Device
  Presenter(s):Stephen E. Hohmann, MD  
3:26 PM - 3:33 PM HeRO Graft With ARtegraft Attachment For Hemodialysis Access: What Are The Outcomes
  Presenter(s):Jesse Garcia, MD  
3:34 PM - 3:41 PM Does A High Bifurcation Brachial Artery Affect Outcomes For AV Fistulas And Grafts
  Presenter(s):John S. Futchko, MD  
3:42 PM - 4:00 PM Panel Discussion
End of Program O

END OF SESSION 111